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General overview 
The development of coronary angiography facilitated a complete new assessment 
of coronary circulation in humans, opening a new age in the study and treatment 
of coronary artery disease. A second revolution came from furrher developments 
of cardiac catheterisation that made possible the performance of percutaneous the-
rapeutic procedures in the coronary arteries. During the last: 10 years balloon 
angioplasry has become not only a useful therapeutic tool for clinicians, but also 
as a model of myocardial ischaemia and vessel wall damage for researchers. More 
recendy, the development of new percutaneous intracoronary devices has provided 
new opportunities in the study of the pathophysiology of coronary artery disease. 
The central topic of this thesis is the use of three of these new technologies for the 
investigation of different aspects of the pathobiology of coronary atheroma: direc-
tional coronary amerectomy, a recanalisation technique based on debulking the 
obstructing atheromatous plaque; coronary angioscopy. which can be used percu-
taneously and allows direct visualizacion of luminal changes in the coronary- arte-
ries; and intravascular ultrasound imaging, which provide information on the 
structure of vascular wall and atheromatous plaque. 
The use of directional coronary atherectomy as a research tool in the investigation 
of coronary atherosclerosis constitutes the kernel of the first part of this thesis 
(Chapters 1-6). AtherectOmy specimens represent a form of biopsy from the target 
atheromatous lesion. With the generalisation in the use of this technique, atherec-
tomy samples can be obtained from a variety of coronary syndromes, including 
stable and unstable angina, restenosis post-intervention, and cardiac allograph vas-
culopathy, providing a unique opportuniry for the study of the pathobiology of 
the atheromatous plaque in each of these conditions. In the work presented in 
Chapter I, directional coronary atherectomy was used as a sampling device to 
compare the characteristics of the atheromatous plaques in stable and unstable 
angina pectoris. The histological information collected in-vivo was analysed 
taking into account a number of clinical and angiographic variables. A unique 
characteristic of coronary atheroma obtained with directional atherectomy is that 
it is biologically viable, and the cellular components present can be dedicated to 
cell culture. Chapters 2-5 focus in the use of this technique to study a number of 
aspects on the biology of smooth muscle cells present in the retrieved specimens. 
The topics of research included the relationship between the ability of smooth 
muscle cells to outgrow or colonize the culture environment and the clinical and 
histological substrate of the specimen (Chapter 2), the determination of growth 
characteristics and extracellular matrLx production by smooth muscle cells from 
primary and restenotic atheromatous lesions (Chapter 3), and the reactiviry 
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towards blood platelets of the extracellular matrix synthetised by the cells 
(Chapter 4). The information obtained from atherectomy specimens can be com-
bined with data obtained during patient follow-up, offering the unique opportu-
nity of studying prospectively the relationship between the anatomopathological 
substrate of the lesion and the subsequent restenosis process. This constitutes the 
tOpic of Chapter 5, where information derived from cell culture and histOlogy was 
analysed jointly with clinical and angiographic data collected prospectively. To 
conclude with the first paft of this thesis, Chapter 6 investigates the effect of 
directional atherectomy in patients with cardiac allografc atherosclerosis from the 
twofold angle of the retrieved atheromatous specimens and the treated vessel, Stu-
died at the time of re-trasplantation or during necropsy. 
In the second part of the thesis, coronary angioscopy and intravascular ultrasound 
imaging were used as investigative tools in studying the substrate of acute coro-
nary syndromes (Chapters 7 to 10). The advantages of angioscopy over coronary 
angiography in assessing the nature of coronary stenoses, the problems derived 
from the lack of adequate validation of angioscopic observations, and the limita-
tions dictated by the state-of-the-art angioscopic equipment are discussed briefly 
in Chapter 7. Chapter 9 repofts on the angioscopic findings in patients with uns-
table angina refractory to medical treatment, and on the comparison of visual fin-
dings with histological information obtained in a number of atherectomy speci-
mens retrieved in the same study population. Chapters 8 and 10 explores the fea-
sibility of studying simultaneously the characteristics of the lumen and the struc-
ture of the arterial wall of unstable patients using combined angioscopy and intra-
vascular ultrasound imaging. Finally, in Chapter 11 the relationship between the 
computerised detection and analysis of coronary stenoses by quantitative angio-
graphy and the underlying degree of atherosclerotic disease, as judged from intra-
vascular ultrasound imaging, is investigated. 
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Part I 
Directional Atherectomy as a 
Research Tool in the Study of the 
Pathobiology of Human 
Coronary Atheroma 

Chapter I 
Histological Characteristics of 
Tissue Excised During Directional 
Coronary Atherectomy in Stable and 
Unstable Angina Pectoris 
Javier Escaned MD, Robert J. van Suylen* MD, Donald C. MacLeod MB 
ChB MRCP, Victor A. Umans MD, Marcel de Jong BEng, Fre T. Bosman* 
MD PhD, Pim J. de Feyrer MD PhD, and 
Patrick W Serruys, MD PhD. 
From rhe Catheterization Laboratory,Thoraxcenter, and Department of 
Parhology*, Erasmus University, Rotterdam, The Nerherlands 
Reprinted with permission from American Journal of Cardiology, 1993; 
71:1442-47. 
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Abstract 
Background 
The collection and analysis of tissue removed during coronary atherectomy has the considerable advan-
tage of allowing the pathologic assessment of coronary arlery disease "in-vivo-~ thus avoiding the selec-
tion bios inherent to post-mortem studies. 
Aim of the study 
To compare the histopathologic characteristics of atherectomy specimens retrieved in patients with sta-
ble (SAP) and unstable (UAP) angina pectoris undergoingpercutaneous coronary recanalisation. 
Methods 
Tissue samples were obtained from 93 atherectomy procedures performed in 48 SAP (52%) and 45 
UAP (48%) patients. Primary and restenotic lesions were included. Clinical variables considered were 
age, sex, previous myocardial infarction, previous coronary intervention, and coronary risk foctors. 
The presence of neointimal hyperplasia (NH), fibrous tissue, cholesterol crystal clefts, necrotic debris, 
calcium deposits, macro phages, thrombus, media or adventitia was recorded. 
Results 
Several differences were noted in both syndromes: First, thrombus showing variable degrees of organi-
sation was found more frequently in patients with UAP than with SAP (10145, 22%, versus 1/48, 
2%, respectively, p = 0.007). The presence of thrombus in UAP bore no relationship to the angiograp-
hie stenosis morphology. Second, calcium deposits were more frequent in UAP than in SAP (18145, 
48% versus 9148, 33% respectively, p = 0.042). The presence of NH correlated strongly with previous 
coronary interventions (17124 restenotic vs 14169 primary lesions, p=O.OOOI), and showed similar 
characteristics irrespective of the technique (balloon or laser angioplasey, directional atherectomy and 
stenting). In primary lesions, the presence of NH bore no relation with SAP or UAP but was observed 
in younger patients (5I±I2 versus 59±IO years respectively, p=0.OI7). 
Conclusions 
These observations provide forther insight into the histopathological substrate of SAP and UAP and 
reemphasise the potential of directional atherectomy in the study of coronary syndromes. 
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Illtroduction 
Unstable angina is an acute coronary syndrome associated with substantial short 
and medium term morbidity and mortality.' The understanding of the pathogene-
sis of this syndrome has been based largely on post-mortem srudies of coronary 
arterieS=: and supported by indirect evidence of coronary thrombosis in relation to 
the syndrome.3.5 Since directional coronary atherectomy is unique in extracting 
intact atheromatous (issue during coronary recanalisation, it may facilitate the 
srudy of the processes taking place in the vessel in different coronary syndromes. 
In the present srudy the histopathological characteristics of atherectomy samples 
retrieved in 93 patients with stable or unstable angina pectoris were compared and 
related to different clinical variables. 
Methods 
We studied 93 patients who underwent directional coronary atherectomy provi-
ding histological material at the Thoraxcenter during the period 1989-1992. 
Following the coronary atherectomy protOcol approved by the Thoraxcenter 
Institutional Review Board, informed consent was obtained in all patients prior to 
intervention. Directional coronary atherectomy was performed using the femoral 
approach. An average of 6±3 passes in multiple directions were performed across 
the stenosis. 
Clinical variables 
Clinical variables recorded included age, sex, previous myocardial infarction, 
current stable or unstable angina pectoris, previous coronary intervention and risk 
factors for coronary artery disease (history of hypercholesterolaemia, non-insulin 
dependent diabetes mellitus, cigarene smoking, hypertension and family coronary 
artery disease). Primary unstable angina was defined as continuous or intermittent 
chest pain at rest requiring hospitalisation, associated with electrocardiographic 
evidence of myocardial ischaemia but without associated increase in the cardiac 
enzymes. The time interval between the onset of chest pain and the atherecromy 
procedure was 7±5 days. 
Histological analysis of the specimens 
The obtained specimens were fixed in 100/0 formalin. Routine processing for light 
microscopy and haematoxylin-azophloxin and Verhoeff-van Giesson staining was 
performed. All specimens were reviewed by two independent observers who were 
blinded to the clinical data. The recommendations layed out in the American 
Heart Association Medical/Scientific Statement on the Definition of the Intima of 
Human Arteries and of its Atherosclerosis-Prone Regions6 were followed in collec-
ting information regarding intimal constituents. Medial tissue was identified on 
the basis of parallel arrangement of smooth muscle cells, embeded in collagen and 
frequently associated with a fragment of the internal or external elastic lamina. 
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Adventitia was recognised by the the presence of coarse bundles of dense collagen 
intermingled with elastin fibers, sometimes in association with fragments of the 
external elastic lamina and media. Fibrous tissue was classified as dense when 
composed of acellular or poorly cellular connective tissue formed predominanrly 
by dense collagen, and classified as loose when the rissue fragments showed a 
moderate cellularity and collagen bundles separated by accumulations of extrace-
llular matrix. Neointimal hyperplasia was defined as fibromuscular connective tis-
sue showing a random orientation of spindle shaped and stellate cells embedded 
in abundant extracellular matrix. Cholesterol ctyStal clefts, necrotic debris and cal-
cium deposits were recorded independently. No special staining was used to iden-
tified calcium. The presence of macrophages was recorded only when rhese for-
med clusters or when they were present in unusually high number. Thrombus 
and! or intraplaque hemorrhage were identified as amorphous material, in close 
apposition with atheromatous material, frequently showing collections of leucocy-
tes between layers of fibrin. Areas consisting mainly of fibrin and not clearly rela-
ted ro the plaque that could have formed during rhe procedure were not recorded. 
The Verhoef-van Giesson staining was used to discriminate between fibrin and 
dense collagen. Organisation was judged when infiltration by cellular elements, 
e.g. smooth muscle cells, fibroblasts, capillary sprouts, was observed, and graded 
from I to IlIon the basis of the number and characteristics of infiltrating cellular 
elements. 
Angiographic morphology 
In the 43 patients with unstable angina lesion morphology was classified accor-
ding to the criteria proposed by Ambrose et al.' by two independent cardiologists 
blinded to the result of the histopathological srudies. Complex lesion morphology 
was recorded when eccentric lesions with overhanging or ragged edges, or lesions 
with multiple irregularies were noted. In case of disagreement, the opinion of a 
third cardiologist was taken into account. 
Statistical analysis 
Mean values and standard deviations are presented for continuous variables. 
Comparison of mean values was performed using two-tailed unpaired Srudent's t-
tests. Discrete variables were compared using chi-square tests, and Yates' conti-
nuity correction applied when indicated. Statistical significance was accepted at 
the 5 % leveL 
Results 
No significant differences were found between clinical characteristics of both 
groups, with the exception of a higher prevalence of previous myocardial infarc-
tion in the unstable group (13/48,27%, versus 21/45, 47%, in stable and unsta-
ble patients respectively, p = 0.05). Several associations between clinical variables 
were observed in the patient population. The mean age of male patients was signi-
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Table I. Characteristics of the study population 
Stable Unstable p 
Clinical variables 
Age (years, mean±SD) 57 .89±1 0 .38 56.84±10.85 NS 
Previous myocardial infarction 13/48 (27%) 21/45 (47%) 0.05 
Male sex 39/48 (81 %) 37/45 (82%) NS 
Serum cholesterol ~ 8 mmol/L 3/48 (6%) 3/45 (7%) NS 
Diabetes mellitus 1148 (2%) 
Systemic hypertension 12/48 (25%) 10/45 (22%) NS 
Cigarrete smoking 18/48 (37%) 16/45 (36%) NS 
Family history coronary disease 6/48 (12%) 9/45 (20%) NS 
Previous coronary intervention 13/48 (27%) 11145 (24%) NS 
Angina class (NYHA) II :22, III : 26 III:3,IV:42 
Histological variables 
Dense fibrous tissue 40/48 (83%) 39/45 (86%) NS 
Loose fibrous tissue 12/48 (25%) 5/45 (11 %) NS 
Neointimal hyperplasia 14/48 (29%) 17/45 (38%) NS 
Cholesterol clefts 4/48 (8%) 4/45 (9%) NS 
Necrotic debris 3/48 (6%) 6/45 (13%) NS 
Calcium deposits 9/48 (19%) 18/45 (40%) 0.042 
Thrombus 1148 (2%) 10/45 (22%) 0.007 
Macrophages 6/48 (12%) 9/45 (20%) NS 
NYHA = New York Heart Association 
ficantly lower than that of females (56±10 vs 64±11 years respectively. p = 0.004). 
Patients with hypercholesterolemia frequently belonged to families with a history 
of coronary anery disease (67% vs 13% in other patients, p = 0.003). Twenty four 
patients had a previous history of coronary intervention, including 14 balloon 
angioplasties, 6 stent implantations, 3 amereCtOIDY procedures and 1 excimer laser 
angioplasty. The mean time interval between previous intervention a.."1d atherec-
tomy was 147±108 days. 
Prevalence and characteristics of thrombus in the retrived specimens 
The most striking difference between the syndromes was the presence of foci of 
thrombus or intraplaque hemorrhage in 10 of 45 (22%) unstable and only in 1 of 
48 (2%) stable patients (p = 0.007). Only one of these patients had had a previous 
coronary intervention. All the samples showed some degree of cellular organisa-
tion, including the presence of endothelial cells covering newly formed channels 
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Figure :1 
Thrombotic milterial in atherectomy specimensftom patimts with unstable angina showing different 
stages of organisation. A: Early organisation 5 days after the onset of angina at rest, showing lacunar 
spaces (arrow~) in the thrombotic bulk that are partially covered by endothelia! cells (con finned by positive 
staining with lectin immunochemistry using Ulex europeus). B: Large area of thrombus (T) 7 days after 
the onset of angina at rest in clog association to newly fimned fibromuscular tissue (FT) and showing 
partial infiltration by myofibroblasts. Fragments of external elastic lamina (EEL)(arrow) and media arc 
evident, indicating that deep vessel reJection ocurred during athercctomy. C and D: Advanced thrombus 
organisation by fibromuscular tissue 2 days after the onset 0/ angina at rest. Although virtu.al 
incorporation to the vessel wall hIlS taken place it is possible to identifY strands o/thrombotic materia! 
surrounded by connective tissue (D). A. C and D: Hematoxylin-ilZIJphloxin: B: Verhoeffvan Giesson 
(original magnification: A, x60; Band C x30; and D, x125J. 
or capillary vessels present in thrombotic mass originating from the surrounding 
tissue, the appearance of smooth muscle cells or myofibroblasts, and the presence 
of thrombotic material embeded in fibrocellular tissue, the latter characteristic sug-
gesting that the areas of fibrin and platelets derived from an episode of thrombosis 
or plaque hemorrhage was being integrated in the atheromatOus plaque (Fig. 1). 
Thrombus was apposed to fibrous tissue in all cases, without endothelial cells in 
the interface between both. A lack of relation between the interval between the 
onset of angina at rest and thrombotic organisation was evident. Likewise, the 
relation between angiographic morphology and the presence of thrombus in the 
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retrieved tissue did not reach statistical significance. Comple..;;: angiographic morp-
hology was noted in 17 of 45 (37%) unstable patients (Fig. 2). Thrombus or pla-
que hemorrhage was ptesent in 6 (35%) of these cases, and in 4 (14%) of those 
with non-complex angiographic morphology (p=NS). 
Calcium deposits were also observed more frequently in patients with unstable (18 
of 45 samples, 67%) than stable angina (9 of 39 samples, 33%) (p = 0.024). No 
significant differences were found with regard co the presence of fibrous tissue, 
cholesterol clefts, necrotic core or clusters of macrophages. In the overall popula-
tion complex atheromatous samples (containing dense fibrous tissue, calcium 
deposits and necrotic debris) were obtained in older patients (58±10 vs 51±12 
years, p < 0.031). Necrotic debris was observed in 7 of 34 cigarene smokers 
(21 %) versus 2 of 59 (4%) non-smokers (p=O.019). Macrophages were identified 
in 4 of 15 (27%) and 5 of78 (6%) samples with and without necrotic debris, res-
pectively (p = 0.05). 
Prevalence neo;ntimai hyperplasia in the retrived specimens 
Neointimal hyperplasia was observed in 17 of 24 (71 %) patients with previous 
coronary intervention and in 14 of 69 (20%) patients with primary lesions (p = 
0.0001). Neointimal hyperplasia had identical characteristics in patients with pre-
vious balloon angioplasry, stenting, atherecromy or laser angioplasty. Particular 
attention was paid to the 14 cases with primary lesions showing typical neointimal 
hyperplasia. When compared to other primary lesions, no relationship with the 
type of coronary syndrome was observed: 6 patients had stable and 8 unstable 
angina pectoris (p=NS). Likewise, no association with sex, coronary artery disease 
rnsk factors or previous myocardial infarction was found. However, the mean age 
of patients with primary lesions showing neointimal hyperplasia was significantly 
lower than that of patients with primary lesions and other histological characteris-
tics (51 ±13 versus 59±10 years respectively, p = 0.017). 
DisclJlssion 
The retrieval of atheromatous material during directional coronary atherectOmy 
has created new possibilities in the study of coronary syndromes. Although limi-
ted by lesion selection and sampling characteristics, ~ the collection and analysis of 
the removed tissue has the considerable advantage of allowing the pathologic 
assessment of coronary artery disease "in-vivo", thus avoiding the selection bias 
inherent to post-mortem studies. To OUf knowledge, the present work represents 
the first comparative study of the histopathological subtrate of t'VIi"O different coro-
nary syndromes using atherectomy retrieved material. 
Primary unstable angina is considered to be an acute thrombotic syndrome~·5 
occurring predominantly in patients with widespread coronary artery disease.') 
Coronary thrombosis does not result initially in transmural myocardial necrosis 
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because of incomplete, episodic vessel obstruction, intermittent spontaneous ves-
sel recanalisation, or the presence of well developed collateral anastomoses. 3 .. , 
Different observations suggest that the associated mural thrombus is very rich in 
platelet aggregates and shows a layered appearence. ~ 
In the present study a higher prevalence of mural thrombus and/or plaque 
hemorrhage in unstable angina was also observed: thrombus was identified in 
atherectomy samples obtained from the ischaemia-related coronary lesion of 22% 
of unstable and in only 2% of stable patients. This figure is lower than the preva-
lence of thrombus suspected in angiographic studies} but similar to that reported 
in a necropsy study of patients with unstable angina.9 It is remarkable that no sta-
distical relation bervveen complex angiographic morphology and presence of 
thrombus in the tissue retrieved could be found, although several e.xplanations can 
be given for this. The persistence of complex angiograpic morphology in the long-
term has been reported in 57% of cases by Haft et al." A complex angiographic 
morphology may also result from multiluminal channels that are frequent in athe-
romatous plaques of unstable patients" (Fig. 3D). Unstable angina may also result 
Figure 2 
Compftx angiographic rtrorphohy in 4 patients with unstable angina and fmtological evidence ofcoronary thrombosis. 
Figures A-D show complex eccentric lesions with overhanging edges (arrows). 
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from changes in plaque geometry secondary to intraplaque hemorrhage, which 
may be difficult [Q diferentiate from mural thrombus during the study of isolated 
fragments of the artetial wall. 
An interesting finding is that all samples containing thrombus or intraplaque 
hemorrhage material showed different degrees of cellular organisation which, on 
the grounds of the time scale of thrombus organisation observed in experimental 
models, I~ bore no relationship to the time interval between the onset of chest pain 
and atherectomy. This may suggest that the onset of coronary thrombosis or pla-
que hemorrhage had pteceeded by several days or weeks the development of angi-
na at rest. The retrieved organising thrombus might thus correspond to either an 
episode of plaque hemorrhage or to a first episode of subocclusive thrombosis that 
after episodic growth or rethrombosis led to the development of symptoms' (Fig. 3A). 
The absence of fresh thrombus in these samples could be due to spontaneous lysis 
and inhibition of further thrombosis by continued systemic heparinisation (Fig. 3B) or 
embolisacion of that labile fraction of thrombus during catheter manipulation 
(Fig.3C). 
These observations may have implications for therapeutic and diagnostic approa-
ches in unstable patients. The low prevalence of thrombus observed and the 
degree of organisation and! or embedment of thrombus in the atheromatous pla-
que may explain the therapeutic failure of thrombolytic agents in primary unsta-
ble angina. 13.H It might be also important to elucidate whether some of the angios-
copic characteristics of coronary thrombus observed in unstable patients, such as 
the characteristic greyish appearance reported by Mizuno et al.,:> could be related 
no only to platelet-rich but also to organising characteristics of thrombus, since it 
is well known that the macroscopic appearance and colour of thrombus shifts pro-
gressively towards a pale, whitish color as organisation increases. I) 
The cause of the initial event in the development of mural thrombosis. plaque 
rupture or fissuring, remains controversial. In this study macrophages, which have 
been identified in areas of u~e fibrous cap that area prone to rupture,I(, were not 
observed preferentially in unstable plaques but preferentially in plaques with 
necrotic core. Only fibrous tissue was found in close association with thrombus, 
an observation that may be relevant to the kind of initiating thrombogenic stimu-
li. Although no endothelium could be identified in the atea covered by thrombus. 
no firm conclusions can be drawn from this as experimental studies have shown 
that endothelial cells are rarely observed 3 days after being engulfed by mural 
thrombosis. 1~ 
The higher prevalence of calcium deposits in unstable plaques may be telated [Q 
the frequent existence of severe and widespread coronary artery disease in unstable 
patients. I I A proportional relation between complex atheroma and age was also 
evident in the overall study population, in agreement with the current knowledge 
on the sequence of events leading to the progression of coronary artery disease. 1-
-~ 22-~ 
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Figure 3 
Organised 
thrombus 
Fresher 
thrombus 
Fresh thrombus embolisation 
byotherocatheter 
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D 
Lysed area of 
fresh thrombus 
\ 
Multiluminal 
channels 
\ 
Persistent complex 
morphology 
Mural thrombosis in unstable angina and histological findings in athereaomy specimens. A: Episodic 
thrombus growth has been proposed as it characteristic feature of unstable angina. yielding areas of 
different degree of organisation. Fresher areas of thrombus may have been missed in atherectomy specimens 
due to spontaneous lysis and concommitant treatm.ent with inrravenOlb' heparin (B) or by dislat{tz.ement 
and embolization of the more labile fraction o/thrombus by the atherocatheter (C). In some cases, 
complex angiographic morphology rmzy have resuued ftom persisting irregularities or muLtiluminal 
channels in relAtion to the recanalisation of prior epiodes of plaque ulceration (D) 
Our results also suppOrt previous observations in coronary atherecromy specimens sho-
wing that neointimal hyperplasia constitutes the pathological subtrate of restenosis after 
coronary intervention,18 irrespectivciy of the revascularisation technique used previously. 
Typical atherosclerotic tissue was also retrieved in a substantial number of restenoric 
lesions, although this is probably due to the sampling characteristics of the device or in 
circumstances where resrenosis was due to other mechanisms than neoinrimal hyperpla-
sia.' In accordance with a previous study," neointimal hyperplasia was also found in a 
substantial number of primary lesions. We noted thar these patients were significantly 
younger than othets with typical primary atherosclerotic lesions, a fact that may have 
panicular relevance since fibromuscular neointimal proliferation has been reported as 
the pathological substrate for coronary artery disease in the young resulting in sudden 
death.'" The ultimate meaning of this observation as to the natural history of atheroscle-
rosis remains unclear. Neoinrimal hyperplasia represents an unspecific vessel wall res-
ponse to different kinds of injury that lead to accelerated forms of atherosclerosis. 
Whether the presence of this type of tissue in primary lesions of young, symptomatic 
patients is a reflection of less-known facrors initiating the atherosclerotic process (e.g. 
viral endothelial injury, generical predisposirion) remains hypothetical. 
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Histological studies based on atherectomy specimens are biassed by selective pla-
que sampling,8 although in the present study this limitation was partially overco-
me by routinely performing multiple cuts in different sectors of the vessel. Case 
selection may have occurred since only vessels judged suitable for the technique 
were intervened (e.g., coronary atherectomy was performed in only 1 patient with 
total occlusion). The differenciation between mural thrombosis and foci of plaque 
hemorrhage is strongly limited by the analysis of isolated fragments of atheroma. 
Atherectomy was performed in stenoses that were identified on the grounds of cli-
nical, angiographic and electrocardiographic data as ischaemia related stenoses. 
However, this "culprit lesion" approach may have not been free from a number of 
confounding factors, including the persistence of complex angiographic morpho-
logy from a previous event'" (Fig. 3D), and the clevelopment of myocardial ischae-
mia "at a distance" by a different coronary narrowing. 
In spite of these limitations, the results of the present study emphasise the use of 
directional coronary atherectomy as a means of investigation during its therapeu-
tic use. The identification of such features as an increased prevalence of organised 
thrombus in patients presenting with unstable angina, and of neointimal hyper-
plasia in primary coronary lesions of younger patients contributes further to our 
knowledge of the processes that take place in the coronary arteries during the 
natural history of coronary syndromes. 
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Abstract 
Background 
Coronary atherectomy provides a unique opportunity to obtain plaque tissue from a 
wide variety of clinical syndromes. We investigated the relationship between the clini-
cal and histopathological substrate of tissue retrieved during directional coronary athe-
rectomy and the proliferative and migratory potential of smooth muscle cells as judged 
from successful outgrowth during cell culture. 
Methods 
Following directional coronary atherectomy tissue samples were examined macroscopi-
cally, divided in two equal pieces and separately subjected to cell culture and histopat-
hological study. Cell culture was performed using an explant technique. In-vitro smo-
oth muscle cell outgrowth was related to clinical (age, sex, coronary syndrome, previous 
MI, previous intervention, risk foaors) and histological variables (presence of neointi-
mal hyperplasia, conneaive tissue, cholesterol clefts, necrotic debris, calcium deposits, 
macrophage;; thrombus, internal elastic lamina, media or adventitia). 
Results 
Atherosclerotic tissue was obtained from 98 consecutive atherectomy procedures. 
Histological examination revealed a broad spectrum of appearances rangingfTom com-
plex plaque containing dense fibrous tissue, calcium deposits, macro phages and necrotic 
debris to neointimal proliferation and organised thrombus. Smooth muscle cell out-
growth was observed in 43 of98 samples (44%). Cell outgrowth was not influenced 
by any of the clinical variables. It was influenced however by histological variables and 
in particular the presence of organizing thrombus. Smooth muscle cell outgrowth was 
successfol in 8 of 10 samples with (80%) and only 35 of88 (40%) without thrombus 
(p = 0.03). 
Conclusion 
The presence of organizing thrombus in the retrieved tissue facilitates smooth muscle 
cell outgrowth and suggests an enhanced proliferative and migratory potential. These 
findings may be relevant to the understanding of neointimal proliferation in coronary 
syndromes where mural thrombosis is likely to occur. 
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Introduction 
Smooth muscle cell proliferation plays a key role in the development of typical 
and accelerated forms of atherosclerosis.' Cell culture of those present in athero-
matous tissue retrieved during directional coronary arherectomy allows us to study 
smooth muscle cells from the pathological substrate of a variety of human coro-
nary syndromes. In studying the pathobiology of coronary atheroma, the use of 
coronary atherectomy specimens for cell culture offers several distinct methodolo-
gical advantages over other sources of atheromatous material, such as that obtai-
ned during peripheral atherectomy, carotid endarterectomy or animal models of 
atherosclerosis. Vascular smooth muscle cells are embryologically derived from 
local mesoderm,'" and those found in the coronary arteries are likely to have bio-
logical differences with those located in other vessels. Likewise, the development 
of the atheromatous plaque is strongly influenced by local factors' that may 
influence cell populations, extracellular matrix composition and plaque architec-
ture. The use of human coronary material makes also possible to avoid some of 
the pirf.llls associated with the use of animal models of atherosclerosis.'''' 
Even cell culture studies using human coronary smooth muscle cells however suf-
fer with some technical limitations. Once in culture these cells undergo a progres-
sive phenotypic modulation that is time dependent and enhanced by successive 
cell passages.'" This process may facilitate the selection of cell clones with a higher 
proliferating capacity. Furthermore, although isolated cell studies provide infor-
mation regarding cellular function and pathopysiological conditions, their e.'<:tra-
polation to the clinical situation is limited because they ignore the complex cell-
cell and cell-extracellular matrix interactions which modulate smooth muscle cell 
growth in vivo. tO 
To minimise these limitations in the present study we have used an e.'<:plant cultu-
re technique! LJ2 to maintain a representative section of the atherosclerotic plaque 
in culture medium, thus retaining the intrinsic distribution and anatomical rela-
tionships of the panicipating cells, cell-cell interactions, the correct chemical con-
figuration of the extracellular matrix, and the general in' vivo millieu of the athe-
rosclerotic plaque. Only coronary material was used. The initial outgrowth of 
smooth muscle cells was then used as a surrogate index for their in-vivo migratory 
and proliferative potential while still under the influence of other histological and 
humoral variables that were present in the atheromatous plaque at the time of 
atherectomy. 
Methods 
Procedural 
Percutaneous directional coronary atherectomy was performed on 98 lesions in 98 
patients. Informed consent was obtained from all patients prior to the procedure 
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according the protOcol approved by the Thoraxcenter Institutional Review Board. 
Atherectomy was performed using the Simpson's Atherocath and a conventional 
technique. 13 Multiple cuts in different sectors of the vessel were routinely perfor-
med. Under sterile conditions, the specimens were removed from the housing of 
the atherocatheter, washed with 0.9% saline and placed in MI99 Hepes buffered 
culture medium (GIBCO LaboratOries) with antibiotics (penicillin 100 IU/ml 
and streptOmycin 0.1 mg/ml). They were immediately transferred to the labora-
tOry where they were flushed with fresh culture medium and examined with the 
help of a dissecting microscope. A representative section was then fIxed in 3.60/0 
buffered formalin for histOpathological examination and the remainder placed in 
culture. 
Clinical variables 
For each patient a number of clinical variables were recorded. These included age, 
sex, previous myocardial infarction, stable or unstable angina pectoris, previous 
coronary intervention and risk factors for coronary artery disease (hypercholeste-
rolaemia, diabetes mellitus, cigarette smoking, hypenension and family history of 
coronary artery disease). Unstable angina was defined as continuous or intermit-
tent chest pain at rest requiring hospitalisation, associated with electrocardiograp-
hic evidence of myocardial ischaemia and no increase in cardiac enzymes. 
Tissue analysis 
Specimens for histopathological study were routinely processed for light micros-
copy and stained with Haematoqlin-azophloxin and Verhoeff-van Giesson. All 
specimens were reviewed independently by two observers, blinded to the clinical 
data. In case of disagreement the opinion of a third pathologist was sought and 
consensus agreement reached. For the analysis of intimal constituents the recom-
mendations of the AHA Medical/Scientific statement on the definitions of the 
intima of human arteries and of its arherosclerosis-prone regions were followed. I~ 
Fibrous tissue was classified as dense when composed of acellular or poorly cellular 
connective tissue formed predominantly by dense collagen, and loose when the 
tissue fragments showed a moderate cellularity and collagen bundles separated by 
accumulations of extracellular matrix. Fibromuscular hyperplasia was defined as 
fibrous connective tissue showing a random orientation of spindle shaped and ste-
llate cells embedded in abundant extracellular matrix. Thrombus was identified as 
amorphous material, often in close apposition with atheromatous material, fre-
quendy showing collections of leucocyres bervveen layers of fibrin. Discrimination 
between fibrin and dense collagen was performed using Verhoeff-van Giesson Stai-
ning. The thrombus was regarded as organizing when infiltration by cellular ele-
ments such as smooth muscle cells or fibroblasts was observed. Cholesterol cryStal 
clefrs, necrotic debris and calcium deposits were recorded independently. The pre-
sence of macro phages was recorded only when these formed clusters or when they 
were present in unusually high number. Medial tissue was identified on the basis 
of parallel arrangement of smooth muscle cells, embedded in collagen and fre-
quently associated with a fragment of the internal or external elastic lamina. 
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figure 1 
Fragment 01 
retrieved tissue after 
12 days in culture 
examined with 
phase-contrast 
microscopy. A dense 
population of cells 
migrating out of the 
athereclomy explant 
are evident. These 
eel/' fulfill the 
morphological 
criteria of 
myofibroblasts 
discussed in detail in 
the u'Xt. (Original 
magnification: x60). 
Adventitia was recognised by the presence of coarse bundles of dense collagen 
intermingled with elastin fibers, sometimes in association with fragments of the 
external elastic lamina and media. 
Cell culture 
The atheromatous tissue was cultuted by a cell biologist (MdJ) blinded to clinical 
data. An explant technique was used. Tissue explants were placed on human fibro-
nectin coated (IO J.Ig/cm') glass cover slips in 2 cm' wells (Four well plates, Nunc) 
and cultured in 3001-11 culture medium (M199 with NaHCO, (GIBCO 
Laboratories) supplemented with glutamine, 10% human serum, 10% fetal calf 
serum, penicillin 100 IU/ml, streptomycin 0.1 mg/ml and mLxed in a ratio of 1:1 
with conditioned medium from established smooth muscle cell lines actively gro-
wing in OUf laboratory). Cultures were maintained in a CO:: incubator at 37°C in 
a humidified atmosphere equilibrated with 5% (v/v) CO, in air. The culture 
medium was changed every 3-4 days. Smooth muscle cell outgrowth was identi-
fied using invened light microscopy and morphological criteria. These included a 
characteristic growth pattern of multiple layers of spindle or stellar shaped cells 
showing stress fibers and lamellipodia (Fig. 1). These morphological criteria were 
reinforced by positive immunostaining against smooth muscle cell (X-actin 
(DAKO, Denmark) with human skin fibroblasts as negative controls. 
Statistical analysis 
Mean values and standard deviations were calculated for all continuous variables. 
Comparison of mean values was performed using two-tailed unpaired t-test. 
Discrete variables were compared using chi-square test, and continuity correction 
applied when indicated. A p value of < 0.05 was considered significant. 
Results 
Clinical 
Of the 98 patients in the study 49 presented with stable and 47 with unstable 
angina pectoris. The remaining 2 were post-cardiac transplantation patients with 
cardiac allograph vasculopathy (Table 1). Twenty four of the patients had a pre-
vious histoty of coronary intervention (14 balloon angioplasty, 6 stent implanta-
tion, 3 atherecromy procedures and 1 excimer laser angioplasty) and had resteno-
sis at the site of previous intervention. The mean time interval berw-een the pre-
vious revascularisation procedure and the atherectomy was 147±108 days. The 
target lesion was located in the lett anterior descending coronary artery in 62 
cases, in the circumflex in 12, in the right coronary in 20 and in saphenous vein 
grafts in 4 cases. An average of 6 ± 3 passes in multiple directions were made 
across each lesion. 
In the study population there was a history of hypercholesterolaemia (serum cho-
lesterol:2: 8 mmol/cU) in 7 patients, systemic hypertension in 27, smoking in 36 
and a family history of coronary artery disease in 18. There were no patients with 
a history diabetes mellitus. None of these risk factors appeared to influence smo-
oth muscle cell outgrowth (Table 1). Likewise, none of the other clinical variables 
discussed above could be related with enhanced cell outgrowth. 
Histological 
Thrombus was present in 10 of the 97 sections examined, predominantly in uns-
table angina patients (9/49 (19%), versus 1149 (2%) stable patients, p = 0.019). 
Some degree of organization was present in all thrombotic specimens examined 
(Fig. 2). This ranged from the presence of endothelial-like cells in lacunar spaces 
or capillaries and the presence of scarce myofibroblasts infiltrating the thrombotic 
mass from the adjacent fibrous tissue to infiltration by high numbers of myofibro-
blasts with the production of extracellular matrix. The thrombotic material appea-
red to be embedded in the fibrocellular tissue suggesting that areas of fibrin and 
platelets derived from an episode of thrombosis or plaque haemorrhage was being 
integrated intO the atheromatous plaque. In 4 cases this process was seen in con-
junction with extensive fibromuscular proliferation. 
Neointimal hyperplasia was observed in 31 samples, predominantly in restenotic 
(17/24,71%) rather than de novo (14/69,20%) lesions (p=O.OOOl). In 7 cases 
(22%) a neovascularisation network was found in the interphase between neointi-
mal hyperplasia and surrounding fibrous dense or loose fibrous tissue (4 in pri-
mary and 3 in restenotic lesions). In secondary lesions neointimal proliferation 
had identical characteristics irrespective of the nature of the previous intervention. 
Dense and loose fibrous tissue was found in 79 and 17 samples respectively. 
Calcium deposits were observed in 27 samples. Macrophages were identified in 15 
samples, predominantly in those with necrotic debris. Media and adventitia was 
found in 23 (23%) and 7 (7%) specimens respectively. 
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Smooth muscle cell outgrowth 
Depending on the volume of the retrieved tissue an average of 4.5 fragments 
(range 2-8), each measuring approximately 1 mm', were placed in culture. Cells 
started to grow out from explants by 4-14 days (Fig. 3) reaching a steady state by 
4-6 weeks. If no outgrowth was observed by 3-4 weeks the samples were discar-
ded. Despite the use of antibiotics in the culture medium six of the cultured speci-
mens developed infections and were discarded. The infections tended to develop 
at 3 to 4 weeks by which time cell outgrowth should have occurred. In none of 
these specimens had it done so however. 
Primary cell outgrowth was observed in 43 of 98 samples (44%). Under light 
microscopy when primary outgrowth occurred the majority of cells tended to 
form multiple layers and had a spindle or polygonal shape with multiple stress 
Table I. Clinical variables and outcome of smooth muscle cell culture 
Successful Failed p value 
Clinical 
Age (years, mean±SD) 57±10 57±11 NS 
Previous MI 14/43 21155 NS 
Syndrome 
-Stable angina 20/49 (41 %) 29/49 (59%) NS 
-Unstable angina 23/47 (49%) 24/47 (51%) NS 
-Transplant vasculopathy 0/2 2/2 
Risk factors CAD: 
-Male sex 34/43 (79%) 46/55 (83%) NS 
-Hypercholesterolemia 3/39 (8%) 4/59 (8%) NS 
-Hypertension 10/40 (25%) 17/58 (29%) NS 
-Smolcing 17/42 (40%) 19/56 (34%) NS 
-Family history CAD 8/43 (19%) 10/55 (18%) NS 
Previous intervention 11143 (26%) 13/55 (24%) NS 
Histological 
Neoimimal hyperplasia 14/30 (46%) 29/68 (43%) NS 
Thrombus (organizing) 8/10 (80%) 35/88 (40%) 0.03 
Dense fibrous tissue 32/79 (40%) 11119 (57%) NS 
Loose fibrous tissue 10/16 (62%) 33/82 (40%) NS 
Cholesterol clefts 4/8 (50%) 39/90 (43%) NS 
Calcium deposits 13/27 (48%) 30/71 (420/0) NS 
Nechrotic debris 6/9 (67%) 37/89 (46%) NS 
Macrophage clusters 7/15 (47%) 36/83 (43%) NS 
Media 11/23 (48%) 32/75 (43%) NS 
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Figure 2 
Histological cross section showing thrombus partia/& infiltrated by myofibroblasu (arrows) in cwse 
association with newly formed fibromuscular tissue (PM). (Origina! magnification: ;00). 
fibers e..xtending to lamellipodia. These light microscopic appearances afe charac-
teristic of smooth muscle cells. The cells were confirmed to be smooth muscle 
cells by positive staining on immunocytochemistry with monoclonal antibody to 
<x-actin. In addition to smooth muscle cells a second cell type oval in shape, with 
eccentrically placed small, indented nuclei was identified in 6 cultures. 
Immunoperoxidase staining with macrophage specific HAM 56 confirmed these 
cells to be macrophages. Macrophages typically disappeared by the 10-14th day of 
culture. 
Cell outgrowth was not significantly influenced by any of the clinical variables 
recorded including patient sex or age, coronary syndrome (stable or unstable 
angina), type of coronary lesion (de novo or secondary) or fisk factors for coro-
nary artery disease (hypercholesterolaemia, hypertension, smoking, family his-
tory) (Table I). Although cell culture failed in samples obtained from both car-
diac transplant patients, the small number involved precludes any conclusions as 
to the statistical significance of this finding. Smooth muscle cell outgrovvrh was 
significantly influenced however by the presence of organizing thrombus on his-
tological examination. Smooth muscle cell outgrovvill was documented in 8 of 
10 (80%) samples with and only 35 of 88 (40%) without thrombus (p = 0.03, 
Table I). None of the other histological variables analysed including the presence 
of neointimal hyperplasia, fibrous tissue (dense or loose), lipid deposits, necrotic 
debris, macrophages, media or adventitia influenced cell Outgrowth. Finally 
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Day 1 
Day 5 
Day 20 
fresh thrombus 
Edematous wall 
acunarspaces 
Thrombus retraction 
Endothelial cells 
Capillary sprouts 
Smooth muscle cells 
"'""-..... - Endothelial cells 
Capillary sprouts 
Figure 3 
A graphic update on the sequence 
of events leading to thrombus 
organization" based on 
observations in experimental 
anima! models.F~~\',.1 Following 
the initial episode a/thrombosis, 
a significant retraction of the 
thrombotic milSS occurs. with the 
formation of lacunar spaces. 
These, as the thrombotic surfoce, 
become quickly endothelialised. A 
granulation reaction with 
capillary ingrowth from the 
vessel wall occurs simultaneously. 
By day 20 ",mooth muscle cells 
that may have migrated from the 
vascular wall during the 
granulation reaction or that are 
derived from circulating cells 
that have infiltrated the 
thrombus are seen along newly 
flnned capillaries. Some of the 
endothelia/ised lacunar spaces may give origin to mulrilumiruzl channels that constitute a classical 
histopathohgical landmark a/prior thrombotic recana/isation. 
rhere was no correlation bervveen the number of explants used in each case and 
the outgrowth of smooth muscle cells (4.5±1.6 and 4.5±1.9 explants in those 
cases with successful or failed culture respectively, p=NS). 
Discussion 
AtherectOmy has facilitated not only the study of the histological constitution of 
the atheromatOus plaque13.15.17 but also the culture of smooth muscle cells present 
in human atheroma. 11.l2.HI.2~ Several groups,19.21 including ours, IS have reported on 
improved cell outgrowth rates when an explant cell culture technique is used. The 
advantage of this method is that it minimizes the modifications of cell phenotype 
associated with enzyrmatic dispersion, prolonged culture, cell division and successi-
ve cell passages7-9 and therefore allows a better appreciation of the in-vivo prolife-
rative and migratory potential of smooth muscle cells. Since cell outgrov.rrh occurs 
in the presence of the normal constituents of the atheromatous plaque present in 
in the culture, it makes possible to examine the influence of the existing plaque 
milieu at the time of intervention on the process of cell proliferation. 
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We found a broad range of histological appearances in both de novo and resteno-
tic lesions ranging from predominant neointimal hyperplasia to typical ameroma 
containing dense fibrous tissue, calcium deposits, macrophages and necrotic 
debris. In agreement with previous communications based on the study of athe-
rectomy specimens, neointimal proliferation was seen not only in the classical sce-
nario of restenosis1.23 but also in a substantial number of primary lesions. i ).17.> 
Although the prevalent view on the development of fibromuscular proliferation is 
that it constitutes a non-specific response to various rypes of vessel wall injury,] it 
remains unclear the type of vascular insult responsible for its development in de 
novo lesions. Its occurrence in younger patients17.:'..)..::, suggests that: it may differ 
from me classical sequence of events observed in the formation of aIheroma,26 lea-
ding to a more aggressive form of atherosclerotic disease. Finally, we have found 
that organization is common in thrombotic atherectomy samples from unstable 
patients, I; a fact that is in agreement with a recent work by Isner et al. ~7 using 
atherectomy specimens but which was not highlighted in post-morrem studies, 
underlining the distinct advantages derived from the use of atherectomy in Ihe in-
vivo study of coronary syndromes. 
Our explam culture success rate (44%) is low in comparison with other srudies"-" 
although this must be due to the sole use of coronary material. Cell culture from 
coronary atherecromy specimens is difficult however because of the small amounts 
of tissue involved and yields significantly lower outgrovvrh success rates than 
peripheral tissue. Wben culture of both coronary and peripheral tissue has been 
attempted, a lower success raIe and a longer time span until outgrowth has been 
observed in the coronary samples." This was explained on rhe grounds of a sma-
ller number of specimens and their lower wet weight. r.::' However, iI must be 
remembered that there are major differences in the histopathological characteris-
tics of coronary and peripheral artery samples. The prevalence of thrombus in 
peripheral artery specimens obtained during directional atherectomy is as high as 
61 %," which is significantly higher than that found in the present and previous 
studies in the coronaries. 16,\; Although the relevance of -chis fact for cell culture is 
highlighted by the conclusions of the present study, it is unfortunate that none of 
the previous studies reponed on the histologic characteristics of the material used 
for culture, a limitation recently acknowledged in a recent report by Pickering et 
al. " 
Our study is the first to consider the influence of a broad spectrum of histoparho-
logical features of retrieved tissue in addition to clinical features on cell outgrowth. 
Like Bauriedel and colleagues" we found that no clinical variables, including uns-
table angina and drug therapy influence the outcome of plaque cultivation. This is 
reflected in the clinical situation where there is little evidence that clinical factors 
influence the restenosis rate and all therapeutic strategies have been singularly 
unsuccessfuL Common sense dictates that if clinical factors are operative it would 
be through the histOlogical milieu of the atherosclerotic plaque. In spire rhar 
human smooth muscle cells cultured from restenotic lesions appear to migrate 
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more rapidly than those from primary atheromal:: and show accelerated growth 
curves,:!.~ we did not find significant differences betviTeen the primary outgrowth of 
smooth muscle cells from explants of restenotic and primary lesions. A possible 
reason for this discrepancy is that some of these studies used isolated smooth mus-
cle cells, obtained after several passages, and free of the complex cell-cell and cell-
extracellular matrL, interactions which modulate smooth muscle cell proliferation 
and migration in the atherosclerotic plaque in vivo. 10 
Evidence suggesting an enhanced proliferative potential of smooth muscle cells 
present in restenotic lesions can be found in the literature. An improved smooth 
muscle cell outgrovvth from the injured vascular wall has been demonstrated by 
Grunwald" in a rat model. Smoorh muscle cell outgrowth has been found to 
occur more rapidly in restenotic than de novo atherectomy specimens obtained in 
peripheral vessels,12..:'l although the initial outgrowth was similar. In our study cell 
outgrowth was not significantly different in explants from de novo or restenotic 
lesions. There are a number of possible reasons for this. Our experiments were 
performed only using coronary atherectomy specimens which, as discussed before, 
may have substantial differences in their histological substrate with those obtained 
in peripheral vessels. The time interval from the former percutaneous intervention 
may also be of importance as there is evidence suggesting that smooth muscle cells 
experience a process of senescence during its migration to the neointima~') and 
decrease their proliferation rate after a period of time. 30 
We found an enbanced proliferating potential of smooth muscle cells present in 
coronary atheroma where thrombotic organization is taking place. This may be 
related to three major factors. First, mural thrombus constitutes a milieu rich in 
circulating elements, such as platelets, monocyres and lymphocytes, which can 
secrete a number of vascular growth factors, I promoting smooth muscle prolifera-
tion. Thrombin and fibrin31 have both been shown to have chemotactic and mito-
genic activity on vascular smooth muscle cells, an effect which may be prolonged 
after thrombus has been incorporated in the plaque. Thrombin may also act as a 
competence factor, stimulating the expression of growth factors including PDGF 
and their receptors32.33 and thus helping to perpetuate the activation of smooth 
muscle cells. Any or all of these mechanisms may have been operative in our 
study, resulting in the increased migratory and proliferative activity of the smooth 
muscle cells when surrounded by thrombus. 
Second, the process of thrombus organization may have played a key role in the 
observed outgrowth of cells. In fact, since organization was taking place in all 
thrombotic specimens we believe that our conclusions should be restricted to the 
presence of organizing thrombus. There is growing evidence suggesting that 
thrombus organization plays a key role in the development of neointimal hyper-
plasia after vascular injury.""" It has been suggested that the smooth muscle cell 
involved in this process are derived from circulating mononuclear cells rather than 
being of intimal or medial origin37.38 (Fig. 4). Thrombus would serve as a biode-
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gradable fibrin matrix, colonized by cirrulating mononuclear cells which heal the 
injury site from the lumen side inwards, towards deeper vascular layersJ7 In this 
scenario the mononuclear cells which have colonized and starred organizing the 
thrombus are self selected for their migratOry and proliferative abiliry, a fact that 
would provide an unexpected explanation to a previous report showing that smo-
oth muscle cells in organizing thrombus have a monoclonal origin.-'9 Although the 
smooth muscle cell cultured from thrombotic and non thrombotic origin were 
morphologically indistinguishable the above tentative scenario remains plausible. 
Finally, a third explanation for our findings is that organizing thrombus may have 
facilitated cell outgrowth by optimizing cell transfet to the culture medium. 
In our study we tried to reach a compromise between obtaining combined infor-
mation from histOpathology and cell culture. As discussed above, meticulous ins-
pection of the samples in the dissecting microscopy was performed to ensure that 
the tissue fragment dedicated to histology and cell culture sample were representa-
tive of the whole specimen. However, the possibility that the two pieces were sig-
nificantly different cannot be ruled out. Atherosclerosis is a segmental disease pro-
cess, and in this regard our study shares the limitations of all histopathological Stu-
dies using atherectomy specimens, where conclusions are reached using fragmen-
ted samples of the artetial walL" A second limitation is that pretreatment of the 
rulture wells with fibronectin may have facilitated the transformation of smooth 
muscle cells from the contractile to the synthetic phenorype',o affecting explant 
outgrowth. We believe that this mechanism is unlikely to be operative in this case 
however as fibronectin is alteady present in serum and any additional effect that 
fibronectin coating of the wells may have had is likely to have been constant in all 
specimens. Furthermore, in the absence of fibronectin poor adherence of atheros-
clerotic tissue to the culture medium occurs resulting in decreased explant success. 
The final potential source of error is variability in the area of contact between the 
explant tissue and the fibronectin. This is likely to have been randomly disttibu-
ted amongst all the specimens studied however making it unlikely to account for 
the observed differences. We believe that these differences in cell outgrowth are a 
true reflection of the growing potential of the cells in the explant. 
Our study emphasizes the research utiliry of clinically indicated directional coro-
nary atherectomy and suggests an enhanced migratory and proliferating potential 
for smooth muscle cells present in atheromatous plaque where thrombotic organi-
zation is taking place, supporting the concept that plaque composition may 
influence progression of atherosclerosis. Furthermore it also suggests that monito-
ring in vitro cell outgrowth may provide a means of assessing important biological 
features of the pathobiology of the atheromatous plaque. 
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Abstract 
Background 
Common to both primary atherosclerosis and restenosis are vascular smooth muscle cell proliferation 
and production of extracellular matrix proteins. The applicability to man of experimental animal 
models of these processes has been questioned 
Aim of the stndy 
To examine the proliferative capacity and extracellular matrix synthesis of human coronary plaque 
cells in vitro. 
Methods 
Primary atherosclerotic and restenotic lesions were excised by percutaneous directional coronary athe-
reetomy in 93 patients. Smooth muscle cells were cultivated by an explant technique and identified by 
their morphology in culture, ultrastructural features under electron microscopy and immuno5t11ining 
using monoclonal antibodies to smooth muscle cell a-actin. Proliferation in secondary culture was 
assessed with growth curves, and the synthesis of collagen and sulfated glycosaminoglycans by the incor-
poration ofW-proline and 35S-sulfate respectively. These studies were also performed in celk' derived 
from human umbilical artery media. 
Results 
Success rates for primary (45%) and secondary (12%) culture of coronary cells were not influenced by 
clinical variables or lesion category. Primary culture success was improved by the presence of organised 
thrombus in the plaque and in relation to increased maximum cell density of the atherectomy speci-
men. Restenotic cells displayed more rapid growth than cells of primary atheroscletotic origin which 
grew similarly to umbilical artery cells; caltulated population doubling times (hours, means and 95% 
C1) for the three cell groups were 52 (48-58), 71 (62-83) and 74 (65-84) respectively. Restenotic and 
primary atherosclerotic cells did not differ in the synthesis of collagen (0. 034± O. 004 and 5. 43±1. 00 
respectively, both p<0.05). 
Conclusions 
The data suggest that an increase in smooth muscle cell proliferative capacity contributes to coronary 
restenosis in man, and support the concept that the extracellular matrix synthesis of adult smooth mus-
cle cells is important to lesion formation. 
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Introduction 
Migration, ,proliferation and extracellular matrix synthesis are properties of the 
vascular smooth muscle cell central to both primary atherosclerosis and Testenosis, 
the vascular response to injury which may be provoked by balloon dilatation,'" In 
cell culture, vascular smooth muscle cells retain many of their in vivo characteris-
tics thus allowing the study of specific cellular prop~rties under controlled condi-
tions in vitro. Early experimental work with smooth muscle cells derived from 
human atherosclerotic lesions depended upon tissue removed from peripheral 
arteries at surgery or post_morrem3•9- 11 but fresh human atherosclerotic tissue can 
now be retrieved from both peripheral and coronary arteries by the procedure of 
directional atherectomy.11·1.3 The feasibility of culture, characterisation and invesri-
garion of smooth muscle cells from tissue obtained by directional atherectomy has 
been demonstrated. H-IY 
Recent reviews of mechanisms in atherosclerosisG and in the arterial response to 
mechanical injury70S have focused more on the migration and proliferation of vas-
cular smooth muscle cells than on extracellular matrix synthesis. However, the 
contribution of the extracellular matrix to primary atherosclerotic and restenotic 
lesions is well defined histologically301so19 and there is experimental evidence that 
following balloon injury, extracellular matrix deposition outlasts cellular prolifera-
tion and accounts for the bulk of the resulting intimallesion.oo It has been propo-
sed, too, that the extracellular matrix may exert important effects on the migration 
and proliferation of the vascular smooth muscle ceiL"'" 
We cultivated smooth muscle cells from primary atherosclerotic and restenotic 
coronary lesions in man, obtained by directional atherectomy, in order to study 
both the proliferative behaviour and the synthesis of collagen and sulfated glycosa-
minoglycans, principal components of the extracellular matrix, of the cultured 
cells. In establishing this in vitro model of processes central to the formation of 
vascular intimal lesions, we also examined whether adult coronary plaque smooth 
muscle cells displayed properties in culture different to those of smooth muscle 
cells form an alternative immature arterial source; the normal media of human 
umbilical arteries. 
Methods 
Patient-population and procedure 
A series of 93 patients underwent percutaneous directional coronary atherectomy. 
Details of the population are summarised in Table 1. Lesions were designated res-
tenotic when associated with a ~50% diameter stenosis at the site of a previous 
intervention of which 18 (75%) were conventional (balloon) percutaneous trans-
luminal coronary angioplasty, 4 (17%) were stents and 2 (8%) directional atherec-
(omy. The target vessels included 4 long-standing saphenous vein grafts, all with 
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Table I. Baseline characteristics of the study population 
Age (years) 58±1 
Gender Male 77 (83%) 
Female 16 (17%) 
Angina Stable 48 (52%) 
Unstable 45 (48%) 
Lesion Primary'" 69 (74%) 
Restenotic 24 (26%) 
Vessel LAD 59 (63%) 
CX 11 (12%) 
RCA 19 (21 %) 
Graft 4 (4%) 
Unstable angina was defined as typical pain occurring at rest, 
with or without accompanying electrocardiographic changes, 
despite maximal medical therapy. 'Primary = primary atheros-
clerotic . LAD: left anterior descending coronary artery; ex: 
circumflex coronary artery; RCA; right coronary artery; Graft: 
saphenous vein coronary bypass graft. 
restenotic lesion. Informed consent was obtained from all patients prior to the 
procedure which was performed using the Simpson Coronary AtheroCath 
(Devices for Vascular Intervention. Redwood Ciry, California, USA) according to 
a protocol approved by our hospital ethics committee and described elsewhere." 
Under sterile conditions, specimens were flushed from the dived with 0.9% saline 
and placed immediately in serum-free M 199 culture medium for transfer to the 
culture laboratory. 
CeUCulture 
Excised coronary tissue was placed in cell culture after the method described by 
Bauriedel et al. 13 Tissue explants were placed on round glass cover slips coated 
with fibronectin (10f.lg.cm") in 2 cm' wells and culture medium (M 199 supple-
mented wirh glutamine, 10% human serum, 10% feral calf serum, penicillin 100 
IU.ml' and streptomycin 0.1 mg.ml') was added. For primary cultures, condirio-
ned medium from actively growing umbilical artery medial smooth muscle cell 
strains was mixed 1: 1 with the srandard culture medium. In secondary culture. the 
culture medium was not supplemented with conditioned medium. For human 
umbilical artery smooth muscle cell culture, 3-4 mm' pieces of arterial wall were 
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dissected free from fresh human umbilical cord sections and cultured in fibronec-
tin-coated 24 well plates using standard unconditioned culture medium. All cul-
tures were incubated at 3rC in a moist atmosphere under 5% CO,. At con-
fluency, cells were subcultured by trypsinizing. 
Histology. 
A small portion of the atherectomy specimen was set aside for histology. This tis-
sue was divided into approximately Imm' pieces with a sterile scalpel, fixed in 
10% buffered formalin and processed for light microscopy with haematoqlin-
azofloxin and Verhoeff-van Giesson stains. 
Assessment of maximum cell density. Early studies used tissue from the initial 12 
patients to assess maximal cell density. Cell nuclei were counted in several micros-
cope fields in haematoqlin-azofloxin stained sections by means of a compurerized 
morphometry system (!BAS, Kontron, Oberkochen, Germany). The maximum 
value recorded was used for the estimation of maximum cell density, expressed as 
cells. mm·'. 
Identification of smooth muscle cells by immunostaining and electron micros-
copy. Cells from passages 2-4 were seeded on round glass cover slips at a density of 
5000 cells. em". Afrer 48 hours, the cover slips were rinsed in phosphate-buffered 
saline (PBS, pH 7.4) before fixing in acetone at -20ce. Immunostaining was per-
formed with monoclonal antibodies directed against smooth muscle cell u-accin 
Figure 1 
Vascular smooth muscle cells in secondary cult:ure showing the typical "hiU-and-valley» grQWth pattern. 
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(DAKO, Denmark) using an indirect immuno-peroxidase procedure.'·' For elec-
tron microscopy, cells cultured in 10 cm' diameter Petri-dishes were fIxed in a 
phosphate-buffered mixture of 4% paraformaldehyde and 1 % gluraraldehyde, 
postfIxed in 1 % OsO, and dehydrated in alcohol. Thereafter, embedding-capsules 
fIlled with epon were placed upside down on the cell monolayer and after polyme-
risation of the epon, the epon blocks were separated from the plastic by immer-
sion in liquid nitrogen. Ultra-thin sections were cut on a Reichert OmL13 
Ultramicrotome, stained with uranyl acetate and lead citrate and examined in a 
Philips E.M. 400 electron microscope. 
Proliferation studies. Cells from passages 2-5 were seeded in 10 cm' culture plates 
at a density of 2000 cells.cm·'. One day after seeding and on evety third day there-
after, the medium was exchanged. At appropriate times, cells of tvYo to four wells 
were washed with PBS, trypsinized for 3-5 minures at 37°C, and counted in a 
haematocytometer. Cell numbers were used to plot growth curves. 
Extracellular matrix synthesis. To determine collagen synthesis, subconfluent cells 
of passage 2-4 were incubated for 48 hours at 37°C in culture medium containing 
2f.iM ascorbic acid and 10IlCi.ml·' 3H-proline (specifIc activity 231 mCi.mg·'). 
Incubations were performed in triplicate in 2 cm' culture wells. Subsequently, the 
medium was removed and combined with twO cell layer washes (PBS) before pre-
cipitating with 20% trichloroacetic acid (TCA): 1 mM proline (24 hours, 4°C). 
Following centrifugation, the pellet was washed with graded concentrations of 
TeA: I mM proline and dissolved in 0.2N NaOH overnight. Thereafter, collagen 
and non-collagen protein synthesis were quantified by a bacterial collagenase 
digestion method (clostridium histolyticum Type III, Calbiochem) modifIed from 
Peterkofsl..-y et al." Collagen synthesis was expressed as nmol 3H-proline.!lg total 
cell protein·'. 
Sulfated glycosaminoglycan synthesis was determined as follows. In triplicate 2 
cm' culture wells, subconfluent cells of passage 3-5 were incubated for 48 hours at 
37°C in culture medium containing 0.5 ml 35S-sul£ue (specific activity 20IlCi.ml·'). 
Thereafter, the medium was washed with PBS ro a fInal volume of 2.5 ml and 
250)ll of this solurion was applied OntO a disposable Sephadex G-25M gel ftltra-
tion column (PD10, Pharmacia) equilibrated and run in 8M urea:0.5% 
TritonX100:0.15M NaCI:50 mM sodium acetate (pH 6.0). Column fractions of 
300)ll were collected and fractions 8-45 counted in Instagel II. The synthesis of 
sulfated glycosaminoglycans, expressed as nrnel 35S-sulfate.~ total cell protein-1, 
was derived from the sum of the counts in the initial peak. 
For total cell protein, cells were detached from culture wells by gentle scraping, 
washed in PBS and precipitated in 20% TCA (24 hours, 4°C). Afrer centrifuga-
tion, the pellet was dissolved in 0.2N NaOH overnight and total protein estima-
ted according to the Pierce BCA assay (Pierce Rochford, Illinois, USA) using bovi-
ne serum albumin as the standard." 
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lFigure 2 
Transmission electron microphotography illustrating the synthetic phenotype of cultured ~mooth muscle 
cells, showing dense perinuclear organelles with endoplasmic reticulum, Golgi appararus and abundant 
ribosomes (x12,OOO). 
Statistical Analysis 
Results are presented as means ± s.e.m .. Group differences in initial smooth muscle 
cell outgrowth (primary culture), success of secondary culture, patient age, gender 
and anginal class, patient medications and histologic features were assessed by 
means of chi-squared tests for categorical variables with a Yate's correction where 
appropriate. Cell population doubling times, e."pressed as means and 95% confi-
dence intervals, were derived following linear regression of log transformed cell 
population growth curves. Otherwise, comparisons between primary atherosclero-
tic and restenotic coronary artery smooth muscle cells and human umbilical anery 
smooth muscle cells were performed using a two-sample t test. Significance was 
accepted at the 5% level. 
Results 
Culture success: relationship to clinical parameters and histologic features. 
Initial cell outgrowth (primary culture) was seen in 37 (40%) of93 attempted cultures 
and successful secondary culture (up to 7 serial passages) was achieved in 11 (12%). 
Clinical data for the patients whose tissue provided secondary cultures were the follo-
wing: 8 male (73%), 3 female (27%); age 56 ± 1 years; stable angina 6 (55%), unsta-
ble 5 (45%); primary atherosclerotic lesions 7 (64%), restenotic 4 (%%). 
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Figure 3 
Immunohistochemical staining with monoclonal antibody (11400 dilution) directed against smooth 
muscle cell specific (f.-actin (x500). Stress fibers are clearly seen. 
Cells started to grow out from explants after 4-8 days and confluent multilayer 
primary cultures from the 11 patients were established after 4-6 weeks. The suc-
cess of initial outgrowth of coronary smooth muscle cells and of serial passage in 
secondary culture was not related to the nature of me lesion; primary atherosclero-
tic or restenotic, or to any patient characteristic including current medication. 
Cell outgrowth was however related to the presence of organized thrombus in the 
plaque. The rate of outgrowth in the presence of thrombus was SO% (S/10), but 
was 35% (29/83) in the absence of thrombus (p<0.025). In the initial 12 patients, 
cell outgrowth improved with greater tissue maximum cell densities (outgrowth: 
922 ± 43 cells.mm' vs. no outgrowth: 213 ± 34, p< 0.01). The four successful 
secondary cultures from restenotic lesions were not associated with unusually 
aggressive restenosis (interval from previous intervention: 130 ± 36 days). 
Morphology and identification of cells cultured from human coronary lesions. 
Subconfluent cultures took the form of a network of multilayered elongated cells 
in interlacing bands separated by lacunae. In confluent multilayer cultures, the 
cells appeared as whorls producing the "hill-and-valley" pattern rypical of vascular 
smooth muscle cells in culture (Fig. 1). This pattern was observed for all serially 
passaged cells. Electron microscopy of cultured coronary cells revealed features of 
synthetic phenotype" with abundant perinuclear organelles and peripheral myofi-
brils (Fig. 2). Immunostaining for (X-actin was positive for both cot0nary (Fig. 3) 
and umbilical cell cultures, identifYing the cells as smooth muscle cells. However, 
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a lesser proportion, approximately 20%, of the coronary cells showed rypical stai-
ning with Stress fibers, consistent vvith the electron micrographic evidence of synt-
heric phenorype. 
Proliferation studies 
When subcultured at the same initial densities, the three groups of cells grew simi-
larly until day 5 (Fig. 4). Thereafter, the cells of restenoric origin demonstrared 
accelerated proliferarion with significanrly greater cell numbers compared to the 
primary atherosclerotic cells whose growth patrern closely resembled thar of the 
umbilical arrery cells. Derived population doubling times (hours, means, 95% CI 
in parentheses) were 52 (48-58) for restenoric cells, 71 (62-83) for primary athe-
rosclerotic cells and 74 (65-84) for umbilical arrery cells. The correlation coeffi-
cientS for the regressions were 0.95 (restenotic cells), 0.87 (primary atherosclerotic 
cells) and 0.88 (umbilical arrery cells). 
Extracellular matrix synthesis 
The resulrs of the exrracellular matrix assays are summarised in Table 2. Collagen 
synthesis, reflecred by the incorporarion of'H-proline, did not differ berween res-
tenotic and primary atherosclerotic cells in culture but was, however, significantly 
greater for cells of coronary than umbilical arrery origin. Production of sulfated 
glycosaminoglycans, as assessed by the incorporation of "S-sulfate, was less for res-
tenotic than for primary atherosclerotic smooth muscle celis, although not signifi-
cantly so, and was more than rwofold grearer for coronary than for umbilical 
arrery cells. 
iable 2. Prodllction of extracellular matrix collagen and 
sulfated glycosam'noglycans. 
Cell SOUIce Collagen Glycosaminoglycans 
Restenotic 0.034 ± 0.004 (n=6) * 11.47 ± 1.07 (n=6) 
Primary ** 0.033 ± 0.004 (n=5) t 15.37±3.10 (n=4) 
Umbilical 0.019 ± 0.004 (n=3) *t 5.43 ± ].00 (n=4) 
# 
§ 
#§ 
Values are mean ± s.e.m., expressed as nmol isotope.!lg rotal cell prorein-1. 
**Primary = primary atherosclerotic. Each observation (n) represents the 
mean result of rriplicalte assay. *t# p<0.05, § p<0.005 
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Discussion 
It is clear that the proliferation and extracellular matrix synthesis of vascular smo-
oth muscle cells are phenomena important in atherosclerosis, and highly relevant 
to restenosis. We describe the first attempt to investigate both of these processes in 
smooth muscle cells cultured from human coronary plaque tissue. In parricular, 
we compared primary atherosclerotic lesions with restenotic lesions~ and adult 
coronary cells with cells derived from the media of umbilical arteries. 
The difference in proliferation we show for human coronary restenotic and pri-
mary atherosclerotic smooth muscle cells in secondary culture is in close agree-
ment with that reported for cells from human peripheral arterial lesions in pri-
mary and early sub_culture. 15,17 OUf data suggests that the proliferative behaviour 
of restenotic cells in vitro reflect a prior phenomenon of phenotypic modulation 
and selection in vivo, rather than some effect of the cell culture process, as the suc-
cess rates of primary and secondary culture for cells derived from restenotic and 
primary atherosclerotic lesions were similar. This concept is supported by the pre-
vious demonstration of a metabolically active subpopulation of smooth muscle 
cells in arterial intima and media" and human peripheral arterial plaques, where 
the active subpopulation was more dominant in restenotic lesions and grew more 
rapidly in secondary culture. \5 Also, experimental studies have shown accelerated 
smooth muscle cell proliferation following balloon injury;'·" and in relation to 
early but not late atherosclerotic lesions in animals and man.-W .30.31 It might be 
proposed that increased growth of restenotic smooth muscle cells in secondary 
culture actually reflects senescence and anenuated growth of cells from chronic 
primary atherosclerotic lesions.3 However, this seems unlikely, as the growth pat-
tern of primary atherosclerotic cells in the present study was very similar to that of 
healthy umbilical artery medial cells which have undergone far fewer in vivo 
population doublings. Interestingly, the population doubling times we report for 
primary atherosclerotic and umbilical artery cells are identical to those previously 
described for smooth muscle cells cultivated from adult human atherosclerotic 
aonic plaques and control aortic media.9 
For all three cell sources, the combination of culture morphology, electron micros-
copy and immunostaining for smooth muscle cell (X-actin was consistent with vas-
cular smooth muscle cell identiry. Vascular smooth muscle cells placed in cell cul-
ture alter from contractile to synthetic phenotype within a few days and this chan-
ge becomes irreversible beyond 5 cumulative population doublingsY The precise 
in vitro age of our cultured coronary cells is not known as a tissue explant culture 
method was used, but in these early passage cells, the ultrastructural features and 
the attenuated expression of smooth muscle cell (X-actin,33.3" as evidenced by 
immunostaining, indicated that the coronary cells in culture were of synthetic 
phenotype. The morphology and behaviour of the cells might therefore be attri-
buted to the culture process. However, the differences in proliferation benveen 
restenotic and primary smooth muscle cells shown in this study and in others\5.\-
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suggests that this is not the case; cells from comparable individuals would be 
expected to react similarly to cultivation. Further, a number of histOpathologic 
srudies have revealed that smooth muscle cells in primary atherosclerotic and res-
tenotic lesions are frequently of synthetic phenotype.3.113536 Also, human coronary 
smooth muscle cells in atherectomized tissue were shown recently to express 
mRNA for non-muscle myosin heavy chain (MHC-B), associated with smooth 
muscle cell synthetic phenotype;3! expression was greater in restenotic than pri-
mary atherosclerotic tissue. In e."<perimental atherosclerosis tOO, the modulation of 
smooth muscle cell phenotype from contractile to synthetic has been reported.·" 
We believe therefore that the nature of the coronary cells in vitro reflected their 
nature in vivo. 
There is much current interest in the stimulation of smooth muscle cell prolifera-
rion and extracellular matrix synthesis in vivo by diverse growth factors, particu-
larly in relation to restenosis. It has been suggested that endogenous mediators, 
platelet-derived growth factOr (PDGF) for example, may influence the initial out-
growth of smooth muscle cells from cultured atherosclerotic plaque tissue.17 In our 
study, the success of primary culture was enhanced in specimens containing orga-
nized thrombus. Despite the low prevalence of thrombus in the specimens (10/93, 
9%), this finding supports the role of thrombus, recently reviewed by Schwartz et 
al.," as the fertile matrix fostering the growth of smooth muscle cells, perhaps by 
being a rich source of growth factors and chemoattractants. 
Coronary intimal smooth muscle cells from both restenotic and primary lesions 
synthesised more extracellular matrix protein than human umbilical artery media 
cells. Two explanations may be offered. Either the difference arose from the 
obvious discrepancy in in vivo age between the coronary and umbilical artery 
cells, or the increased extracellular matrix synthesis of the coronary cells was a 
manifestation of disease. The tOtal arterial content of glycosaminoglycans, particu-
larly sulfated glycosaminoglycans, certainly increases with age;'O but this increase 
in total content is heavily influenced by the increase in vascular intimal and 
medial thickness which occurs with age. The relative tissue concentration of sulfa-
ted glycosaminoglycans, a better source of reference for the the measurement 
made in the present study, varies to a lesser extent. Relevant to our findings is the 
evidence that glycosaminoglycans are increased in atherosclerosis; in coronary 
lesions in man"W .. ll and in lesions induced by diet or genetic predisposition in ani-
mals.3:M1 Arterial collagen appears to alter little with age·'3 but is associated with 
more severe of chronic lesions19 •. 1l and has also been shown to be elevated in experi-
mental atherosclerosis:'" Thus, the increased matrix synthesis of the coronary cells 
is likely to be related to vascular disease as opposed to in vivo age. 
Having observed a difference in the proliferative behaviour of restenotic smooth 
muscle cells compared to primary atherosclerotic cells, reasons for not detecting a 
difference in matrix synthesis merit consideration. Although collagen synthesis 
appears to be unaffected by cell proliferation rate;' glycosaminoglycan synthesis in 
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Figure 4 
Growth curoes in seconkry culture afsmooth muscle cells derived from restenotic, 
prir11l11] atherosclerotic and umbilical vein media. Each point represents the mean 
(±5.EM) of a minimum of 4 observarions from at least two passages of different cel! 
strains. Restenotic cell numbers significantly exceed primary atherosclerotic cell 
numbers at the times indicated 
cell culture has been shown to fall during log phase growrh·'6 and with increasing 
cell density.'" Accordingly, the more rapid proliferation of the restenotic cells may 
have led to a reduction in 35S-sulfate uptake, obscuring any potential difference 
from the primary atherosclerotic cells. This is speculative, as we did not estimate 
the glycosaminoglycan synthesis of restenotic cells under other conditions, such as 
grovvth arrest. 
There were limitations to the study. First, the small amount of tissue retrieved 
during directional coronary arherectomy, typically 15-20 mg"··'s particularly when 
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of low cellularity, limits the success of secondary culture, and primary culture suc-
cess rates fall to 60% of those with tissue from peripheral atherectomy. '" A quarter 
of our procedures were for restenotic lesions which provided only 4 secondary cul-
tures. Although our proliferation results are wholly consistent with other recent 
studies, they may only be extrapolated to the general population with caution. 
Second, in view of the proliferation finding, timing and cell density may have 
affected the estimation of sulfated glycosaminoglycan synthesis. New studies are 
under way to address this question. Third, with regard to the influence of vascular 
disease as opposed to in vivo cell age on extracellular matrix synthesis, it would be 
advantageous to study adult arterial smooth muscle cells cultivated from osten-
sibly healthy vessels, such as the internal mammary artety. This is also a focus of 
current experimental work. 
In summary, the more rapid proliferation rate of resrenoric lesion smooth muscle 
cells subcultured in vitro attests to a mechanism of likely importance in the vascu-
lar response to injury, and thus highly relevant to the clinical problem of pOSt-
angioplasty restenosis. The increased ability of adult coronary smooth muscle cells 
in secondary culture to synthesise collagen and sulfated glycosaminoglycans sup-
ports the putative role of the extracellular matrix in lesion formation and consoli-
dation. Further research into this aspect of vascular smooth muscle cell (dys)func-
tion is required to explore the possibility of manipulating extracellular matrix 
synthesis by pharmacological means. Smooth muscle cells cultivated from primary 
atherosclerotic and restenotic coronary lesions following directional atherectomy 
constitute a useful experimental model for the identification of pathophysiological 
phenomena and thus, potentially, for the selection and testing of novel therapies. 
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Abstract 
Background 
ProducTIon of extracellular matrix by vascular smooth musce cells is an important 
aspect of the development of atherosclerotic lesions, since not only contributes to 
the overall increase in plaque bulk, but also may promote incorporation of lipids 
or facilitate thrombotic events. In this study, we focused on the reactivity tOwards 
blood platelets of the extracellular mauix produced by vascular smooth muscle 
cells derived from atheroma obtained in primary and restenotic coronary stenoses 
and coronary intima and media. 
Methods 
Coronary specimens were obtained during the performance of percutaneous direc-
tional atherectomy or at the time of cardiac transplantation from the heart of the 
receptor. Mter successful primary culture, the cells were subcultured on glass 
coverslips. Later, the extracellular matrix generated from these cells was exposed to 
flowing blood in an in vitro perfusion system, and the reactivity towards blood 
platelets quantified using specific immunostaining against glycoprotein lB. The 
proco~oulant activity of the extracellular matrices was also estimated from the rate 
of activated factOr X generated after adding human coagulation factors VII and X. 
Results 
A similar platelet coverage was found in coverslips with matrices from intimal 
(l4.55±1.2, n=l6) and medial smooth muscle cells (l6.57±O.60/0, n=28). Platelet 
coverage was significantly increased in smooth muscle cell cultures from primary 
atheroma (22.8±1.30/0, n=41), and was maximal in cultures from restenotic athe-
roma (41.9±1.70/0, n=12). The high platelet coverage observed in restenotic matri-
ces was due to increased platelet spreading. The procoagulant activity of the 
various matrices varied considerably, but an increase in tissue factor activity was 
not observed for matrices from atherosclerotic and restenotic smooth muscle cells. 
Conclusions 
The results of this study suggest that smooth muscle cells derived from atheroscle-
rotic coronary lesions synthesize extracellular matrix that is more reactive towards 
blood platelets than that from normal smooth muscle cells. 
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Introduction 
Atherosclerosis is a disease predominantly of the intimal vascular layer in which 
rhe vascular smooth muscle cell plays a key role. ,., In addition ro rhe rypical slow 
development of atherosclerotic plaques, which evolve over decades,"" several forms 
of accelerated atherosclerotic disease have been described,6 including restenosis 
after percutaneous vascular recanalisation, saphenous vein graft attrition and car-
diac allografr vasculopathy. Although smooth muscle cells can be found in the 
normal vascular intima, it is generally accepted that those found in the atheroscle-
rotic intima have a medial origin. -; Prior to or during the process of migration~ 
smooth muscle cells undergo a phenorypical shin from "contractile" to ':syntheric" 
phenotype, the latter having an increased capacity for extracellular matrix produc-
tion.8,9 The production of large amounts of extracellular matrix by synthetic smo-
oth muscle cells constitutes the main factor leading to a progressive increase of 
plaque bulk and gradual obstruction of the vascular lumen. Alternatively, throm-
botic complications can take place when the extracellular marrix and other plaque 
components are exposed to the blood afrer spontaneous fissuring of the plaque, w.n 
or afrer mechanical disruprion of rhe lesion by mechanical percuraneous recanali-
sation devices.l~ In earlier studies,13Y, we observed that the connective tissue of the 
atherosclerotic plaque was more reactive towards blood platelers than that obser-
ved in the healthy vessel wall. At present it is nor known whether extracellular 
matrices synthesized in vitro show similar differences. 
Several groups15.1i have reported on successful smooth muscle cell culture from 
coronary specimens obtained during directional atherectomy. This technique may 
be of use in studying the pathology of coronary disease, and may be preferable to 
the use of atheroma obtained nom peripheral arteries (in which smooth muscle 
cells have a different embryological origin than those from the coronaries llU?) or 
animal models of atherosclerosis, which present a ~ariety of limitations recently 
reviewed by Muller er al." and Ferrel er al.21 
The aim of the present study was to invesrigare whether the extracellular matr;'" 
synthetised by smooth muscle cells present in primary atherosclerotic and resteno-
tic coronary lesions is more reactive towards platelets than thar synthetised by 
smooth muscle cells present in the media. For this purpose, smooth muscle cells 
were cultured on glass coverslips, and the produced extracellular matrices were 
exposed to flowing blood in a rectangular perfusion chamber.22.23 We also measu-
red the procoa"o-ulant activity of these matrices by adding purified human coagula-
tion factors VII and X and assessing the rate of activated factor X generated. 
Materials and methods 
Smooth muscle cells were obrained by using an explant culture technique. Fresh 
coronary arteries were obtained from the explanted hearts of patients undergoing 
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cardiac transplantation (Department of Cardiology, University Hospital Utrecht). 
The specimens were rinsed in cold sterile phosphate buffered saline (PBS) and 
transferred to rubes containing cold culture medium without serum supplement. 
Within 12 hours, the adventitia was removed, and the media was microscopically 
separated from the (atherosclerotic) intima. The distinct layers were cut into small 
pieces of about 1 mm', and directly placed on fibronectin-coated tissue culture 
plates (Costar, Cambridge, MA, USA). Fresh culture medium was supplemented 
with 200/0 conditioned medium to facilitate outgrowth of cells. After outgro\Vth 
this was immediately replaced by 100% fresh medium (Incubation ar 37°C under 
5% CO,). Specimens for histological examination were formalin fixed and stained 
with Haematoxylin-Eosin. 
Table :I.. Patient and sample characteristics 
Patient! Substrate Age Gender Vessel Lesion 
cell passage (Years) 
U69/P3 *Dilated 52 Male RCA none 
cardiomyopathy 
U811P3 *Ischaemic 42 Male LCirc pnm. 
heart disease ath. 
U85/P3 *Ischaemic 52 Male RCA pnm. 
heart disease ath. 
U86/P3 '"'Ischaemic 38 Male RCA pnm. 
heart disease arh. 
R193/P4 tUnstable 71 Male LAD resteno-
angma tic 
R84/P4 tUnsrable 69 Male LAD pnm. 
angIna ath. 
RI09/P3 tUnstable 44 Male LAD pnm. 
angma ath. 
*Tissue obtained from explanted hearts after transplantation; t tissue obtai-
ned during directional coronary atherectomy. 
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Figure 1. 
Rectangular peifusion chamber used in the study. Covers/ips with extracellular matrix foom cultured 
smooth muscle cells were exposed to non pulsatile heparinised blood flow at a shear rate of 1000 ;-1. See 
text for details. 
Arheroscleroric plaque material was also obrained from patients who were under-
going percutaneous coronary atherectomy at theThoraxcenter (Erasmus 
University, Rotterdam) using the Simpson atherectomy device and following a 
conventional prorocol described elsewhere." The retrieved material was also cut in 
small pieces of about 1 mm' and was handled as described above. 
After cell outgrowth, the cells were transferred towards culrure bottles (Cosrar). At 
confluence, 50% of the cells were frozen and stored in liquid nitrogen (for other 
experiments), the remaining cells were subcultured on gelatin coated glass covers-
lips (Menzel, Braunschweig, Germany). Smooth muscle cells were identified by 
their typical growth pattern and by staining with a monoclonal antibody (mAb) 
against a-actin (Boehringer, Mannheim, Germany). The cultured smooth muscle 
cells failed to react with a mAb against desmin (Boehringer), which was in agree-
ment with the studies of Thomas and Kim" and Dartsch et al." After the smooth 
muscle cells had grown to confluence, matrices were isolated by exposing the cells 
to 0.1 M NH,OH (5 min. at rOom temperarure; Houdijk er al.") This step was 
followed by tree washes with PBS (pH 7.35). Coverslips wirh matrices were stored 
in PBS ar -20°C and were used within 2 weeks for perfusion experiments. 
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Cult:ure medium 
Cells were cultured in M199 Modified Earle's Salts (Gibco Europe Ltd., Paisley, 
UK) supplemented with 10% pooled human serum, 10% fetal calf serum 
(Gibco), Penicillin (l00 U/ml), Streptomycin (lOO).!g/ml) and Fungizone (2.5 
).!g/ml). Conditioned medium was prepared by mixing 20% medium from proli-
ferating umbilical smooth muscle cells line and 80% fresh medium. 
PeifUsions 
Fresh blood from normal donors who denied to have taken aspiring in the prece-
ding ten days was anticoa"oulated with 1110th volume of 50 Ulml unfractionated 
heparin (Organon, Oss, The Netherlands). Heparin did not cause increased plate-
let clumping under the flow conditions of our experiments. Platelet deposition 
under non pulsatile flow conditions was performed using a rectangular perfusion 
chamber as described."'" Whole blood (15 ml) was prewarmed at 3JDC for 5 min. 
Duplicate coverslips were inserted into rhe perfusion chamber and the blood was 
then circulated rhrough the perfusion chamber for 5 min. The studies were per-
formed at a wall shear rate of 1000 s·'. The system was rinsed with 10 mM Hepes 
buffered saline (HBS) afrer each perfusion. Platelet counts were measured with a 
Platelet Analyzer 810 (Allentown, PA, USA) wirh apertures set between 3.1 and 
16 fl.lll. Platelet counts before perfusion were between 150.000 and 300.000/fJ.l. 
Microaggregate formation during recirculation of the blood was less than 30%. ~g 
Evaluation of platelet deposition 
The coverslips from rhe perfusion chamber were removed and rinsed with HBS, 
fIxed in acetone for 5 min., and rinsed in 0.05 M Tris buffered saline (TBS). 
Adhered platelets and platelet thrombi were visualized by staining with a biotiny-
lated mAb against glycoprotein Ib" and an avidin-biotin-horseradish peroxidase-
complex (Vector Laboratories, Burlingame, CA, USA). Cobalt chloride (0.025%) 
and nickel ammonium sulfate (0.020%) were added to the chromogenic substrate 
3,31-diaminobenzidine (Sigma, St Louis, MO, USA) to yield a black reaction 
product." Platelet deposition was quantifIed with a light microscope coupled to a 
compurerized image analyzer (AMS 40-10, Saffron Walden, UK). Platelet deposi-
rion was expressed as rhe percentage of rhe surface covered with plarelets and pla-
telet aggregates. 
Collagen synthesis of smooth muscle cells derived from atherectomy tissue 
The synthesis of collagen was assessed by the incorporarion of 3H-proline using a 
modifIcation of rhe method described by Peterkofsl--y et al.30 which has been pre-
viously used in our laboratory.31 Subconfluent cells of the same passages as used in 
perfusion experiments were incubated for 48 hours at 37°C in culture medium 
containing 2 f1M ascorbic acid and 10 !1Ci.ml·' 3H-proline (specifIc activity 231 
mCi.mg·'). Afrer incubation in 2 cm' culture wells (in triplicate), the medium was 
removed and the cells were washed with PBS before precipitating with 200/0 trich-
loroacetic acid (TCA)/1 mM proline (24 hours, 4°C). Afrer centrifugation, the 
pellet was dissolved in 0.2 N NaOH overnight. Thereafrer, collagen was quanti-
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£led by a bacterial collagenase digestion method (Clostridium histOlyticum type 
III, Calbiochem, La Jolla, CA, USA) and "-'<pressed as runol 3H-proline.f1g total 
cell protein·'. For total cell protein, cells were detached from culture wells by gen-
de scraping, washed in PBS and precipitated in 20% TCA (24 hours, 4°C). Afrer 
centrifugation, the pellet was dissolved in 0.2 N Na OH overnight and tOtal pro-
tein estimated according to the Pierce BCA assay (Pierce Rochford, IL, USA) 
using bovine serum albumin as the. standard.32 
Tissue foetor (TF) activity 
Smooth muscle cells were subcultured on gelatin coated Tharmanox" coverslips 
(Miles, Naperville, IL, USA). Afrer growing to confluence, matrices were isolated as 
described under: "Cell culture". The amount ofTF present in the ""-"tracellular matri-
ces of smooth muscle cells was estimated by the rate of activated factor X (F Xa) gene-
rated after addition of factor VII and factor X. Coverslips (I0.5x20 mm) with extrace-
llular matrices were cut into 2 pieces and translated tOwards 24 well culture plates 
(Costar). Afrer washing with a Hepes/saline buffer (25 mM Hepes, 135 nu'vl NaC!, 4 
mM KOL, 3 mM CaCL, 0.3% bovine serum albumin, pH 7.4), matrices were prein-
cubated with 400 !-t1 of the sarne buffer to which 2 nM factor VII was added (IO min., 
37°C). At t = 0 min. factor X was added (160 nM). Samples were collected in dupli-
cate at 10 and 20 min. The formation of F Xa was inhibited by an excess of 
EDTA(20mM). Concentrations ofF Xa were estimated using the chromogenic subs-
trate S2222 (Chromogenix, Moindal, Sweden). Hydrolysis of the substrate was measu-
red as the change of adsorbence at 405 run using a V-max ELISA reader (Molecular 
Devices, Menlo Park, CA, USA). Standard curves were prepared using purified F XaY 
Factor VII and factor X were purified from freshly frozen plasma essentially as descri-
bed by Bajaj er al.Y' and by Miletich et al." The factor VII preparation was free of acti-
vated (two chain) F VII as judged by irnmunoblotring of reduced F VII with polyclo-
nal rabbit anti-F VII antibodies (kindly provided by Dr. Mertens, CLB, Amsterdam, 
The Nerherlands). The factor X preparation was free of activated F X after removing 
traces ofF Xa by passing the preparation over SBTI-Sepharose (Sigma). 
Statistical analysis 
Resulrs were expressed as mean ± standard error of the mean (SEM). Unpaired twO-
tailed 5rudent Ts T test was used for comparison bervveen groups, with Bonferroni 
correction applied when required. A p-value < 0.05 was considered significant. 
Results 
Smooth muscle cells 
Cells started to grow our from explants after 7-21 days independent of cell origin 
(intima, media, plaque). Initial cell outgrowth was seen in 25 (83%) of 30 
anempted cultures (2/3 of the small tissue pieces were involved in cell outgrowth). 
Only 7 of them could be subcultured and were used for perfusion experiments: 
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Table 2. Platelet oo~ of SIJI<IOIiI muscle cell (SMC) maIrices 
Source ofSMC matrices 
U69 intima 
U85 intima 
U69 media 
US5 media 
US6 media 
U81 plaque 
U86 plaque 
R84 plaque' 
Rl09plaque 
R19 restenosist 
Platelet coverage (%) 
16.1 ± 1.7 (n=8) 
13.0 ± 0.7 (n=8) 
17.5 ± O.S (n=14) 
16.2 ± 0.4 (n=6) 
15.1 ± 0.6 (n=8) 
22.7 ± 1.4 (n= ll) 
23.5 ± 1.4 (n=S) 
23.1 ± 1.1 (n=14) 
21.9 ± 1.3 (n=S) 
41.9 ± 1.7 (n=12) 
Platelet coverage was defined as the percentage of the surface 
covered by platelets and platelet aggregates. Values are mean ± 
SEM, n = number of coverslips evaluated. The smc matrices 
were tested in 2 independent experiments (blood from different 
donors), except' and t, which were tested in 4 (*) and 3(t) 
independent experiments. 
U69 (intima + media), USI (plaque), US5 (intima + media), U86 (media + pla-
que) (Table 1). The R-numbers in Table 1 represent cells obtained from atherec-
tomy specimens: 2 from primary atherosclerotic lesions (R84 + RI09) and 1 from 
a restenotic lesion (R19). Time to reach confluence was independent of its origin. 
Pe7fusions over smooth muscle cell matrices 
The results of the perfusion experiments are summarised in Table 2. Matrices 
derived from primary atherosclerotic lesions show a mean increase in platelet 
coverage of 46% compared with matrices derived from healthy intima and media. 
The higher platelet coverage on matrices of primary atherosclerotic lesions was 
observed in 4 independent experiments. 
Platelets deposited on matrices of healthy intima and media formed dense aggre-
gates with lime platelet spreading (Fig. 2A). Platelet aggregates on matrices of pri-
mary atherosclerotic lesions were larger (elongated), less compact and the platelets 
were more spread (Fig. 2B). A large increase in platelet coverage (169%) was 
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observed on matrices derived from restenotic lesions (Table 2). This increase was 
reflected in both an increase in the number of aggregates. and particularly an 
increase in platelet spreading (Fig. 2C). 
Collagen synthesis of smooth muscle cells derived from atherectomy tissue 
The resultS of the synthesis of collagen by smooth muscle cells obtained from pri-
mary and restenotic atheromatous lesions is shown in Table 3. Matrices syntheti-
sed by restenotic smooth muscle cells had a significantly higher content of colla-
gen than those from primary lesions. 
Tissue foctor (TF) activity of smooth muscle cell matrices 
The F Xa formation showed great variation between matrices derived from various 
patients (404-)05) ng.mt'min·', Table 4), but there was no systematic difference 
for smooth muscle cells from primary atherosclerotic or restenotic lesions. 
Table 3. Collagen synthesis of smooth muscle cells derived from 
atllerectomy tissue 
Patient No. 
R)9 
R84 
R)09 
Plaque origin 
Restenotic 
Primary ath. 
Primary ath. 
Collagen synthesis 
0.04) ± 0.004 (n~3) 
0.023 ± 0.00) (n~3)* 
0.025 ± 0.00) (n~6)t 
Synthesis of collagen was assessed by the incorporation of 3H-proline. 
The amounts are expressed as nMol.~ protein". Values are mean ± 
SEM. n ~ number of experiments. (*) p < 0.05, (t) p < 0.005 
Primary ath. ~ primary atherosclerotic plaque. 
Discussion 
Vascular smooth muscle cell proliferation and production of extracellular matrix 
are phenomena important to both typical and accelerated forms of 
atherosderosis.l.S.936 The advent of directional atherecroffiY as a therapeutic tool in 
percutaneous coronary revascularisation has facilitated the access to fresh samples 
of human atherosclerotic tissue from these syndromesY-39 Being biologically via-
ble, atherectomy specimens can be subject of cell culture, facilitating the study of 
their biological processes taking place in the atheromatous plaque from where 
they were obtained.1S-17.26 Likewise, in patients undergoing cardiac transplantation it is 
possible to use coronary material from the recipients heart for biological studies. 
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Tallie 4. TISSUe facIor (TF) acIMty of smooIi1 muscle cell (SMC) maIric:es. 
Source of SMC matrices 
U85 intima 
U69 media 
U85 media 
U86 media 
R84 plaque 
RI09 plaque 
Rl9 restenosis 
fXa formation (ng/mI) 
709 ± 44 (n= 7) 
1051 ±36 (n=8) 
715 ± 29 (n=7) 
1345 ± 69 (n=8) 
404 ±30 (n=8) 
990 ± 77 (n= 7) 
733 ± 65 (n=8) 
TF activity was estimated as activated factor X (F Xa) formation 
(ng.ml"' .min"') afrer preincubation of SMC matrices with factor VII 
and factor X. Values are mean ± SEM. n = number of coverslips. 
Studies using atherectomy specimens to investigate aspects of the thrombogenicity 
of coronary atheroma are still scarce. Lucore et al:,Q measured the procoagulant 
activity of atherectomy specimens obtained in 10 patients with acute coronary 
syndromes. The rate of elaboration of fibrinopeptide A of plasma incubated with 
the samples was compared with the angiographic morphology of the lesion and 
their hisrological buildup. Procoagulant activity was detected in samples contai-
ning only intima, and was particularly marked when organising thrombus was 
present. In the present study. we focused on the extracellular matrix produced by 
vascular smooth muscle cells and its reactivity towards blood platelets. Blood pla-
telets play an important role in the progression of atherosclerotic lesions by 
thrombus formation on damaged atherosclerotic tissue and release of growth fac-
tors. 1Oell In spite of this, the increased thrombogenicity of the neointima in animal 
models;12 or in the atherosclerotic plaque in human coronary aneries·13 is mainly 
thought to be the result of an increased tissue factor activity and fibrin formation. 
We demonstrated however that increased reactivity of the connective tissue 
towards blood platelets also contributes to the increased thrombogenicity of the 
atherosclerotic plaque. 13 In the current study we show that cultured smooth mus-
cle cells from atherosclerotic and restenotic coronary lesions produced extracellu-
lar matrices which were more adhesive for blood platelets than the extracellular 
matrices of cultured smooth muscle cells from healthy intima and media. 
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Figure 2 
Platelet deposition on smooth muscle cell matricesftom media 0), primdry atherosclerotic lesion (B), and 
r<Stenotic ksian (C), bar 0 2iJm. (D) Magnification oj(e) showingplatelet spreading (arrows), bar 0 1 Ljlm. 
Plarelers on smoorh muscle cells mauices of primary and resrenotic lesions showed 
a more spread deposition than on matrices of normal smooth muscle cells. This 
observation is relevant for several physiopathological processes at the level of the 
arterial wall (Fig. 3). Platelet spreading facilitates better platelet vessel wall interac-
tion; contact platelets and small thrombi with little platelet spreading are swept 
away more easily by the arterial blood flow. Furthermore, the amount of growth 
factors contained in platelets, such as platelet derived growth factor (PDGF), is 
strongly dependent on the surface covered by platelets, and not by the absolute 
number of platelets forming aggregates.? Platdets adhering the extracellular matrix 
of the subendothelium lose 97% of their a-granules in a very short period of 
time, while those forming aggregates do not undergo degranulation.~3 
Why do platelets adhere more to exuacellular mauices derived from atheromatous 
plaques, and why adhesion varies with different forms of atherosclerosis? We mea-
sured the amount of collagen in extracellular matrices of cultured smooth muscle 
cells derived from primary atherosclerotic and restenotic lesions treated with direc-
tional atherectomy, and found that the synthesis of collagen was significantly hig-
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Platelet aggregation 
Gf 
Platelet spreading 
GF 
Figure 3 
Implications of platelet 
spreading on vascular events. 
While contact platelets and 
small thrombi with little 
platelet spreading are swept 
away easily by the arteria! 
blood flaw (AJ. spreading 
Jacilitates better platelet vessel 
wall interaction (B). 
Furthermore, the absolute 
amount of growth foctors 
(CF) contained in platelet 
granules delivered to the 
arterial wall (small arrows) is 
proportional to the area 
covered by platelets. and not 
by its absolute number, as in 
forming aggregates. 
her in restenotic matrices. Although this might appear as a potential explanation 
for our observations, it must be remembered that an overall increase in collagen is 
not a prerequisite for enhancement of platelet adhesion, and in that regard pro-
bably the "quality" of matrix synthesis is a more determinant facror. Thus, increa-
sed platelet adhesion without a concomitant increase in collagen synthesis has 
been observed on extracellular matrices of fibroblasts cultured in the presence of 
ascorbic acid.4"1 An increase in platelet spreading on atherosclerotic plaques was 
also described by Nichols et a1:'s in von Willebrand Disease pigs. At this moment 
it is not clear for us which proteins are involved in increased platelet deposition 
observed in restenotic matrices, a fact that jUStiJY that more attention should be 
paid to extracellular matrix production in telation with the process of vessel hea-
ling after percutaneous revascularisation. 
There is evidence that the patrern of induction of tissue factor mRNA observed in 
vivo46 is similar to that observed in vitro in cultured cells:17 We did not find clear 
differences between smooth muscle cells matrices from healthy intima and media 
and matrices from atherosclerotic and restenotic lesions. Although high absolute 
levels of tissue factor activity were found in smooth muscle cells matrices derived 
from healthy intima and media, this was probably due to the presence of human 
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serum in the culture medium used. This observation corresponds with immu-
nohistochemical studies on cross section of coronary arteries in which the macrop-
hage derived foam cell was the most prominent cell type in the atherosclerotic pla-
que showing tissue faeror antigen, which has been either undetectable or found at 
low levels in the media of coronary arteries.41M '9 
The present study has severallimirations inherent to the use of smooth muscle cell 
culture as a model. First, isolation from the complex interaction that occur in vivo 
betvVeen smooth muscle cells and the surrounding extracellular matrix or other 
cell lines (eg., endothelial cells), may have caused modifications in cell phenoty-
pe.'" Nevertheless, this should have affected equally to smooth muscle cells derived 
from normal media. primary and restenotic atheromatous lesions. Selection may 
have occurred during cell passage and subculture (which constitute the material 
used in our perfusion studies). Finally, limitations in the availablity of tissue from 
restenotic coronary lesions precluded the realisation of a similar number of experi-
ments as those performed with the remaining sources of vascular material. 
This study is the first in which platelet deposition on extracellular matrices of cul-
tured smooth muscle cells from coronary lesions is investigated. In spite of the 
limitations discussed above, we believe that the results obtained justifY more atten-
tion to extracellular matrix synthesis in connection with platelet adhesion. 
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Abstract 
Background 
Tissue fragments obtained during directional coronary atherecromy may be used 
as biopsy material from the target atheromatous lesion, providing a direct insight 
on the pathological substrate and the characteristics of the smooth muscle cells 
(SMC) present in the plaque. By combining this information with clinical or 
angiographic data obtained during patient follow-up, it may be possible to study 
prospectively the relationship between the anaromopathological substtat, of the 
lesion and the likelihood of developing restenosis. 
Aim of the study 
To determine whether the degree of luminal renarrowing (loss of luminal cross-
sectional area) after successful atherectomy is related to 11 the ability of SMC pre-
sent in the atherecromy specimen to grow in a cell culture model, as well as to 21 
the presence of thrombus and 3/ the maximal cell density (MCD) documented 
during histological examination of the specimen. 
Methods 
A total of 86 directional atherectomy procedures were included in the study. 
Quantitative angiographic analysis was perfotmed before, after atherectomy and at 
follow-up in all cases. Cell culture was performed using an explant technique, 
choosing successfUl primary SMC outgrowth as a surrogate for the migratory and 
proliferative potential of SMC present in the specimen. In 26 cases plaque MCD 
was measured in a separate fragment of the cultured specimen using quantitative 
histology. 
Results 
Successful SMC outgrowth was obtained in 35/86 cultures (41 %). Significantly 
less loss in luminal area occurred in vessels giving samples with positive SMC out-
growth (1.69±1.74 mm' versus 2.62±2.08 mm' respectively, p=0.03). A strong 
trend tOwards less luminal renarrowing was observed in 8 patients (9%) whose 
atherecromy specimens contained thrombus (1.75±1.10 mm') than in those who 
did not (2.46±2.23 mm'). Mean MCD was 440:1:303 cells/mm'. A significant 
inverse telationship was found between MCD and luminal renarrowing (Luminal 
renarrowing =-2.20 Log MCD + 7.97, r=0.42, p < 0.05). 
Conclusions 
We found an invetse relationship between 2 indices of biological activity of SMC 
in atherectomy explanrs and the degree of subsequent restenosis. This may indica-
te that the removal of tissue with enhanced proliferative potential may be associa-
ted with less propensity to restenosis. 
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introduction 
Since its relatively recent introduction as a therapeutic device, directional coronary 
atherectomy has also attracted investigators as a potential tool for obtaining infor-
mation on the constitution of atheromatous plaque treated with the device. 1"(' In 
particular, most investigators have focussed their research on the vascular smooth 
muscle cell, which constitutes the kernel in the development of neointimal hyper-
plasia and restenosis after percutaneous intervention.6>7 
Several groupS,8.11 including ours,13.H have reported on the feasibility of culturing 
smooth muscle cells present in atherectomy specimens using a miniaturized cultu-
re system. The use of this model has facilitated observations on the migratory,;! and 
proliferative10. t .\ potential of smooth muscle cells from primary and restenotic 
lesions, and on the factors influencing this phenomenon. 13 However~ it remains 
unknown whether information obtained from smooth muscle cell culture can be 
used to gain insights on the clinical problem of restenosis. 
In the present study we investigate the relationship between an inde.x of biological 
activity of the atheromatous plaque, namely the ability of smooth muscle cells in 
the retrieved atherectomy specimen to proliferate in culture conditions, and the 
degree of angiographic renarrowing (measured as luminal loss) observed at the site 
of atherectomy in the long term. In a subset of patients the cellularity of the speci-
men was estimated and compared with the same purpose with the degree of 
angiographic renarrowing. 
Methods 
Study population 
The population in this study consisted of 86 patients who underwent directional 
coronary atherectomy and fulfilled the following criteria: aJ coronary angiography 
suitable for quantitative angiographic analysis pre-, POSt atherectomy and at 
follow-up, and (b) the procedure yielded atheromatous tissue which could be used 
for cell culture studies. Atherectomy was performed using the Simpson 
Atherocath and a conventional technique. t The coronary atherectomy protocol 
was approved by the Thoraxcenter Institutional Review Board, and informed con-
sent was obtained in all patients prior to intervention. In all patients a number of 
clinical details were recorded, including sex, age, coronary syndrome (stable or 
unstable angina), and previous coronary intervention at the site of atherectomy. 
Unstable angina was defined as continuous or intermittent chest pain at rest 
requiring hospitalisation, associated with electrocardiographic evidence of myocar-
dial ischaemia, but without associated increase in the serum cardiac enzyrn~. 
Quantitative angiographic analysis. The cineangiograms obtained before-, afcer 
atherectomy and at follow-up were analysed using the Cardiovascular 
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Angiography Analysis System (Pie Medical, The Netherlands)." All measuremems 
were performed in end-diastolic frames with optimal vessel opacification. Prior to 
quantitative analysis all contour positions of the contrast-free catheter tip and opa-
cified arterial segment were corrected for pincushion distortion induced by the 
individual intensifiers. 
Edge detection analysis was performed after selection and digitalization of a region 
of interest in a 512x512 pixel matrix using a high-fidelity charge couple device 
(CCD) videocamera. Luminal edges were then detected using a weighted sum of 
the first and second derivative function of the brightness profile of each vessel 
scanline. A diameter function was determined by computing the shortest distance 
berween the left and right Contour positions. Conversion of these measurements 
to absolute values was achieved by using the filmed contrast-free catheter tip as a 
scaling device. The diameter values are then plotted against the length of the 
analysed to obtain a so-called diameter function. Application of specific algo-
rithms to the diameter fUnction makes possible the calculation of a number of 
angiographic parameters, including the minimal luminal diameter. To facilitate a 
comparison with densitometric luminal area measurements, diameter values were 
transformed to area by assuming a circular morphology. 
The basic principle upon which videodensitometry is based is the existing rela-
tionship between the attenuating power of the lumen filled with contrast 
medium, which is a function of luminal area, and the X-ray image intensity.](' 
From this information a densitometric profile, which is proportional to the cross-
sectional area of the lumen, is obtained. To improve the relationship between den-
sity and luminal area, subtraction of patient structure noise is applied after com-
puting the linear regression through the background pixels located left and right 
of the detected luminal contours. In a similar fashion as described for edge detec-
tion, a cross-sectional area function on the analysed segment was obtained by 
plotting consecutive densitometric profiles in all scan-lines perpendicular to the 
vessel. An interpolated reference area was then calculated in a similar way to that 
described in the edge detection algorithm. Likewise, minimal cross-sectional area 
was calculated and expressed in mm:!. Conversion of individual videodensitome-
tric profiles to absolute values was performed after a transformation of the video-
densitometric profile found at the reference diameter with the corresponding geo-
metrical area (calculated from the reference diameter and assuming a circular 
cross-section at that point). 
Estimation of restenosis 
In an attempt to calculate the area of neointimal hyperplasia developing during 
follow-up after atherectomy, an angiographically-derived "restenotic area" was 
defined as the difference between the luminal cross-sectional areas documented 
immediately after atherectomy and at follow-up (Fig. 1). Restenotic areas were cal-
culated independently from both edge detection and densitometric data. 
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EDGE DETECTION DENSITOMETRY 
Figure :I. 
MlCA 
post DCA 
MlCA 
atFU 
Calculation of restenotic area foom edge detection and densitometric quantitative angiographic analysis. 
Dot:ted lines correspond to luminal boundaries immedio.te/y after atherectomy (post DCA), while solid 
edges correspond to those at flllaw-up (FU). Restenotic area was defined as the thorus of nssue comprised 
between both measurements {shadowed area}. Areas derived from edge detection analysis were derived 
from luminal diameters assuming a circular Luminal cross-section. Such assumption was not required 
with densitometry. MID: minimal luminal diameter,' MICA: minimal luminal cross-sectionttl area. 
Cell culture 
Atherectomy specimens were cultured by a cell biologist blinded to clinical data. 
The technique is shown schematically in Figure 2 and has been described in detail 
previously.13 .After being examined macroscopically, me atherectomy specimen was 
divided in two representative pieces. One of these pieces was dedicated to cell cul-
tures using an explant technique. Tissue explants were placed on human fibronec-
tin coated (10 Ilg/cm') glass cover slips in 2 cm' wells (Four well plates. Nunc) 
and cultured in 300!!1 culture medium {M199 with NaHCO, (GIBCO 
Laboratories) supplemented with glutamine, 10% human serum, 10% fetal calf 
serum, penicillin 100 IU/ml, streptomycin 0.1 mg/ml and mixed in a ratio of 1:1 
with conditioned medium from established smooth muscle cell lines actively gro-
wing in our laboratory). Cultures were maintained in a C02 incubator at 37°C in 
a humidified atmosphere equilibrated with 5% tv/v) CO, in air. The culture 
medium was changed every 3-4 days. Smooth muscle cell outgrowth was identi-
fied using inverted light microscopy and morphological criteria. These included a 
characteristic growth pattern of multiple layers of spindle or stellar shaped cells 
showing stress fibers and lamellipodia (Fig. 3). These morphological criteria were 
reinforced by positive immunostaining against smooth muscle cell a-actin 
(DAKO, Denmark) with human skin fibroblasts as negative controls. 
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Histology 
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Figure 2: 
Schematic representation of the techique of cell culture used in the present study (see text for detaiL~). 
Since primary outgrowth represenrs rhe ability of the cells to colonize the culture 
environment, this was chosen as a surrogate for the proliferadve and/or migratOry 
potential of the smooth muscle cells present in the specimen. We have previously 
used this index since it minimizes the modifications of cell phenotype associated 
with enzymatic dispersion, prolonged culture, cell division and successive cell pas-
sages,17o J9 and does not abolish the influence of other components of the atheroma-
tous plaque present in the explant that may contribute to the functional status of 
smooth muscle cells. 13 
Histology 
The fragmenrs of the atherectomy specimens dedicated to pathological examina-
tion were processed for light microscopy using hematoxylin-azophloxin and 
Verhoeff-van Giesson stains. Immunohistochemical staining for smooth muscle 
cell <x-actin was performed in selected cases. Thrombus was identified as amorp-
hous material, often in close apposition with atheromatous material, frequently 
showing collections of leucocyres between layers of fibrin. Discrimination berv,reen 
fibrin and dense collagen was performed using Verhoeff-van Giesson staining. 
Cell counting was performed in hematoxylin-azofloxin stained sections using a 
computer assisted system coupled to the microscope (!BAS 2000, Kontron, 
Oberkochen, Germany). After estimating the number of cell nuclei present in 
several microscope fields, the ma..ximal value recorded was used as an index of 
maximum cell density, and expressed in cells/nun". 
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Statistical ana!:ysis 
Mean values and standard deviations were calculated for all continuous variables. 
Linear regression analysis was performed using a least squares method. 
Comparison of mean values was performed using two-tailed unpaired (-test. 
Discrete variables were compared using chi-square test, and continuity correction 
applied when indicated. A p value of <0.05 was considered significant. 
Results 
The mean age of the 86 patients included in the study was 57±10 years. There 
were 69 (80%) males and 17(20%) females. Fifty patientS (58%) presented with 
stable and 36 (42%) with unstable angina pectoris. Most patients (67, 78%) 
underwent atherectomy in a de novo or primary atherosclerotic lesion. In 19 
patients (22%) atherectomy was performed in a restenotic lesion which developed 
after a previous revascularisation procedure, performed a mean of 159±119 days 
prior to the date of atherectomy. An average of 6±3 Cuts in multiple directions 
were made across each lesion. 
Analysis of atherectomy specimens 
Microscopic examination of the atherectomy fragments dedicated to histology 
revealed the presence of thrombus in 8 (9%) cases, more frequently in unstable 
than stable patientS (6/36, 17% versus 2/50,4% in stable and unstable patients 
respectively, p<O.05). Evidence of media or adventitia, indicating mat resection of 
deep layers of the vessel had occurred, was found in 23 (27%) cases. Quantitative 
histological analysis revealed a mean maximal cell density in the specimens of 
440±303 cells/mm'. 
Results of smooth musck cell culture 
Successful smooth muscle cell outgrowth was obtained in 35/86 cultures (41 %). 
Smooth muscle cell outgrowth appeared as multiple layers of cells with spindle or 
polygonal shape and multiple stress fibers extending to lamellipodia. In the same 
cultures macrophages were clearly distinguished from smooth muscle cells on the 
grounds of a characteristic oval morphology, with eccentrically placed small, 
indented nuclei. Immunoperoxidase staining with macrophage specific HAM 56 
was used to confirm that these cells were macrophages. 
Results of quantitative angiography 
Quantitative angiography revealed a mean reference diameter in the treated vessels 
of 3.17±o.66 mm. Minimal luminal diameters before, after atherectomy and at 
follow-up were L26±O.50, 2,41±0,48 and L70±0.58 mm respectively, from 
which luminal cross-sectional areas of L47±L46, 4.81±L83 and 2.56±L55 mm' 
(before, after atherectomy and at follow-up respectively) were calculated by assu-
ming a circular luminal morphology. Densitometric analysis revealed a reference 
area of 8.16±3.27 mm', and a minimal luminal cross-sectional area of L52±L40, 
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Figure 3 
Fragment of retrieved tissue 
after 11 days in culture 
examined with phase-
contrast microscopy. A dense 
population of cells migrating 
out of the atherectomy 
explant are evident. These 
eelb folfill the 
morphological criteria of 
myofibroblastJ discu~·sed in 
detail in the tlxt. (OrigiWl! 
magnification: x60, X120). 
4.71±1.80 and 2.83±2.24 mm' before, after atherectomy and at follow-up respec-
tively. After atherectomy, the discrepancy between edge detection and densitome-
tric minimal luminal cross-sectional area values was higher in lesions where deep 
vessel resection had occurred, as judged from the presence of media±adventitia in 
the retrieved specimen (discrepancy of 0.27±o.97 mm' versus -0.00S±o.37 mm' 
in cases with and without deep vessel resection respectively, p~0.06) 
From the obtained angiographic data, restenotic areas of 2.23±1.99 mm2 (edge 
detection) and 1.88±2.53 mm' (densitometry) were derived. Figure 3 shows the 
linear regression analysis beevveen edge detection and densitometric restenotic 
areas. Correlation coefficient was 0.89. When compared with videodensitometry, 
edge detection tend to overestimate restenotic area (mean difference between edge 
detection an video densitometry 0.14±o.91 mm', intercept +0.37). The discre-
pancy between edge detection and densitometry restenotic area values was more 
marked in lesions with evidence of deep vessel resection in the retrieved specimen 
(discrepancy of 1.15±2.93 versus O.09±o.87 mm' in cases with and without evi-
dence of media or adventitia in the retrieved specimen respectively, p~O.Ol). 
Figure 4: 
Correlation between 
restenotic areas derived 
from edge detection 
and densitometric 
quantitative 
angiographic aWllysis. 
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Comparison between histological, cell culture and angiographic data 
A significantly smaller angiographic restenotic area was observed to have develo-
ped in cases with successful smooth muscle cell outgrowth duting culture (Fig. 5). 
Restenotic area derived from edge detection analysis was 1.69±1.74 mm' and 
2.62+2.08 in cases with and without documented smooth muscle cell outgrowrh 
respectively (p=0.03). This difference was also noted in restenotic areas obtained 
from densitometric analysis: 1.22±2.99 mm' and 2.34+2.10 mm' in cases with 
and without documented smooth muscle cell outgrowrh respectively (p=0.04). 
0 Successful 
I Failed 
Resten. 
area 
(mm2) 
Figure 5 
3 
1.69 
:to.29 
Edge detection 
p = 0.04 
1.22 
:to.50 
2.34 
:to.29 
Densitometry 
Comparison between restenotic areas in vessels with and without smooth muscle cell outgrowth from the 
retrieved specimens. 
The presence of thrombus was associated with an increased outgrowth rate (6/8, 
75% versus 29/78, 37%, in specimens with and without documented thrombus). 
There was a strong trend tOwards less angiographic restenotic area at follow up in 
patients whose atherectomy specimens contained thrombus (n=8, restenotic 
area=1.75±1.10 mm') than in those without documented thrombus (n=78, reste-
notic area=2.46±2.23 mm'). 
A significant inverse relationship was observed between angiographic restenotic 
area and me degree of cellularity documented in the retrieved atherectomy speci-
mens. Figure 6 shows the regression analysis of cellularity and restenotic area esti-
mated with edge detection and densitometric quantitative angiography. 
No significant difference was found in restenotic area documented in vessels v.rith and 
'Without evidence of deep resection in the atherectomy specimen. Vessels where resec-
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Linear regression 
analysis between 
the maximLZi 
cell density 
documented in 
the atherectomy 
specimen and the 
subsequent 
degree of 
restenotic area, 
as estimated 
from edge 
detection 
(squares) and 
densitometric 
{circles} 
quantitative 
angiography 
measurements. 
cion of media ± adventitia in the retrieved specimen had mean restenotic areas of 
2.43±2.09 (edge detection) and 1.88±2.56 (densiwmetry) mm', while in those 
without evidence of deep vessel resection restenotic area were 12.17±2.02 (edge 
detection) and 2.08±2.07 (densiwmetry) mm'. 
Comparison between clinical, cell culture and angiographic data 
No significant differences in the rate of smooth muscle cell outgrowth was noted 
between patients with stable or unstable angina (18/50, 36%, versus 17/36,47% 
in stable and unstable patients respectively, p=NS), nor between patients with res-
tenotic or de novo lesions (9/19, 47%, versus 26/67, 38% in restenotic and de 
novo lesions respectively, p=NS). Likewise, quantitative angiographic analysis 
using edge detection revealed no significant differences in restenotic area was 
noted in relation with the coronary syndrome (2.36±1.91 mm'vs 2.08±2.13 mm' 
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in stable and unstable patients respectively, p=NS), nor between restenotic and de 
novo lesions (2.10±2,28 mm' vs 2.28±1.93 mm' in restenotic and de novo lesions 
respectively, p=NS). Densitometry revealed similar results to edge detection analy-
sis: restenotic area was 2.04±2.16 mm' vs 1.68±3.03 mm' in stable and unstable 
patients respectively (p=NS), and 2.21±2.28 mm'vs 1.79±2.63 mm' in restenotic 
and de novo lesions respectively (p=NS). 
Discussion 
The vascular smooth muscle cell plays a key role in the development of restenosis 
after percutaneous revascularisation techniques. j Fibromuscular hyperplasia is 
recognised as the dominant pathological subsuate of restenosis;'.5 and represents a 
response of the vessel wall ro the damage inflicted by the recanalisation procedure. 
Although the sequence of events leading to the development of restenosis starts 
after intervention and appears to be proportionally related to the degree of vessel 
wall injury, it is quite likely that the preexisting lesion substrate may influence the 
subsequent degree of smooth muscle cell proliferation in the intima. By serving as 
biopsy material from the target amerornatous lesion, atherectomy specimens can 
offer a more direct insight on the pathological substrate and the characteristics of 
the smooth muscle cells present in the treated lesion. In addition ro this, the infor-
mation obtained from the retrieved tissue can be combined with clinical or angio-
graphic data obtained during patient follow-up, offering the unique opportunity 
of studying prospectively the relationship between the anatomopathological subs-
trate of the lesion and the likelihood of developing restenosis. 
The present study is the first to compare the ability of smooth muscle cells present 
in atherectomy specimens to grow in culture conditions with the change in lumi-
nal dimensions in the target lesion. As stated above, we believe that documenta-
tion of smooth muscle cell outgrowth serves as a simple index of the ability of 
smooth muscle cells in the retrieved tissue to colonize the surrounding environ-
ment, and constitutes a surrogate for their proliferative and migratory potentiaL 
Some of the limitations of cell culture as an experimental model for this purpose, 
such as the modification of cell phenotype associated with enzymatic dispersion, 
prolonged culture, cell division and successive cell passages"-" and lack of the 
influence of other components of the atheromatous plaque were minimized in the 
present study by using an explant technique and limiting observations to the pri-
mary culture. 
Particular attention was paid to the collection and analysis of angiographic data 
and its correlation with biological variables. First, we used an angiographically-
derived area of restenosis which appears as a direct index of the amount of neoin-
timal tissue formed and is not influenced by vessel size. This offers the advantage 
of using a continuous variable which is likely to be a better estimate of the deve-
lopment of neointimal hyperplasia than discrete variables (eg.2500/0 diameter ste-
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nosis)."'" The second aspect relates to the modality of quantitative analysis used. 
Estimation ofluminal cross-sectional area may be influenced by marked irregularities 
in luminal morphology resulting from localized excision of tissue. A lack of relations-
hip between the volume of extracted atheromatous fragments and the change in 
luminal area has been reporred by using edge detection quantitative angiography.::~ In 
that regard, densitOmetric analysis may constitute the technique of choice since it cal-
culates luminal cross sectional area directly from the densitomettic profile without 
any assumptions on luminal morphology.'" Alternatively, it would be expected that 
routine performance of multiple cuts in different directions would contribute to 
achieve a rather circular lumen, and that the use of edge detection in estimating lumi-
nal cross-sectional area would be justified." However, no firm conclusions have been 
derived so fur as to which is the angiographic modality of choice in the assessment of 
luminal area afier atherectomy, and a similar degree of discrepancy between luminal 
cross-sectional area derived from edge detection and densitometry to that found 
balloon angioplasry has been reporred.'" On these grounds, in the present study we 
report luminal area and restenocic area measurements using both approaches. In fact, 
concomitant use of both methods has provided new insights on the evaluation of 
atherectomy results with quantitative angiography: Alier atherectOmy the discrepancy 
observed in luminal area (as well as in the restenotic area) calculated by both techni-
ques was related to the presence of media or adventitia in the retrieved specimen. 
Opacification of deep localized cuts might have caused overestimation of both lumi-
nal dimensions and restenotic area as assessed by edge detection. 
The principal finding of this study was the observed inverse relationship between 
smooth muscle cell outgrowth from atherectomy specimens and the degree of reste-
notic area developing during follow up. Although these results may appear paradoxi-
cal, a possible explanation may be that unlike balloon angioplasty, evacuation of athe-
roma with a high proliferative potential for smooth muscle cells may effectively remo-
ve a favorable plaque substrate for restenosis. 
Several studies have suggested the existence of a relationship between the develop-
ment of restenosis and me presence of hisrological or molecular markers in atherec-
tomy specimens thought to identifY smooth muscle cells with an enhanced prolifera-
tive potential. Leclerc et al.::s found that smooth muscle cells present in restenotic 
lesions express the B isoforrn of nonmuscle myosin heavy chain (NMMHC) more 
frequently than primary lesions. The expression ofNMMHC was used as an index of 
the activation of a gene which is involved in cellular events crucial ro restenosis, such 
as involved in cell division, alteration of cell shape and chemotaxis. In a later work," 
the same authors investigated prospectively a population of 20 patients undergoing 
directional atherectomy. The obtained specimens were hybridized with a probe for 
the heavy chain ofNMMHC. An increase in the e.xpression of this marker was rela-
ted with a higher restenosis rate, defined as a diameter stenosis> 50% at follow-up. 
With a similar aim, Depre et alY studied the predictive value of atherectomy speci-
mens incubated in tritiated thymidine and later Stained with phosphotunstic acid hae-
matoxylin. Thymidine labeling was observed in 75% and 25% of cases with and wit-
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hout restenosis respectively, although the experiments were performed in only 9 
patients. Restenosis was defined categorically, by grouping patients in 3 categories of 
lwninal diameter loss (loss 20.72 rrun, 20.36 rrun and <0.36 rrun respectively). The 
authors found that the presence of abnonnal fibromyocytes with stellar shape correlated 
with inereased thymidine labeling and lwninalloss 20.72 rrun. Based on the hypothesis 
that the identified cells were activated smooth muscle cells, the same authors have 
recently tested their initial findings in a retrospective fashion~<l using histologic and 
angiographic data from 105 patients enrolled in the CAVEAT srudy.>' In this larger 
population 3 continuous angiographic variables (luminal diameter loss, relative loss and 
% diameter loss) were used to assess restenosis. Contrary to the preliminary results, this 
study demonstrated that restenosis was not increased in patients wim documented ste-
llar-shaped fibromyocytes in the retrieved specimens. In fact, a trend towards less lumi-
nalloss in those cases where such cells were present was noted. 
In a recent report by Isner et al." on the histological samples obtained during the 
CAVEAT srudy an inverse relationship between the presence of thrombotic material in 
athereeromy specimens and the subsequent degree of lwninal diameter loss was also 
noted. This finding is supported by our data, where the angiographic restenotic area 
was subStantially less in atherectomy specimens containing thrombus. Such findings 
also appear paradoxical since development of mural thrombus has been proposed as a 
key faeror in the development of neointimal hyperplasia.""'" Thrombin e.,errs a che-
motactic and mitogenic effect on vascular smooth muscle cells and stimulates the 
expression of both growth faerors and their receptors.3637 Our group has demonstrated a 
link between mural thrombosis and enhanced proliferative potential of the smooth 
muscle cells present in the atheromatous plaque, using the same cell culture model as in 
the present study." The presence of thrombus in cultured coronary atherectomy speci-
mens was the only clinical or histological variable with a positive influence on smooth 
muscle cell outgrowth. The explanation of this paradox is again that removal of the 
thrombus containing plaque may in some way diminish the propensity to restenosis. 
We also found an inverse relationship between the angiographic restenotic area and the 
maximal cellularity documented in the atherectomy specimen. To our knowledge only 
one previous srudy has correlated the cellularity of atherectomy specimen with the deve-
lopment of restenosis. Suarez de Lew et al." have reported that the degree of lwninal 
loss was proportionally related to the cellularity of the atherectomy specimen. In that 
study restenosis was defined as a loss 250% of the gain in lwninal diameter documen-
ted afrer atherectomy. Using this categorical definition the authors found that the nucle-
ar content (defined as percent area of the histological cut covered by cell nuclei) in the 
resected material was higher in those patients who later develop resrenosis. At first glan-
ce these results are in disagreement with those from the present study, where the existen-
ce of an inverse relationship between restenotic area and cellularity was disclosed. 
However, this may be artributable to major differences in the methodology, such as the 
use of computerised quantitative angiography and analysis of restenosis as a continuous 
variable in our srudy, as well as the application of a different quantirative histological 
analysis. On the other hand, support for a negative relationship between cellularity in 
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atherecromy specimens and restenosis can be found in the work of Depre er al. 0' dis-
cussed above, where a trend towards an inverse relationship between restenosis and the 
presence of stellar shape fibromyocyres (typically found in hypercellular lesions)" in the 
reseered tissue was noted. 
What are the potential implications of these findings for the clinical application of 
directional atherecromy? Should this proposed hypothesis receive further suppOrt in lar-
ger series, identification oflesions with a high potencial for smooth muscle cell prolifera-
tion might lead to selection oflesions which would benefit from the use of directional 
atherecromy in reducing restenosis in the long-term. Information might be derived 
from inuacoronary imaging techniques. Angioscopy is a sensitive technique in detec-
ting inuacoronary thrombus. Likewise, further developments in fluorescence spectros-
copy may allow identification of hypercellular lesions. Furthermore, the considerations 
giving origin to the hypothesis used in our study have major methodological implica-
tions for longitudinal studies using atherectomy specimens to assess baseline characteris-
tics of the atheromatOus plaque. Researchers should be aware that the e.,-uaction of 
atheromatous tissue imposes a significant modification of plaque substrate, which is 
likely to result in a modification of plaque evolution. 
study l.imiratWns 
Although an angiographically-derived area of restenosis was used in an attempt to get 
an optimal correlation between the biological phenomenon of restenosis, other non-
proliferative components of the process of restenosis cannOt be excluded. By comparing 
the actual volume of tissue retrieved and the angiographic change in luminal volume 
Penny er al. have suggested that atherectomy may be usually associated with Dotter or 
"facilitated mechanical angioplasry" eifecr." Whether a recoil phenomenon similar to 
that observed after balloon angioplasty may occur is uncertain, but remains a potential 
inrerference with our methodology, based upon the premise that resrenotic area correla-
tes well with the development of neointimal hyperplasia. However, we cannot find any 
reason for which such effect would be unevenly distributed betWeen the groups consi-
dered in this study. 
Although the samples were meticulously studied to ensure thar the rissue fragment 
dedicated to histology and cell culture sample was, at least from a macroscopic poinr of 
view, representative of the whole specimen, the possibility thar the two pieces were sig-
nificantly different cannot be ruled out. However, we and other authors' feel that the 
benefit derived from the combined information obtained from histopathology and cell 
culture justifies this methodological approach. 
Two major randomised multicenter clinical trials have demonstrated that the res-
tenosis rate associated with the use of directional amerectomy is similar to that of 
balloon angioplasty.30M It is beyond the scope of the present study to compare the 
two subsetS of patients identified by smooth muscle cell culture with a comparable 
popularion of patients treated with balloon angioplasty in rerms of restenosis 
development. 
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Abstract 
Two methods of percutaneous coronary recanalisation, balloon angioplasry and directional atherec-
tomy, have been reported for the non-surgical treatment of focal atherosclerotic lesions in transplanted 
hearts. Little is known on the changes that take place at the site of intervention in these patients, who 
develop accelerated atherosclerosis and are under immunosupressive therapy. In the present study we 
present the clinical and angiographic evolution of 3 patients with atherosclerosis of the cardiac allo-
graft in whom directional atherectomy was used to treat a focal stenosis. Histological evidence on the 
histopathological characteristics of the stenoses was obtained by stndying jirst the retrieved atherectomy 
spetimens, and later (5301114 days) the cardiac allograji, obtained during autopsy in 2 cases and 
ofter retransplantation in 1 case. 
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Ilitroductioll 
Atherosclerosis following heart transplantation that constitutes the main cause of 
death in patients surviving the first postoperative year. Although limited by the 
characteristic diffuse involvement of the coronary tree, percutaneous recanalisa-
don using balloon angioplastyt.s or directional coronary atherectornr-8 constitute 
helpful therapeutic alternatives in the treatment of focal stenoses. However, vir-
tually no information is available on the histological changes taking place at the 
site of percutaneous intervention in these patients, in whom the biological subs-
trate of accelerated atherosclerosis and the concomitant use of immunosuppressive 
therapy can modifY the development of restenosis. We present three cases of ort-
hotopic cardiac transplantation and new focal atherosclerosis treated with directio-
nal coronary atherectOmy in which a histopathological study of the of the trans-
planted heart was available in the long-term. 
Methods 
Clinical and procedural characteristics. 
Directional coronary atherectomy using the technique described by Simpson et 
al.') was performed in 3 patients who developed focal coronary stenoses in a car-
diac transplant allograft. Two of these procedures were performed at the Academic 
Hospital Dijkzigt in Rotrerdam, The Netherlands, and 1 at the Cardiac Center in 
San Diego, California. In both institutions the procedure was performed accor-
ding with procedural protocols approved by the respective ethical committees and 
after obtaining written consent. All three patients undervvent recanalisation with a 
6 Fr atherocatheter without adjunctive balloon angioplasry. Aspirin and dypirida-
mol was given in the 3 cases following intervention. Patient follow-up was perfor-
med prospectively as part of the cardiac transplant program in which the patients 
were enrolled. In the long term, (\Vo of the patients died and one undervvent car-
diac retransplantation. This made possible the documentation of the pathological 
changes that took place in the treated coronary segment from the time of atherec-
tomy (mean ± SD days). 
Pathological examination 
The coronary arteries were removed once the site where atherectomy took place 
was identified with the help of angiographic frames obtained at the time of the 
procedure. In two cases (1 and 3) fIxation was performed under pressure. Multiple 
sections at 2 mm intervals were obtained and processed for light microscopy. 
Sample staining was performed using hematm.:ylin-azophloxin and Verhoeff-van 
Giesson techniques, as well as immunohistochemical staining for smooth muscle 
cell <x-actin (Sigma, Sf. Louis, USA). 
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Results 
Casel 
A 28 year-old caucasian female underwent orthotopic heart transplantation for 
the treatment of peripartum cardiomyopathy. She experienced recurrent episodes 
of acute and ongoing cardiac rejection which were treated with methylprednisolo-
ne and anti-T cell antibodies initially, and chronic azathioprine therapy thereafter. 
Systemic hypertension and mild chronic renal failure developed gradually. At the 
3rd year angiographic follow-up, a focal 50% stenosis was disclosed in the mid 
segment of the left anterior descending coronary artery. The following year the 
lesion had progressed to an 80% stenosis. Stress scintigraphy was performed, sho-
wing a reversible anterior perfusion defect. Directional atherectomy was perfor-
med successfully and uneventfully. Follow-up angiography 10 months later disclo-
sed an acceptable long-term result, with <300/0 residual narrowing, although a new 
focal 400/0 diameter stenosis was evident in the proximal segment of the right 
coronary artery. This new stenosis was judged as not requiring recanalisation. 
Twelve months after atherectomy the 
patient presented with left ventricular failu-
re due to a silent inferior myocardial infarc-
tion, which was treated conservately. 
Sixteen months after atherectomy the 
Figure 1 
Histological findings in patient 1. 
(A) Atherectomy specimen showing a predominantely fibrous 
t1ssue with a fragment of internal elastic lamina (arrow) and 
medw. (Elastic stain). 
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(B) Duringpost-
mortem examination 
the site of 
atherectomy could be 
clearly identified by 
the discontinuation 
of internal elastic 
lamina (arrow) and 
media in the vascular 
wall. There was 
extensive neointimal 
proliferation 
protruding in the 
vascular lumen. 
(Elastic stain). 
patient was admitted with hypotension and acute renal failure. An ECG showed 
an acute myocardial infarction in the anterolateral territory. Although her condi-
tion was initially controlled with inotropes, the patient died as a consequence of 
asystOle refractory to cardiopulmonary resuscitation. 
Pathological findings 
Two tissue fragments were obtained. Serial sections of one of the specimens sho-
wed fragments of the internal elastic lamina? media and adventitia, providing evi-
dence of deep vessel resection (Fig lA). No evidence of foam cells or cholesterol 
crystal clerrs was found. 
During examination of the coronary vessel dur;n:::: autopsy the site corresponding 
to the atherectomy could be clearly identified in consecutive transverse sections by 
the absence of the deep vessel layers which were previously noted in the atherec-
rorny specimens (Fig IB). A large area of neointimal hyperplasia originating from 
this point and causing severe compromise of the vascular lumen was clearly distin-
guishable from the denser fibrous tissue of the older plaque. This area of newer 
tissue was significantly more cellular than pre-existing tissue (as documented in 
the specimen and in remanant plaque) (Fig. 1 C). No lipid deposits were found. 
Immediately distal to the site of atherectomy. the coronary vessel was occluded by 
a thrombus with areas of platelet rich and red constitution. An area of myocardial 
infarction was evident in the distribution territory of the vessel. Areas of old myo-
cardial infarction were identified in the inferior ventricular wall. 
Case 2 
A 51 year-old caucasian male underwent cardiac transplantation for end-stage 
ischemic cardiomyopathy. Post-operative recovery was complicated by necrotizing 
pseudomonas pneumonia requiring right upper lobe resection. Cytomegalovirus 
viremia was diagnosed five months after transplantation but resolved without tre-
atment. No acute moderate rejection or significant infection followed. During the 
4th annual arteriogram, a 500/0 mid right coronary and 80% posterior descending 
artery stenoses were noted. Intravascular ultrasound imaging of the mid right 
coronary lesion revealed homogeneous echogenicity consistent with a fibrous, 
non-calcified, plaque buildup. Lerr ventricular angiography show a 65% ejection 
fraction and no significant ventricular wall motion abnormalities. Over the next 
two months increasing exenional dyspnea and intermittent ankle edema develo-
ped. Repeat angiography showed further progression of the mid right coronary 
and posterior descending artery stenoses (750/0 and 850/0 diameter stenosis respec-
tively). Stress scintigraphy showed a large, reversible inferior ischemic zone. 
Percutaneous revascularisation of both lesions was performed using directional 
atherectomy in the mid right coronary and balloon angioplasry in the posterior 
descending stenoses. Both procedures were uncomplicated and the patient was 
discharged. However, 48 hours afi:er the procedure had a pre-syncopal episode 
accompanied by profuse sweating bur did not seek medical advice. Several weeks 
later the patient was examined during rourine follow-up. Resting electrocardiogram revealed 
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Figure 2 A 
Histological findings in Case 2. 
A: Atherectomy specimen showing dense 
fibrous tissue. 
new, small Q waves and inverted T 
waves in the inferior leads with non-
specific ST changes. Thallium exerci-
se treadmill demonstrated a large, 
fLxed perfusion defect. The study was 
prematurely terminated after AV 
block resulting in syncope developed. 
Ambulatory electrocardiographic monitoring was performed, showing long sinus 
pauses leading to an idioventricular rhythm associated with exertional dyspnea. A 
new coronary arteriogram disclosed a 900/0 mid right coronary stenosis and occlu-
sion of the posterior descending artery, as well as diffuse progression of atheroscle-
rosis in the proximal segment. Further narrowing was also noted in other epicar-
dial branches. Ventriculography showed an 39% ejection fraction with posteroba-
sal and inferior akinesis. The patient was evaluated for retransplantation which 
was successfully performed a year later. 
Pathological findings. 
Four small pieces of whitish-gray tissue were recovered, consisting of moderately 
dense fibrous tissue (Fig. 2A). Some cholesterol crystal clefts were also noted. A 
fragment of media was also evident in one of the specimens. 
Examination of coronary sections obtained from the hean after re-transplantation 
showed a virtual occlusion of the vessel at the level where atherectomy had taken 
place. Around 40% of the area comprised within the internal elastic lamina 
corresponded to mixed atheromatous plaque containing both fibrous tissue and 
cbolesterol crystal clefts. The remaining lumen was filled by neointimal proliferation 
showing multiple multiluminal channels, suggesting organisation of a previous 
episode of thrombotic occlusion (Fig. 2B). At the site of occlusion the interphase 
between pre·existing cholesterol crystal clefts and newly formed neointimal hyper· 
plasia showed numerous multinucleated giant cells (Fig. 2C), which are likely to 
represent a foreign body reaction against the lipidic plaque core after being expo-
sed to the bloodstream by atherectomy. Distal to this segment the depending 
myocardium showed patchy fibrous scarring consistent with an old sub-endocar-
dial infarction of the infero-posterior wall. 
Case 3 
Patient 3 was a 37-year-old caucasian male transplanted for the treatment of dilated 
cardiomyopathy. He had one episode of acute rejection after transplantation. He 
resumed smoking. Average cholesterol during follow-up was 5.9 mmoliL and serum 
triglyceride 1.8 mmoliL. A focal eccentric lesion was identified during the 5th year 
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Figure 2 Band C 
Histological findings in Case 2 
{continuation}. 
B: Cross section of the vessel at the 
site of atherectomy obtained in the 
transplanted heart after 
retransplantation, showing total 
vessel occlusion by fibrous tissue 
with multiluminal channels, the 
latter suggesting a prior episode of 
thrombotic occlusion with partial 
recanalisation. The remnant 
plaque shows dense fibrous tissue 
with areas of cholesterol crystal 
clefts· 
C: At the interphase between the 
occludingfibrous tissue and the 
old plaque numerous 
multinucleated giant cells (arrow~) 
were visible, probably in relation 
with the exposure of lipidic plaque 
material to the bloodstream after 
control angiogram in the 
left circumflex coronary 
artery. Reversible ischaemia 
in rbe left ventricular poste-
rior wall was demonstrated 
during stress scintigraphy. 
Directional arberectomy was performed successfully and uneventfully. Coronary 
angiography 7 months later revealed no significant restenosis. He subsequently 
underwent laparotomy twice because of a perforated peptic ulcer and peritonitis.The 
post-operative course was complicated by adult respiratory distress syndrome, multi-
organ failure and pneumonia. After this hospital admission, rbe patient was started 
on haemodialysis for chronic renal insufficiency secondary to cyclosporin treatment. 
Twenry-two monrbs after arberectomy rbe patient suffered circulatory arrest. The 
patient was resuscitated, alrbough did not regain consciousness and died 3 days later. 
Pathological findings. 
Three pieces of whitish tissue wirb brownish areas were obtained. These were compo-
sed mainly of poorly cellular fibrous rissue. Evidence of internal elastic lamina and 
media were also found. At rbe site of arberectomy, rbe circumflex artery obtained 
during auropsy showed evidence of rbe prior excision of deep vessel layers, reaching 
rbe adventitia. A large area of neointimal hyperplasia filled rbe resected area of plaque 
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Figure 3 
Histological finding;-
in patient 3. 
(AJ In the post-mortem 
coronary specimen a 
large area of 
fibromuscular 
hyperplasia (FMH) 
originates }Tom the site 
of atherectomy, which 
can be identified (B) 
by the missing internal 
and external elastic 
lamina (arrowj), 
media and adventitia 
in the vascular wall. 
(Elastic stain). 
and deep vessel wall, """tending to the remaining lumen. The newly formed tissue 
was clearly more cellular and had a looser eA1:Tacellular matrL" than that forming the 
old plaque, and contained numerous plasma cells. No cholesterol crystal clefts or 
foam cells were identified. 
Discussion 
Cardiac allograft atherosclerosis has a reponed prevalence of 2% and 25% in the 
first year, and as high as 50% at 5 years after transplantation. <C." It constitutes the 
predominant cause of death of cardiac transplant patients following the first pos-
toperative year. Retransplantation does not constitutes a practical solution to this 
problem since it is currently associated vvith an increased mortality,13 while puts in 
--105--
jeopardy the higher chances of survival of patients waiting for their first cardiac 
transplantation. Coronary angioplasry has been proposed as a potential alternative 
for the treatment of focal occlusive disease in transplanted patients,'·5 and prelimi-
nary results from a multicenter study suggest that although its procedural success 
and complication rate are similar to that associated -with routine coronary angio-
plasty, it is associated with a high restenosis rate. The feasibility of directional 
coronary atherectomy as a recanalisation technique in these patients has also been 
reporred.6-' The potential benefit derived from the use of percutaneous coronary 
revascularisation is emphasised by recent evidence that the presence of focal steno-
ses in the proximal and mid-epicardial vessels drecrease actuarial survival in heart 
transplanted patients. I', 
The cause of post-transplant accelerated atherosclerosis remains unclear. Several 
causes have been proposed, including ongoing immune-mediated vascular 
injury,15.16 endothelial injury during the pre-implantation period,16 injury associa-
ted with viral infection,17.18 cardiac denervation, and a high prevalence of risk fac-
tors for coronary artery disease, particularly hyperlipidaemia and hypertension 
which were either preexisting or develop as a result from cyclosporin and corticos-
teroid therapy. <6. " Transplant vasculopathy presents histological differences with 
classic forms of atherosclerosis, including the absence of medial thinning, a predo-
minantly concentric distribution of atheroma. ".20." Indeed, early transplant athe-
rosclerosis resembles post-angioplasty restenosis in the development of neointimal 
hyperplasia as the dominant pathological feature of the disease, having been docu-
mented as early as 1 week after transplantation. ll Late development of more com-
plex atheroma in the transplanted heart, with extensive lipid deposits, appears to 
be related to a number of concomitant pro-atherogenic factOrs that are nearly uni-
versal to all transplanted patients, including the development of unfavorable lipid 
profiles and systemic hypertension associated with the use of immunosuppressive 
drugs. 19 A relation between these factors is becoming clear. In a recent report using 
combined angioscopy and intravascular ultrasound imaging, Ventura et al.~~ has 
demonstrated that xanthomatous atherosclerotic plaques, which suggest the pre-
sence of lipid deposits in the plaque, were associated with a longer time interval 
from transplantation, higher serum cholesterol levels and more severe obstructions 
than those atheromatOus plaques with white surface. This is in agreement with the 
findings of Johnson et al.'" who found that, in contrast with diffuse lesions, focal 
coronary stenoses present in transplanted patients are frequently rich in lipid 
deposits. In this regard, the characteristic extracellular matrix of neointimal hyper-
plasia, which is rich in glycosaminoglycans," may favor the uptake of lipids as 
during the early stages of coronary atherosclerosis.2.' 
The consequences that plaque disruption secondary to percutaneous intervention 
has on subsequent pathobiological events of this particular type of accelerated 
atherosclerosis are unknown. Potentially, the development of a restenotic neointi-
rna could be either potentiated by the biological substrate (enhanced reactiviry 
towards blood platelets, presence of activated cells"''') or reduced by the adminis-
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cranon of concomitant .immWlosuppressive therapy. Information on the long-term pat-
hological changes found at the site of angioplasry in transplanted hearts is extre-
mely limited. Shandu et al:' make a short tefetence to the autopsy findings in 2 
heart transplant patients after balloon angioplasty included in his series. 
Neointimal hyperplasia was the dominant pathological finding. No significant dif-
ferences were noted bervveen the angioplasry site and neighbor coronary segments. 
At a difference with these observations, in our 3 patients we could identifY the 
exact location of the treated site not only by comparing the angiogram with the 
coronary anatomy while dissecting the heare, but also by the absence of internal 
elastic lamina and media resulting from atherectomy. Our observations suggest 
nOt only that neointimal hyperplasia is found in response to percutaneous inter-
vention in transplanted hearts, but also that it presents different morphological 
features than the pree.xisting fibrous tissue existing in the plaque. 
All 3 cases presented in this work fall in the angiographic category of type A 
lesions. ""0 Type A lesions have been shown to contain lipid deposits in 67% of 
cases, in conttast with 14% of type B." In the present study, lipid deposits in the 
atherectomy specimen or at the treated segments could be demonstrated only in 1 
patient, although the small number of patients studied ptecludes any conclusions. 
It is interesting to note that atherectomy in the stenosis containing a lipidic core 
was associated with subsequent occlusive thrombosis. Figure 2C shows the interp-
hase bervveen the preexisting atherosclerotic material in the plaque and that for-
med after directional coronary atherectomy. Numerous multinucleated giant cell 
are visible in the transition between the deposits of cholesterol crystal cleft and 
neointimal hyperplasia, which are likely to represent a foreign body reaction 
a,,<>ainst the lipidic core when exposed to the bloodstream. The high thrombogeni-
city of lipid deposits" may be related with the thrombotic event that followed 
directional atherectomy in this patient. 
Clinical consequences 
The three cases also illustrate that coronary eventS following coronary intervention 
in transplanted patientS manifest atypically when compared with non-transplan-
ted patients. In the first patient heart failure was the only manifestation of acute 
myocardial infarction, which during post-mortem examination appeared to be 
related to the previously intervened site. In the second patient dizziness and malai-
se was the only manifestations of myocardial infarction resulting from subacute 
vessel closure after DCA. The remaining patient died suddenly ptesumably due to 
an unnoticed ischemic event triggering ventricular arrhythmia, and no evidence 
suggesting a direct link between intervention and cardiac death was found. 
Although no coronary angiogtaphy was performed besides the fneed annual eva-
luations, the degree of luminal obstruction found in 2 of the treated lesion appea-
red to be significantly higher than that suspected in the 6 month angiographic 
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Figure 3 C 
Herm:ttoxi.lin~azophhxin 
stain of Figure B revealing a 
substantial diference in the 
cellularity of the old and 
newly flnned neointirna. 
follow-up after atherectomy_ This fact poses the question that in these patients 
neointimal proliferation may have continued beyond the classical 6 month period 
reponed in multiple longitudinal studies on restenosis after balloon angioplasty." 
In a larger series reported on transplanted patients undergoing balloon angioplasty 
(n=35), only 43% were free of the combined end-point myocardial infarction, 
death, retransplantation or repeat angioplasty at 8±1 months of follow-up. 
Unfonunately, no clear information can be obtained from that srudy on whether 
myocardial infarction was a direct result of a cardiac event in the previously dila-
ted artery, nor on the histopathological substrate of such events.) However, it is a 
matter of COncern that a previous repor'f9 fatal cardiac events occurring subacutely 
after directional coronary atherectomy occurred with extensive development of 
neointimal hyperplasia. This might be due to intrinsic differences in the mecha-
nism of action of directional atherectomy and balloon angioplasty, and its funher 
study merits more attention if future application of the technique to cardiac trans-
plant patients is planned. 
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Introduction 
Although coronary angiography is still the gold standard coronary imaging moda-
lity for the interventional cardiologist~ more information is emerging on the speci-
fic limitations that percutaneous recanalisation poses to the interpretation of 
angiographic images. Coronary angioscopy, which can be used during percutane-
ous coronary interventions and provides a more accurate picture of the luminal 
aspect of the vessel, has been shown to be complementary to angiography.' We 
review some of the contributions that coronary angioscopy has made to interven-
tional cardiology during its shorr existence, as well as the current trends for its 
application in a wider spectrum of clinical situations. 
Contributions of angioscopy to the study of acute coronary syn-
dromes 
One of the strengths of coronary angioscopy over other imaging techniques such 
as angiography and intravascular ultrasound is its high sensitivity for the detection 
of coronary thrombosis:!.3 which stems from the marked differences in colour bet-
ween mrombus and the normal arterial wall or atheroma. Using intra-operative 
angioscopy during bypass grafting~ Sherman et al .. 1 found that coronary thrombus 
is common in patients with unstable angina~ and that frequently are not identifia-
ble by coronary angiography. Although this work was limited by patient selection 
and the performance of retrograde visualization of the lesion from the arteriotomy 
site, it set a landmark in the in-vivo study of the substrate of unstable syndromes. 
The development of more flexible angioscopes that can be used percutaneously 
and allow antegrade visualization of the culprit lesion has facilitated further pro-
gress in this field.5-7 Differences in the visual characteristics of thrombus have been 
reported in unstable angina and myocardial infarction. Mizuno et al. (, reported 
that thrombus in unstable angina is predominantly grayish and non-ocdusive~ 
while thrombus associated with myocardial infarction is predominately red and 
causes complete occlusion. The former was though to correspond to platelet rich 
thrombus, while the latter was identified as rich in red blood cells and poorer in 
fibrin. Conclusions on the pathological substrate giving origin to thrombosis have 
also been drawn from angioscopic examination. Xantomatous plaques have been 
identified particularly in patients with myocardial infarction,' providing additio-
nal suppOrt to the hypothesis that plaque rupture leading to myocardial infarction 
often happens in weakened lipid-rich plaques.' 
Although coronary angioscopy has played a significant role in facilitating the 
study of acute coronary syndromes in-vivo, most studies have been biased by 
translation of visual findings to pathological terms by the cardiologist, without the 
assistance of a cardiovascular pathologist. As discussed above, the sensitivity of 
angioscopy in detecting thrombus probably relies on the existence of substantial 
chromatic differences between red thrombus and the arterial wall (Fig. 1). 
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Figure :1 
Angioscopy of it stenosis in the mid left anterior descending coronary artery in it patient with post-
inforction angina pectoris. Although the angiographic morphology of the lesion rA) does not suggest the 
presence of coronary thrombus, angioscopy (BJ reveals a large area of ulceration and thrombus which can 
be clearly differentiated from the white vascular waiL Note the heterogeneity a/the thrombus, with white 
areas that may correspond to fragment;; of the fibrous cap, deposits of platelet-rich thrombus or areas of 
thrombotic organisation. 
Figure 2 
Intracoronary imaging in it patient with unstable angina pectoris. A globular mass that resembles it 
platelet rich thrombus was evident during angioscopic examination (A). However, concommitant 
examination with intravascular ultrasound suggests that this structure had it moderately high echogenicity, 
suggesting that visualised structure was more likely to have a fibrocalcific substrate (B). 
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Figure 3 
Coronary angioscopy during intracoronary 
thromborysis. During coronary angioscopy of 
a major obtuse marginal branch in a patient 
presenting with unstable angina, the vessel 
lumen WtlS found to be obstructed by a red 
thrombu,' (A.). An infosion of urokinase wllS 
started through the flushing port of the 
angioscope and regular visualisation of the 
lesion was performed. After 250. 000 
urokinase units were given, a substantial 
reduction in the amount of red material 
present became evident (B). Further 
administration of 100.000 units yielded 
complete dissappearance of red thrombus (C) 
and marked angiographic improvement. The underlying lesion was a grayish lesion with irregular 
borders mggestingplaque ulceration (Courtesy of Dr Anumi Serra, Hospital Clinic, Barcelona, Spain). 
However, it is a matter of concern that structures that are not "red" are identified 
as "white" or platelet thrombus. The various steps leading to the development of 
red occlusive thrombus in the injured vessel have been documented by angioscopy 
in animal models.3., The first step of this process consists of adhesion of fibrinous 
network-like material and white components of thrombus (platelet aggregates), 
followed by the apposition of mixed red and white components that finally occlu-
de the vessel lumen. Analysis of the white components of the observed thrombus 
has demonstrated that it was composed of platelet aggregates and strands of fibrin, 
while the red thrombus was rich in red blood cells trapped in a fibrin network.3 It 
has not been established that in clinical practice angioscopy may be equally sensi-
tive to the detection of white components of thrombus, since the latter may not 
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differ significantly in colour from other structures. In addition to this, it is well 
known that thrombus organisation modifies red thrombus to a wide range of 
hues, ranging from opaque red or pink (after endothelialization of the thrombotic 
surface) to gold (as macro phages are transformed into foam cells by digesting cho-
lesterol from red blood cell membranes) and white (infiltration by myofibro-
blasts).lo.l~ The use of directional atherectomy as a sampling tool in acute coronary 
syndromes has led to the suggestion that a higher prevalence of these changes are 
to be expected in-vivo man in post-morrem studies.1."H In this regard, it is foresee-
able that the validation of in-vivo angioscopic observations will emerge from the 
concomitant use of other imaging devices and the study of atherectomy samples 
obtained during the same study (Fig. 2). 
Angioscopy in stratification and assessment of patients with uns-
table angina 
The contribution of angioscopy to the study of acute coronary syndromes goes 
well beyond the pure study of natural history and may contribute to unveil several 
management dilemmas posed by patients with unstable angina. The first of these 
has been precipitated by the failure of thrombolytic agents in reducing morrality 
or morbidity in that syndrome. Although the current paradigm of the syndrome 
postulates that mural thrombosis is me key cause of myocardial ischaemia in uns-
table angina through several mechanisms (thrombotic occlusion, enhanced vasore-
activity),"'" multiple randomized rrials have failed in showing any clinical benefit 
of thrombolytic treatment." The reasons for this failure are unknown. A lower 
prevalence of thrombus than expected from coronary angiography and post-mor-
tem studies, or an enhanced resistance of thrombus to lytic therapy, secondary to 
organisation or protection from circulating lytic agents by mechanical barriers, 
have been proposed as possible explanations. It is clear that angioscopy could pro-
vide furrher insights on whether these hypothesis have a real basis. Furrhermore, 
it is foreseeable that the combination of angioscopy and thrombolysis, which has 
been reporred in experimental models,"" will be more frequenrly used in the cat-
heterisation laboratory in the near future. This might facilitate not only the selec-
tion of candidates for thrombolysis based on a more specific detection of throm-
bus, but also a more objective assessment of the success or failure of thrombolytic 
therapy. In a recent work, Inoue et al. 19 have reporred on the success of systemic 
thrombolysis based on angiographic and angioscopic criteria. Residual thrombus 
was disclosed by angioscopy in 50% and 100% cases with TIMI reperfusion gra-
des III and II respectively. In addition to the assessment of its efficacy, angioscopy 
may playa more participative role in coronary thrombolysis, facilitating the deli-
very of high concentrations of thrombolytic agents through the flushing porr of 
the angioscope while assessing lysis (Fig. 3). Likewise, the effect of novel non-
pharmacological thrombolysis such as that performed with ultrasonic devices," 
which can that theoretically overcome some of the limitations of the pharmacolo-
gical agents outlined above, could be also tested. 
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Angioscopy may also be useful in investigating the pathological substrate for the 
high complication rate of percutaneous coronary interventions in unstable 
patientS. Again, the presence of intraluminal thrombus has been proposed as a 
key factor, since its disturbance may potentiate further episodes of thrombosis. ~L~~ 
However, the use of thrombolytic agents prior to intervention in vessels with 
angiographically suspected thrombus has failed to reduce procedural complica-
tions, even showing a trend toward increase. 2.'o As discussed above, the use of 
angioscopy may contribute to a more selective stratification of patients based on 
the presence or extent of coronary thrombosis than can be achieved by applying 
angiographic criteria.2'1 On the contrary, the detection of other mechanisms lea-
ding to sudden change in plaque morphology, such as plaque disruption, aggressi-
ve atherosclerosis or intramural hemorrhage may favor the selection of specific 
recanalisation techniques, such as balloon angioplasry, coronary stenting or athe-
rectomy. 
Optimizing and assessing tile results of coronary intervention 
with angioscopy. 
Angioscopy has been used to document the changes undergone by the vessel wall 
immediately after balloon angioplasty18.25.~7 and new interventional devices. 1S.18-.,\o 
These studies have similar findings than those reported in post-mortem examina-
tion of vessels that had undergone percutaneous recanalisation and that frequently 
are undetected by angiography, such as intimal flaps, major vessel wall disruption, 
thrombus and subintimal hemorrhages.31 In many of these instances, the informa-
tion obtained with angioscopy can be comparable to that obtained with intravas-
cular ultrasound. Figure 4A shows a major plaque dehiscence originating after 
balloon dilatation. The concomitant use of intravascular ultrasound imaging 
makes possible to document a deep extension of the dissection to medial layers 
(Fig. 4B) , similar to that found in a post-mortem examination of a dilated arterial 
segment (Fig. 4C). 
The consequences of vessel wall laceration are rwofold. Firstly. vessel wall dissec-
tion can lead to the development of acute vessel closure, as demonstrated in angio-
graphic studies.32 Several reports based on experimental1SJ3 and clinicalH .35 work 
suggest that the use of angioscopy can be superior to angiography in detecting 
intimal flaps and filling defects originating from wall injury (Fig. 5). Using percu-
taneous angioscopy, Jain et aL.'o6 identiEed the primary cause of acute occlusion 
during PTCA in 10 patients as occlusive thrombus in 2 cases and vessel dissection 
in 8. 
A second aspect of the consequences of vessel wall laceration during intervention 
is its impact on the long-term procedural outcome. Although reports on the use of 
angioscopy to study the substrate of restenosis are scarce, ~9.37 it is likely that this 
application of angioscopy will be implemented in the design of future clinical stu-
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Figure 4 
Vessel wall disruption after balloon 
dilatation. (A) Coronary angioscopy revealed 
it large plaque split from which an edge of 
lifted plaque extends out of the field of vision 
a/the angioseope. (B) These changes 
corresponded to It large circumferential 
dissection that was evident during 
intravascular ulmtsound imaging (arrows) of 
the same vessel, and c!enrry resemble those 
found in a different patient who died after 
balloon dilatation, showing split and 
circumferential dehiscence of the 
atheromatous plaque as it consequence of the 
procedure (C). 
dies for the prevention of restenosis. The first and perhaps more unexplored area 
of restenosis consist in the identification of suboptimal procedural results that 
escape angiographic detection and that can lead to a phenomenon of "pseudores-
tenosis". This is particularly important since although coronary angiography has 
been the only method used in assessing restenosis post intervention, the complex 
vessel morphology associated with several recanalisation techniques makes difficult 
the interpretation of the angiographic image as to the gain in true luminal dimen-
sions achieved, a fact that may explain why the reliability of quantitative coronary 
angiography decreases significantly after percutaneous interventions.3lu9 
A proportional relation between the extent of vessel wall injuty and the subse-
quent loss of luminal dimensions has been suggested:1O-41 Angioscopic quantifica-
tion of vessel damage may found a better predictive value than angiography, allo-
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wing a more direct assessment of the results obtained with different recanalisation 
techniques.""&30 The relation between wall injury and lining coronary thrombosis 
has also been proposed as a key factor in the development of neointimal prolifera-
tion;13 and has been suggested as the cause for the high restenosis restenosis rate 
associated to percutaneous interventions performed in unstable patients. 44 As 
shown by den Heijer et al., ~9 angioscopy demonstrates coronary thrombus pro-
gression during the first hour after balloon angioplasty that is otherwise undetec-
ted by angiography. A wider application of this concept might provide informa-
tion on the relationship between mural thrombosis and restenosis, as well as cons-
titute a tOol in assessing the efficacy of pharmacological strategies directed tOwards 
the avoidance of this phenomenon. 
Although the use of angioscopy as a quantitative technique has been neglected, 
new methods are currently being applied to obtain an angioscopic estimation of 
Figure 5 
Quantitative angiographic analysis (..4) after 
deployement of a Palmar-Schatz stent in the 
mid !eft anterior descending lesion, showing a 
large discrepancy (arrow) between luminal 
area obtained with edge detection (upper 
curve) and videodensitometric analysis (lower 
curve). During angioJCopy a good result was 
noted in the distal subunit of the stent (B). 
However, a large area of disrupted vessel wall 
(c, arrows) was evident at the point where 
the two subunits of the stent are articuulted 
by a single strut, foiling to provide adequate 
scaffolding. 
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luminal size. Preliminary results with the use of a light wire have recently been 
reported by Spears et al .. '" Other authors have proposed a semi-quantitative appro-
ach, using the width of the guidewire as a scaling device. Several outstanding 
issues that may affect the reliability of the measurements obtained have yet to be 
solved. The distending coronary pressure during imaging may differ significantly 
from normal. Funhermore, a coaxial placement of the angioscope is not always 
possible to ensure complete visualization of the coronary lumen. 
State-of-the-art and future developments in coronar), angiosco~_ 
From the first coronary angioscopy performed with a 1.8 mm thick fiber optic 
angioscope and reported by Spears et al. in 1983, the technique has undergone 
major changes. Today's angioscopes are highly sophisticated system that can be 
used without difficulty in most routine cases performed in the interventional cat-
heterisation laboratory. In the following paragraphs we review some of the advan-
tages and limitations of the state-of-the-art angioscopy, as well as some of the rese-
arch trends in new applications. 
Current angioscopy systems are built using bundles with a high number of inde-
pendent fibers, tipped with highly regular epoxy lenses ofless than 0.3 mm in dia-
meter, have a high flexibility and provide excellent image quality. Charge couple 
device (CCO) cameras which are small and can be easily handled are used. Full 
compatibility with conventional over-me-wire equipment is now the rule. Better 
visualization is facilitated by a new generation of delivery catheters with low-pres-
sure inflatable cuffs to temporarily interrupt antegrade blood flow. These systems 
are difficult to use in very proximal arterial segments or when cuff inflation com-
promises blood supply to more than one large epicardial vesseL A variety of dedi-
cated irrigation pumps is used to flush transparent medium during angioscopy. 
The use of Ringer's lactate is preferred over saline by some operators since it has 
been suggested to have less arrhythmogenic potential. O).-ygen-carrying solutions 
may facilitate longer visualization times during angioscopy, and its performance in 
patients with moderately impaired left ventricular function, or a large area of 
dependent myocardium, but their use has been limited thus far by high viscosity. 
Establishing the spatial location of the angioscope in the vessel during on-line 
and off-line image analysis can be facilitated by simultaneous recording of angios-
copic and fluoroscopic images with a video mixer during the procedure. As pro-
gressive refinements and improvements are made, steerability of me catheter tip is 
now the main limitation to collecting adequate information, panicularly in tor-
tuous vessels. Several systems to correct for misalignment of the angioscope and 
to facilitate more selective visualization are under development. 
Many of the strengths of coronary angioscopy discussed in previous sections of 
this anicle are related to the capability for retrieving chromatic information of the 
structures present in the luminal aspect of the vessels. Most available systems have 
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automatic white balance systems aimed to ensure a faithful reproduction of lumi-
nal colours. However, the angle of incidence of the light beam on the visualized 
surface and manual adjustment of light intensity, which is frequently needed to 
optimize visualization, may significantly alter colours in the obtained images. 
Although no studies are yet available on the interobserver variability associated 
with this type of observations, the fact that in a normal population the ability to 
distinguish between colours varies significantly from one individual to other 
makes probable that it is significantly high. Automated colour analysis can possi-
ble contribute to the solution of this limitation, as suggested by preliminary 
results obtained by our group. Other factors may interfere with colour characteri-
zation, including the chromatic aberration resulting from the absorption of parti-
cular wave-lengths by optic fibers and the modifications due to magnetic storage 
in videotapes and their subsequent off-line analysis. 
Further technological developments in image processing may allow interpretation 
of angioscopically obtained images to provide objective information on the consti-
tution of the atherosclerotic vessel wail, which does nOt rely on subjective evalua-
tion. Based on the characteristic absorption patterns of the constituents of the 
atheromatous plaque, several groups have reported in the possibility of applying 
laser-induced fluorescence to the diagnosis of atherosclerosis:))'·" Although still in 
its developmental stages, this "spectroscopic angioscopy""'6 might provide insights 
to the structure of the vascular wall which have so far been confined to the realm 
of intravascular ultrasound imaging. 
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Abstract 
We report on the use of intravascular ultrasound, coronary angioscopy and on-line quantitative angio-
graphy in a unstable patient soon after myocardial infarction. Combined intracoronary imaging made 
possible to solve the therapeutic problem posed by an unusual angiographic appearance secondary to 
intracoronary thrombolysis during coronary recanalisadon. The concomitant use of directional athe-
reetomy made possible the pathological validation of the observations performed with angioscopy and 
intravascu!ar ultrasound 
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Introduction 
We present the case of a patient with postinfarction angina where the combined 
use of on-line quantitative analysis, intravascular ultrasound and angioscopic ima-
ging greatly facilitated the therapeutic strategy and the understanding of the pat-
hological substrate of a patient with an unusual angiographic morphology after 
intracoronary thrombolysis. 
Case report 
We report on a 49 year old white caucasian male with post-infarction angina pec-
toris was referred to our Institution as a candidate for percutaneous coronary 
angioplasty. The patient had been admitted 9 days before in a different Hospital 
with chest pain at rest lasting for more than 48 hours. An ECG disclosed sinus 
rhythm with Q waves in leads II. III and a YF. Physical examination, chest X ray, 
blood biochemistry (CPK 120 U/I ) and hematology were normal. Blood pressure 
was 135/70 mm Hg. Coronary risk factors included smoking and a family history 
of coronary artery disease. After admission he had intermittent episodes of chest 
pain at rest. Intravenous nitroglycerine and heparin were started. Betablockers, 
calcium antagonists and aspirin were also given. Coronary angiography performed 
at the referring Hospital revealed a severe eccentric stenosis with smooth borders 
in the mid right coronary artery which was identified as the culprit lesion. Left 
ventricular angiography disclosed an ejection fraction of 52% and an area of pos-
terobasal hypokinesis. 
The following day the patient was transferred to our Institution for percutaneous 
coronary intervention. Repeat angiography of the right coronary disclosed a new 
overhanging, moving filling defect originating from one of the borders of the ste-
nosis (Fig. lA). Some minor irregularities were noted in the proximal segment of 
the vessel, which were judged to correspond to a separate, non-significant stenosis. 
Quantitative angiography was performed on-line from the digital angiogram 
(ACA, Philips DCI, Eindhoven, The Netherlands). Stenosis severity in the mid 
segment was 76%, obstruction diameter was 0.84 mm and the interpolated refe-
rence diameter was 3.55 mm. Interpolation of the reference dimensions showed 
inverted tapering of the vessel, which was thought to indicate the existence of 
post-stenotic dilatation (Fig. 2A). The moving defect was identified as a tail of 
thrombus and intracoronary thrombolysis was performed with rTPA (50 mg over 
30 minutes). Repeat angiography 30 minutes later revealed the disappearance of 
this overhanging filling defect and an obstruction diameter of 0.82 mm, but was 
followed by the appearance of a new large contrast opacification protruding outsi-
de the luminal borders identified in previous views (Fig. IB). The nature of this 
new opacification could not be ascertained, and the possibilities considered inclu-
ded major intraplaque bleeding, extravasation of contrast medium or vessel dis-
section, all of them posing a serious problem to continuing thrombolytic treatment. 
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Figure 1 
A: Coronary angiography showing an overhan;,ring, mobile filling deftet (black arrow) distal to the mid 
right coronary artery JtOlosis that was identified as a tail a/thrombus. Minor irregularities in the 
proximal segment Wt7e aho noted but thought to correspond to a separate non-.,ignificant stenosis. E: 
Repeat angiography 30 after intracoronary thrombolysis disclosed complete disappearance of the filling 
defict. However, a new large contrast opacification protruding out the original luminal borders (white 
arrow) became evident. 
In an attempt to obtain complementary information on the changes raking place 
within the arterial wall, nvo-dimensional ultrasound imaging of che proximal and 
stenotic segment was performed with a 4.3 Fr 30 MHz intracoronary probe 
(Cardiovascular Imaging Systems, Inc., California). Proximal to the stenosis the 
vessel showed a well-defined ultrasonic 3-layer appearance (Fig. 3). The area com-
prised within the ultrasound-defined internal elastic lamina was 25.5 mm', much 
larger than expected from the angiographically-derived reference area (9.92 mm'). 
Only 7.9 of the tOtal 25.5 mm' (31 %) corresponded to vessel lumen, the remai-
ning corresponding to occluding material presented low echodensity and spec-
kling. Proximal to the stenosis several luminal ch3.J.."lnels, mat were best visualized 
during the injection of saline, were seen (Fig. 3). The penetration of contrast 
medium in these newly formed channels or lacunar cavities was identified as the 
cause for the protruding opacification. Based on this information, a large mass of 
remaining thrombus was judged as the underlying substrate of the images, in spite 
that intravascular ult:rasound has a low sensitivity in detecting thrombotic mate-
rial. 1 Since any contraindication for thrombolysis was ruled out, an intravenous 
infusion of streptokinase (1.500.000 units) was started and continued overnight. 
The patient was reinvestigated the following day. Repeat quantitative angiography 
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Figure 2 
A: On-line quantitative angiographic 
analysis pt'iformed prior to thrombolysis. 
An inverted tapering of the vessel is noted 
in the diameter function {arrow}. B: 
Quantitative analysis after thrombolysis. 
Although there is no substantial change 
in obstrnction diameter .. significant 
remodeling of the plaque is evident 
(white plaque area), with normalization 
of the inverted vessel taperingfound the 
day before. 
revealed significant remodeling 
of the stenosis. with marked 
disappearance of the plaque 
bulk and considerable expan-
sion of the extraluminal opacifi-
cation. The obstruction diame-
ter remained virtually unchan-
ged (0.82 mm). The reference 
diameter was 3.94 mm (0.49 
mm increase from the previous 
day). Marked attenuation of the 
inverted vessel tapering demons-
trated during quantitative analy-
sis the day before was 
evident(Fig. 2B). Coronary 
angioscopy (Baxter Edwards. 
Irvine, California) was perfor-
med to discriminate between 
rhe components of the stenosis on the grounds of their chromatic characteristics. 
This angioscopy system used includes a proximal compliant occlusive cuff that 
abolishes antegrade blood flow to facilitate visualization of the lumen while 
Ringer's lacrate is flushed. A mobile optical bundle with 5 cm capacity was mani-
pulated IO obtain images over the coronary segment of interest. The luminal sur-
face showed a very irregular morphology, with wall disruption, intraluminal flaps 
and large areas of red material extending from the proximal right coronary seg-
ment ro the site of the stenosis (Fig. 4), confirming that the occluding material 
identified by intravascular ultrasound was thrombus. Vessel disruption and areas 
of yellowish material were also seen. Directional atherectomy was performed using 
a 7 Fr atherocatheter (DVI, San Diego, California). Three passages were done at 
the stenosis site. The retrieved material showed areas of dense fibrous tissue and 
thrombus, the latter containing cholesterol crystal clefts and necrotic debris (Fig. 5). 
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Figure 3 
Intravascular ultrasound imLlging immediately after intracoronary thrombolysis. In the proximal segment 
of the vessel only minimal atheroma was disclosed following a concentric distribution (1). However, 
forther advance of the probe revealed a larger vessel than expected foom coronary angiography. occluded by 
homogeneous mLlteriai of moderate echogenicity with a concentric lumen in eccentric position (2). At the 
level of the protruding angiographic opacification (3), the occluding material showed areas of low 
echogenicity suggestive of newly flnned vascular channels or lacunar spaces. 
The immediate result of atherectomy was good as judged from the images obtai-
ned with the 11 Fr atherectomy catheter, and the atherectomy system, including 
the guidewire, was removed. However, repeat angiography performed with a con-
ventional 7 Fr diagnostic coronary catheter revealed an major ostial dissection of 
the right coronary artery which rapidly lead to acute vessel occlusion. The dissec-
tion could not be recrossed with the guiding wire and the procedure was abandoned. 
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Figure 4 
A: Coronary angioJCopy showing red material with large disntption of the vessel wall. B: The true vascular 
lumen can be identified by the position of the guidewire (WJ used to cross the lesion. 
No emergency surgery was performed. The patient developed transient 1 mm ST 
elevation in leads II, III and a VF and ST depression in the anteroseptalleads wit-
hout concomitant hemodynamic embarrassment. The CPK raised to 492 Ull. 
Afi:er this episode of reinfarction the patient followed an uncomplicated evolution 
and was discharged 8 days later. 
Discussion 
It is well known that the complication rate of coronary angioplasry in unstable 
patients is higher than in stable patients, particularly in the presence of coronary 
thrombus. In those cases, intraco'ronary thrombolysis prior to coronary interven-
tion has been used in attempt ro decrease procedural risk.2 However, the induction 
of a lytic state may facilitate the extension of plaque fissures to deep layers of the 
vessel wall, leading ro the formation of an intramural or extravascular haematoma 
and causing subsequent vessel dissection or lumen compression:' This was suspec-
ted from the angiographic image shown in Figure lB. The additional information 
obtained with intravascular ultrasound imaging excluded such potential complica-
tion and suggested continued thrombolytic treatment for the dissolution of an 
otherwise unsuspected large thrombotic mass. The criteria used for the ultrasonic 
characterization of the occluding material were later reinforced by angioscopic 
examination. 
Other observations made in this case illustrate several interesting aspects of the 
pathophysiology of myocardial infarction and post-infarction angina. Plaque rup-
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Figure 5 
Atherectomy ~pecimen 
obtained from the lesion 
showing dense fibrous 
t~"Ue (kfo) and fresh 
thrombotic 11Ulteriai 
(right) in association with 
areas of cholesterol crystal 
clefts and inflammatory 
cells. 
ture and exposure of plaque material to the bloodstream has been suggested as a 
common initial event of acute coronary syndromes.~ During plaque rupture 
embolisation of atheromatOus material has been shown to occur.'l This is consis-
tent with the histopathological findings in the atherectomy retrieved tissue of the 
present case showing cholesterol crystal clefts isolated from plaque material and 
embedded in the retrieved thrombus. The fresher tail of thrombus that had deve-
loped at the narrowest stenotic point in the interval from the diagnostic angio-
gram and that waS first lysed during the administration of intracoronary throm-
bolytics was probably the combined result of preexisting thrombus and high shear 
stress at that point of the vessel. 5 As observed by other authors, remodeling of ste-
nosis morphology secondary to the lysis of older thrombus was observed during 
angiography after sustained thrombolysis and anticoagulation.6 However, the pre-
sent case illustrates how visual angiographic assessment may underscore the degree 
of remnant coronary thrombosis. The concomitant use of on-line computerized 
angiographic analysis can improve the sensitivity of coronary angiography and 
offer additional data that otherwise might be missed by the observer, such as 
changes in tapering characteristics of the vessel or modifications in luminal 
dimensions secondary to thrombolysis (Fig. 2). 
Angioscopic and intravascular ultrasound findings have been previously validated 
in vitro,l suggesting that the information obtained with both methods can be 
complementary in the study of coronary artery disease. The present case shows 
how different imaging techniques can contribute to the solution of a specific pro-
blem found during coronary intervention, and how tissue retrieved by directional 
atherectomy can facilitate the validation in-vivo of such observations. Although 
we feel that the unfortunate ostial dissection that complicated this case was related 
to the withdrawal of the atherectomy catheter, the possibiliry that this could be 
related to the use of concomitant intracoronary imaging cannot be ruled out. 
Should further studies demonstrate the safery of intracoronary ultrasound and 
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angioscopic imaging, the harmonic integration of data obtained by rhese two 
techniques may contribute to the understanding of the anatomopathological subs-
trate of coronary syndromes, and subsequently influence the therapeutic manage-
ment. 
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Abstract 
Background 
Coronary angioscopy constitutes a potential tool in determining which is the predominant cause of 
coronary obsmtction in unstable patients refractory to medical treatment. 
Aim of the study 
To investigate with intracoronary angicoscopy the charoaeriJtics of the culprit lesion of primary or 
post-infarction unstable angina pectoris Teftactory to medical treatment, and to establish the relatiom--
hip betwem the obtained visual findings with coronary angiography and histopathological characteris-
tics of retrieved atherectomy specimens. 
Methods 
Angioscopy was perfonned in 41 patients at the time a/percutaneous recanalisation. In all cases visual 
finding,. were cumified objectively, without making a translation to histological terms. In 9 (22%) 
examination of tissue samples obtained during directional atherectomy possible the correlation betwe-
en histopathological and angioscopic features. Quantitative angiography and classification of angio-
graphic morphology wl1S performed in all cl1Ses and correlated with angioscopic findings. 
Results 
Red material was seen in 25 (60%) C/h'es, more frequently in patient with post-infarction angina 
(13117, 76%) than in primary unstable angina (12124, 50%), and promtded "ignificantly in the 
lumen in 7 (41%) patients with postinforction and in 3 (12%) with primary unstable angina. 
Atherectomy specimens revealed the presence of red thrombus. The promtsion of red materid correla-
ted significantly with a lower minimal luminal diameter (0.55±0.56 mm verStts 1.11±0.42 mm in 
stenoses with and without protruding red material, p=0.009) and greater percent diameter stenosis 
(79±19 % versus 64 ±15% in stenoses with and without protruding red material, p=O.04). 
Conversely, the angiographic morphology correlated poorly with the pm-ence of red material during 
angioscopy (15121, 71 %, with and 10120, 50%, without complex angiographic morphology (p=NS). 
Xanthomatous plaques presented more ftequently in patients with postinforction (10117, 58%) than 
in unstable patients (5124, 21%) (p = 0.02), ftequently in I1Ssociation with red material (13115, 
87%, versus 2/15, 13%, in stenosis with and without red material respectively, p=0.02), and were 
associated with deposits of cholesterol crystal clefts in 2 atherectomy specimens. Pink areas were identi-
fied in 12 (50%) and 2 (12%) patients with unstable and post inforction angina respectively (p = 
0.03). White-gray protruding masses were observed more ftequently in unstable (8124, 33%) than 
postinforction patients (3117, 19%), with 2 atherectomy specimens revealingfibrin-rich and organi-
sing thrombus. Finally an stenotic vessel wafl with normal coloration was found in 4 (10%) cases, 3 
of which showing an smooth suiface and 1 evidence of wall disruption. 
Conclusions 
These observations provide information as to the cause of luminal obstruction in unstable patients 
refractory to medical treatment that may be relevant for the formulation of therapeutic strategies. 
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Introduction 
The understanding of the pathological substrate of acute coronary syndromes has 
been based largely on post-mortem studies of coronary arteries. 1--', These studies 
have suggested that sudden disruption of rhe atheromatous plaque is the common 
initiating factor of myocardial infarction, primary unstable angina and sudden 
death, through the onset of several pathogenic mechanisms such as platelet activa-
tion, adhesion and aggregation, vasoconstriction and thrombus formation. ),6 
In spite of the considerable knowledge accumulated on these pathophysiological 
mechanisms, the management of primary unstable and post-infarction angina 
pectoris still presents a major therapeutic problem.7.s Conventional diagnostic 
tools provide no direct insight on which pathogenic mechanism is operative or 
prevails in an individual patient presenting with unstable symptoms. This may 
pardy explain the refractoriness to conventional treatment. Furthermore, it is pos-
sible to speculate that some of the pitfalls in the pharmacological treatment of 
unstable angina are due to incomplete understanding of a continuously evolving 
pathological substrate. 
Percutaneous angioscopy constitutes a unique tool in the study of the coronary 
syndromes, by facilitating direct visualization of changes taking place in the lumi-
nal environment of the culprit stenosis.9-1) Previous angioscopic studies1l.l 1 have 
identified marked differences in the characteristics of the culprit lesion in stable 
and unstable patients. However, these studies have been focused on changes at the 
time of the initial clinical presentation, which may be substantially different from 
those found in patients in whom medical treatment has proved ineffective. 
Furthermore, a common bias of these studies has been the direct translation of 
visual findings to pathological terms by the investigating cardiologist. 
In the present study we investigated the angioscopic substrate of patients presen-
ring with refractory unstable angina with or without a history of recent myocar-
dial infarction. Visual findings were objectively classified according to chromatic 
and morphological characteristics, and conclusions on the corresponding patholo-
gical substrate were drawn from histological study of atherectomy specimens 
obtained in a representative sample of the study population. 
Patients and methods 
During the period between September 1992 and May 1993 percutaneous coro-
nary angioscopy was performed in 41 patients presenting initially with primary 
unstable angina (class llB and llIB in the classification proposed by Braunwald''') 
or postinfarction angina (class lIIC in the same classification).'" In all cases the 
patients were receiving intravenous heparin and nitrates since the date of admis-
sion. In 6 cases (15%) systemic thrombolysis had been performed. In addition, all 
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patients were receiving oral antianginal medication, consisting of beta blockers, 
calcium antagonists or a combination of both. Catheterization was performed 
with a view to coronary intervention due to persistent clinical evidence of myocar-
dial ischaemia. The investigations were approved by the Institutional Review 
Board of the Cardiology Department of the Dijkzigr Ziekenhuis and the patients 
were studied only after giving informed consent. 
Table I. Baseline characteristics of 4:1. patients 
n~ 41 
Age (years) 
Male sex 
Time from onset of syndrome (days): 
-Unstable angina 
-Post-infarction angina 
Ischemia-related vessel : 
-RCA 
-LAD 
-LCX 
Reference diameter (mm) 
Minimal luminal diameter (mm) 
% diameter stenosis (%) 
Complex angiographic morphology 
Multivessel disease 
Prior coronary intervention 
Thrombolysis 
59±10 
33 (SO%) 
IS±16 
15±15 
17 (41%) 
15 (36%) 
9 (23%) 
3. 15±o.71 
0.9S±o.51 
67±16 
21 (51 %) 
9 (23%) 
3 PTCA, 2 DCA 
6 (35 % of all 
POSt MI) 
RCA: right coronary artery; LAD: left anterior descending coronary 
artery; LCX: lefr circumflex coronary artery: MI: myocardial infarction. 
Procedures 
Selective coronary angiography in multiple projections was performed before and 
after intervention. All patients received aspirin (250 mg) and i.e. nitroglycerin before 
the procedure and were on optimal anticoagulation with heparin, with an activared 
clotting rime was over 300 seconds. During the procedure patients received intrave-
nous diazepam. After passage of a 0.014 in. guide wire across the culprit lesion, coro-
nary angioscopy was performed. In all cases an atrempt was made to cross the lesion 
with the angioscope to obtain information from both the proximal and distal aspect 
of the lesion. Following angioscopy, balloon angioplasty (n~32) or directional coro-
nary atherectomy (n~9) were performed according to standard pracrice. 
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Selection of ischemia-rewed lesion 
Culprir lesion was selected as follows: in cases with single vessel disease the most 
severe lesion within that vessel was selected; in cases with multivessel disease the 
selection was determined using angiographic and electrocardiographic criteria, 
including the location of transient ST-T segment changes in the electrocardio-
graphic leads occurring during ischaemia at rest. 
Angiography 
Luminal dimensions at the stenotic and reference segment were obtained with 
quantitative coronary angiographic analysis, which was performed using the 
CAAS Mark II sysrem,15,16 which constitutes the latest generation of a previously 
validated system. 1i Qualitative information was also recorded according to a modi-
fication of the angiographic classification of lesion morphology proposed by 
Ambrose et al." Comple.x lesion morphology was recorded when eccentric lesions 
with ragged or overhanging edges were present, or when intraluminal filling 
defects were noted. 
Angioscopic device 
The angioscope used was a 4.5 Fr polyethylene monorail catheter (Baxter-
Edwards, Irvine, California). The catheter features a compliant occlusive cuff, a 
flush port, guidewire compatibility and a movable optical bundle with a depth of 
field> 1 mm and an excutsion capability of 5 cm. In order to keep a uniform 
color temperature in the light source, light intensity is modified by the use of a 
diaphragm. Thus, artificial variations in the observed colors were minimized. To 
facilitate the review process of the obtained images, real-time fluoroscopy or cine-
angiography was recorded simultaneously with angioscopic images using a digital 
video mixer. This provides a better estimation of the location of the angioscope 
within the coronary tree. 
Analysis of angioscopic images 
All images were analysed off-line by three independent interventional cardiologists 
familiar with coronary angioscopy. In addition, the films were reviewed by an 
independent cardiovascular pathologist blinded to clinical, angiographic and pat-
hological data. At the site of the stenosis the arterial wall was classified as disrup-
ted (loss of continuity in the arterial wall), irregular (rough surface with wall inte-
grity preserved). or predominantly smooth surface. The presence of red material 
was recorded, and classified as mural (lining the arterial wall bur without signifi-
cant protrusion in the lumen) or occlusive (accounting for a significant oblitera-
tion of the arterial lumen during angioscopy). White protruding masses were 
recorded independently. The presence of pink areas in the arterial wall or on the 
surface of a white protruding mass was also recorded. Yellow plaques were defined 
as areas of homogeneous yellow color clearly identifiable from a neighboring area 
of normal white wall. 
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Figure 1 
Red materia! as visualised by angioscopy i~ 2 patients with primary unstable angina and culprit stenoses 
located in the mid right coronary artery. A: Coronary arteriogram showing an eccentric lesion with an 
overhanging edge in its distal aspect (arrow). B: Angioscopy revealed that the latter was due to vessel wall 
disruption, with underlying mural red material Co On-line quantitative angiagraphic analysis of it 
concentric stenosis. D: A protrnding reddish J'mlSS, clearly distinguishable from the vessel wall became 
evident during angioscopy. 
Histopathological studies of atherectomy specimens 
In the 9 cases undergoing directional coronary atherectomy the obtained speci-
mens were removed from the atherocatheter, flushed with saline, examined 
macroscopically and then fixed in 10% formalin. Routine processing for light 
microscopy and haematoxylin-azophloxin and Verhoeff-van Giesson staining was 
performed. All specimens were reviewed by twO independent observers who were 
blinded to clinical data. The recommendations layed out in the American Heart 
Association Medical/Scientific Statement on the Definition of the Intima of 
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Human Arteries and of its Atherosclerosis-Prone Regions 19 were followed in 
collecting information regarding intimal constituents. Fibrous tissue was classified 
as dense when composed of acellular or poorly cellular connective tissue formed 
predominantly by dense collagen, and classified as loose when the tissue fragments 
showed a moderate cellularity and collagen bundles separated by accumulations of 
extracellular matrix. Neointimal hyperplasia was defined as fibromuscular connec-
tive tissue showing a random orientation of spindle shaped and stellate cells 
embedded in abundant extracellular matrix. Calcifications and lipid deposi(S such 
as cholesterol cryStal clefts or foam cells were separately recorded independently. 
No special staining was used to identified calcium. Thrombus and I or intraplaque 
hemorrhage were identified as amorphous material, in close apposition with athe-
romatous material, frequently showing collections of leucocyres between layers of 
fibrin. Large masses of fibrin that might correspond to platelet-rich thrombus and 
were unlikely to be solely related to the atherectomy procedute wete recorded. 
The Verhoeff-van Giesson staining was used to discriminate berw-een fibrin and 
dense collagen. Organisation was judged when infiltration by cellular elements, 
e.g. smooth muscle cells, fibroblasts, capillary sprouts, was observed. 
Statistical analysis 
Mean values and standard deviations are presented for continuous variables. 
Comparison of mean values was performed using rw-o-tailed unpaired Student's t-
tests. Discrete variables were compared using chi-square tests, and Yates' conti-
nuity correction applied when indicated. Statistical significance was accepted at 
the 5 % level. 
Results 
The baseline characteristics of the 41 patients included in the study are shown in 
Table l. In 35 (85%) cases the entire target stenosis was satisfactorily visualised by 
angioscopy, while in the remaining 6 (15%) the stenosis was not crossed with the 
angioscope and only the proximal aspect of the stenosis was visualised. The intro-
duction of the angioscope at the ischemia-related lesion was associated with chest 
pain and electrocardiographic ST-T segment changes in 33 cases (80%). These 
changes were quickly reversible after cuff deflation and withdrawal of the catheter, 
with the exception of rw-o patients (40/0) in whom abrupt coronary occlusion 
developed. This was effectively treated by balloon angioplasty, without adverse 
sequelae. In a third patient a small non-occlusive dissection was noted immedia-
tely after angioscopy. Subsequent balloon angioplasty resulted in occlusive dissec-
tion, which was effectively managed by stem implantation. Finally, in a fourth 
patient with post-infarction angina, an occlusive dissection in the right coronary 
ostium, unrelated to angioscopy, was caused during the removal of the atherec-
tomy guiding catheter, following a technically successful procedure in a mid right 
coronary artery stenosis. This was complicated by re-infarction (max. CK 600 
UIl) which was treated conservatively. 
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Angioscopic characteristics of the culprit lesion. 
In all cases visualization of >7/3 of the circumference of the inner vascular wall 
was achieved. Vessel wall disruption, suggesting ulceration, was identified in 27 
(66%) patients. The stenosis presented an irregular surface in a further 8 (19%) 
patients. In the remaining 6 (l5%) patients the stenotic wall was smooth, without 
disruption or marked irregularities. 
Red material (Fig. 1) was seen in 25 (60%) of all cases, more frequendy in postin-
farction (I31l7, 76%) than in primary unstable angina (12/ 24, 50%), although 
this difference did not reach statistical significance. The presence of red material 
was not influenced by the time elapsed from the beginning of the syndrome to 
angioscopy: 15±17 days versus 18±13 days in stenosis with and without red mate-
rial, respectively. Red material was occlusive in 7 (41%) patients with postinfarc-
tion and in 3 (12%) with primary unstable angina (p=NS). The protrusion of red 
material correlated significantly with a lower minimal luminal diameter 
(O.55±o.56 mm versus 1.1l±o.42 mm in stenoses with and without protruding 
red material, p=0.009) and greater percent diameter stenosis (79±19 % versus 64 
±15% in stenoses with and without protruding red material, p=0.04) measured 
with quantitative angiography. The prevalence of red material was significantly 
related to the angioscopic characteristics of the vessel wall, being present in 19 
(70%) of the cases with disrupted, 5 (62%) of the lesions with irregular, and 1 
(I7%) of the lesions with smooth vessel wall (p=0.05). Conversely, there was no 
statistical relationship between the existence of a complex angiographic morpho-
logy and the presence of red material during angioscopy, the latter observed in 
15/21 (71 %) lesions with and 10120 (50%) without complex angiographic morp-
hology (p=NS). 
Xanthomatous plaques presented typically as discrete raised plaques with a mar-
ked homogeneous yellow color, suggesting the existence of a very thin fibrous cap 
(Fig. 2A). They were identified in 15 (37%) of all patients, and presented more 
frequently in patients with postinfarction (I01l7, 58%) than in unstable patients 
(5/24, 21 %) (p = 0.02). Yellow plaques were found more frequently in stenoses 
containing red material (I3/15, 87%, versus 2/15, 13%, in stenosis with and wit-
hout red material respectively, p=0.02). 
Pink areas were identified in 12 (50%) and 2 (I2%) patients with unstable and 
POSt infarction angina respectively (p = 0,03), White-gray protruding masses (Fig. 
1B) were observed more frequently in unstable (8/24, 33%) than postinfarction 
patients (3117,19%), although the difference was not statistically significant. In 4 
cases (100/0) a white protruding mass was seen in a stenosis containing also red 
material (3 unstable and 1 post-infarction patients). Finally, stenotic vessel wall 
with normal coloration was found in 4 (I 0%) cases, of which 3 showed smooth 
surface and 1 showed evidence of wall disruption. 
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Figure 2 
Angioscopic characteristic of a xanthomatous 
plaque (AJ, with marked yellow coloration that 
contrasts with that of the nonna! white 
appearance of the arteria! walL Analysis of 
atherectomy specimens (B) obtained in this type 
of lesions made possible the identification of 
cholesterol rich plaques (arrow). In a fragment 
retrieved from the same lesion numerous 
cholesterol crystal clefts could be found enbedded 
in fresh thrombus (C). 
Prevalence of red material after thrombolysis 
In the postinfarction angina group, 6 patients had received systemic thrombolysis 
9±7 days before angioscopy. No significant differences with regard to the presence 
of red material were noted when this group was compared to the other 11 patients 
wiLh. postinfarction angina who did not receive thrombolysis, showing a prevalen-
ce of 4/6 (66%) in patients with and in 9/11 (82%) without prior thrombolysis. 
Likewise, thrombolysis did not influence the degree of luminal occlusion caused 
by red material, which was occlusive in 2/4 (33%) and 5/11 (45%) cases with and 
without previous thrombolysis respectively (p~NS). In one additional patient 
intracoronary thrombolysis was performed after coronary angioscopy demonsrra-
red total luminal obs(fuction by red material. Using the distal lumen of the 
angioscope, the thrombolytic agent (rTPA) was introduced to the space existing 
between the occlusion and inflated proximal cuff, in an attempt to increase the 
concentration of lytic agent in contact with the thrombus (Fig. 4A ). After 20 
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minutes, coronary angiography revealed incomplete coronary recanalisation, while 
angioscopy showed a substantial change in the color of the previously red mate-
rial, which now presented several mobile Structures of pinkish color which had 
been covered by the red occlusive mass and which remained unlysed during furt-
her observations (Fig. 4B). Subsequent balloon angioplasry yielded an optimal 
result, with complete restoration of antegrade blood flow through the stenosis. 
Analysis of atherectomy specimens 
Directional atherectomy was performed in 9 cases (22%), each yielding pathologi-
cal specimens. Macroscopic examination of the specimens allowed identification 
of several features visualized during angioscopy. The correlation between histopat-
hological and angioscopic findings in these 9 patients is summarized in Table II. 
Histopathological analysis of the material retrieved in all 5 stenosis containing red 
material showed fresh red thrombus (Fig. 2). In thtee of these patients the presen-
ce ofaxantomatous plaque had been reported by angioscopy (Fig. 2A). The 
retrieved material demonstrated the presence of numerous cholesterol cryStal clefts 
with inflammatory cells, associated with fresh red thrombus (Fig. 2C) in two 
cases, suggesting that extrusion and exposure of lipid material to the bloodstream 
was the precipitant cause for coronary thrombosis. Directional atherectomy was 
not performed in any of the cases where pink areas had been visualized. Coronary 
samples were obtained from (\vo lesions with white-gray protruding masses. 
Microscopic examination revealed the presence of a large fibrinous mass in one 
case, and otganizing thtombus in the other (Fig. 3B). Finally, atherectomy was 
petfotmed in one case with a normal-coloured stenotic wall, with the specimen 
showing the presence of dense fibrous tissue and neointimal hyperplasia. 
Discllssion 
The information accumulated during the last decade on the pathophysiological 
mechanisms involved in the genesis of acute coronary syndromes5,6 has enabled 
the development of specific therapeutic strategies targeted against particular pat-
hophysiological processes. ,,·eo Some of these approaches have been shown to redu-
ce significantly the mottality and morbidiry associated with the syndrome. 
However, the management of unstable patients is still far from being straightfor-
ward. Although a thrombotic origin in primary unstable angina seems well esta-
blished,""" the syndrome is frequently tefractory to thrombolysis, platelet antiag-
gregants and systemic anticoa"oulation. ,.,., Likewise, the advent of the thrombolytic 
era has not diminished the number of patients presenting with unstable angina in 
the weeks following acute myocardial infarction':':; 
Part of this therapeutic problem may be related to the lack of knowledge on the 
evolution of the pathological substrate from the initial stages of the acute coronary 
syndrome. While post-mortem srudies have contributed substantially to the 
understanding of the underlying pathology, it is obvious that this source of know-
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Table II. Correlation between angioscopic and histological findings in 
patients treated with directional coronary atherectomy. 
Pat. no. Angioscopic findings Histological findings 
1 Red (protruding) material, Dense fibrous [issue, fresh 
xanthomatous plaque thrombus, cholesterol crystals 
2 Red (mural) material, Dense fibrous [issue, fresh red 
xanthomatous plaque thrombus, cholesterol crysrals 
3 Red (occlusive) material Dense fibrous tissue, fresh red 
thrombus, neointimal hyperplasia 
4 Red (mural) material Dense fibrous tissue, 
fresh thrombus, media + advent. 
5 Red (mural) material Dense + loose fibrous tissue, 
fresh red thrombus 
6 Red (mural) material, Dense fibrous tissue, 
xanthomatous mass fresh thrombus. 
7 White mass Dense fibrous dssue, 
fibrin rich thrombus. 
8 White mass Dense fibrous tissue, 
organizing thrombus 
9 Normal vessel wall Dense fibrous tissue, 
neointimal hyperplasia 
ledge is biased by case selection, presumably reflecting more acute and extensive 
changes than those existing in the majority of patients. 
Coronary angioscopy may serve as a useful tool in visualizing the ischemia-related 
vessel in unstable patients, providing insight not only on the genesis but on furt-
her evolution of the changes taking place in the environment of the atheromatous 
plaque. Previous studies using angioscopy have suggested a high frequency of 
coronary thrombosis in patients with unstable angina and myocardial infarction.\Q.1.' 
Grayish, non-occlusive, presumably platelet rich thrombus has been described as a 
common subsuate of patients presenting with. unstable angina, while red, occlusive 
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thrombus was found mainly in patients with myocardial infarction." In the latter 
group, a higher prevalence of xanthomatous plaques was also found." Although 
these studies have contributed signwcandy to the in-vivo study of acute coronary 
syndromes, they share the common limitation that translation of the visual fin-
dings to pathological rerms was performed automatically. This is particularly rele-
vant since pathological validation of angioscopic studies has never been performed 
in-vivo, and in-vitro studies are scarce. These include the work of Tomaru et aL'-6 
and Mizuno et aL,~7 reporting on the formation of thrombus and subsequent 
action of thrombolysis in two different experimental models, and that of Siegel et 
al.~ validating angioscopic and intravascular ultrasound observations obtained in-
vitro in peripheral human arteries. Although in rhese studies pathological exami-
nation of the imaged vascular substrate was performed, it is likely that the models 
used may be quite far from being representative of those changes found in the cul-
prit lesion of of patients with unstable angina. 
Our work differs from all these previous studies in several aspects. First, an objec-
tive approach to evaluation of the visual findings was followed to classifY the chro-
matic and morphological characteristics of the culprit stenosis as visualized during 
angioscopy. To reduce the potential interobserver variability associated with 
angioscopy we performed panel review of me images, a method which has pre-
viously proved usefUl for mis purpose in studies using coronary angiography'::') A 
translation to pathological findings was attempted only after concomitant direc-
tional amerectomy was performed, yielding histological specimens mat were com-
pared with visual findings. The independent contribution of a cardiovascular 
pathologist was also sought in an attempt to get an expert opinion on the changes 
seen during angioscopy. Second, the study population was a representative sample 
of unstable patients with or without previous myocardial infarction, with the 
common denominator of being refractory to medical treatment and referred for 
percutaneous recanalisation. This implied a longer time interval (I6±15 days) bet-
ween the onset of the syndrome and the time of angioscopy. Finally, patients with 
prior thrombolysis were also included in the study. 
We found that the chromatic characteristics of the stenotic wall found in the 
study population were similar to those reported by Mizuno et al. I':: in the very 
early stages of the syndrome. Red intraluminal material was a frequent finding in 
unstable and postinfarction patients, and the study of atherectOmy specimens 
revealed that its histological substrate was in fact red thrombus. Thrombus was 
frequently present in spite of relatively prolonged treatment with therapeutic 
doses of intravenous heparin, in agreement with the work of Badimon et al 
demonstrating that anticoagulation with heparin does not abolish thrombus 
growth.30 In the post-infarction group previous treatment with thrombolytic 
agents did not appear to reduce the prevalence of red thrombus. 
Likewise, we found that white protruding masses are relatively common in unsta-
ble patients, and occur mainly in patients with primary unstable angina. Insight 
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Figure 3 
A: lntracoronary angioscopy in a patient with unstable angina pectoris showing a globular white mass 
that protrudes in the lumen. B: Histological examination of a similar mass observed in a patient 
undergoing atherectomy revealed moderately cellular fibrous tissue with evidence of thrombotic 
organisation. 
to the pathological nature of this observation was obtained in twO cases. A fibrin-
rich thrombus was found in an atherectomy specimen obtained from a lesion with 
a white-grayish protruding mass. In the second specimen, the underlying substrate 
was identified as fibrous tissue in association with organising thrombus. In pre-
vious studies, we and others found that thrombus organisation is common in 
atherectomy specimens obtained in patients with primary unstable angina pecto-
ris, even in the early stages of the clinical syndrome.3"" It is likely that modifica-
tion of the color of thrombus which occurs during the process of organisation,3} 
with a shift from red to a pinkish, color, can make it undistinguishable from plate-
let rich thrombus. We also observed a statistically significant preponderance of 
pink areas in the vessel wall in patients with unstable angina, although its patholo-
gical nature remains unclear since no atherectomy was performed in any of these 
cases. It is possible, however, to speculate that these may correspond to mural 
thrombus being organised and integrated in the arterial wall, or to the presence of 
haematic material in the sub intima. 
Several observations relevant to the vascular substrate underlying thrombus forma-
tion were dravm from the angioscopic images. We found a significant gradation in 
the presence of red material in stenoses with disrupted, irregular and smooth ves-
sel wall. It is likely that these stenosis characteristics imply a variable thromboge-
nic potential of the stenotic wall. Exposure of deep components of the plaque 
(type III vascular injury in the classification suggested by Ip et al.)" may cause 
thrombosis more frequently than in areas with merely absent or dysfunctional 
endothelium (vascular injury type II in the sarne classification), promoted by shear 
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Occluding cuff 
Dead space 
filled with 
thrombolytic 
agent 
Red thrombus 
Flushing catheter 
Fiberoptic 
bundle 
figure 4 
A: Coronary angioseapy can be 
used tIS an effective method for 
thrombolytic drug delivery in 
selected patients. By inflating the 
proximal occluding cuff of the 
angioscope, which is normalfj 
used to interrupt ante grade blood 
flow and facilitate viswziisation, 
thrombolytic agents can be 
delivered at the site of occlusion, 
reaching high local concentrations 
that may facilitate thrombolysis. 
B: This technique was successfully 
applied in a mid righ coronary 
occlusion by red material, 
suggestive of ftesh thrombus. 
During thrombolysis, angioseapy demonstrated marked remodelling of the occluding red material. A 
mobile, whitish core (arrows) which was underlying the original occluding mass became evident and 
remained unchanged during the rest of the examination. 
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stress in segments presenting an irregular lumen;») Our study supports a previous 
report on a higher prevalence of xanthomatOus plaques in patients who developed 
myocardial infarction. The presence of red material and xantomatOus plaques 
were strongly correlated. Concomitant study of atherectomy specimens obtained 
from xanthomatous lesions revealed the presence of cholesterol cryStal clefts, 
sometimes in close association with inflammatory cells and embedded in red 
thrombus, suggesting that, in accordance with previous postmortem studies, 
extrusion and dispersion of plaque material secondary to plaque rupture had pre-
ceded the episode of thrombosis,".'36 (Fig. 2). Xanthomatous plaques appeared as 
discrete, raised plaques where a thin, transparent fibrous cap is assumed since the 
underlying yellow lipid material can be seen. These observations suppOrt current 
views on the genesis of myocardial infarction. precipitated by rupture oflipid-rich 
plaques5>3i that promote thrombus formation.3S301 
Which is the main cause of persistent luminal obstruction in unstable patients 
refractory to medical treatment? As judged from angioscopy in the present study, 
red material protruded significantly in the coronary lumen only in 24% of the 
cases. Even if patients with a protruding white mass are added to this figure (9 
patients, since 1 concomitantly presented a red mass), obstruction by an intralu-
minal mass occurred in only 46% of all cases. Since the primary aim of throm-
bolysis is to tackle coronary thrombus as the main cause of intraluminal obstruc-
tion, this observation provides clear evidence as to why thrombolytic treatment 
has previously not been helpful in the treatment of unstable patients. Interestingly. 
in this study the only angiographic characteristic of lesions showing a significant 
obliteration of the lumen by red material was the presence of significantly greater 
stenosis severity by quantitative angiographic analysis. This finding may provide 
an unexpected explanation of the findings reported by De Zwaan et al:'o in the 
sense that only unstable patients with total or subtotal coronary occlusion 
demonstrated benefit from thrombolytic treatment. In the light of the observa-
tions of the present study, such benefit would be derived from selecting cases for 
treatment where occluding red thrombus plays a considerable aetiological role. As 
in the present study, less severe stenoses probably present a lower contribution of 
thrombus to luminal obstruction. These findings suggest that angioscopy may be 
more useful than angiograhy in reliably and specifically identifying the presence of 
intraluminal thrombus in order to perform a more selective use of thrombolyri~ 
agents. 
This applies also to patients with unstable postinfarction angina, as suggested by a 
pilot study from the John Hopkins Hospiral:' In that work, intracoronary strepto-
kinase was given in postinfarction patients with a persistently occluded vessel. 
Coronary reperfusion was achieved in 9/15 (60%) of patients, who had a berter 
clinical outcome than patients not receiving thrombolysis, or in whom coronary 
reperfusion was not achieved. We could document the modification of the angios-
copic characteristics of occlusive red material in a postinfarction patient following 
exposure to a highly concentrated dose of thrombolytic agent. An underlying whi-
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tish, mobile core which remained unlysed (Fig. 4B) became evident. This observa-
tion fits nicely with that of Uchida et al.1O in their in-vitro angioscopic study on 
the effect of thrombolysis, where pale material was later identified hisrologically as 
a fibrin-rich thrombotic core. It remains unknown whether a similar effect of 
thrombolysis is to be expected in cases where an intraluminal white protruding 
mass rich in fibrin predominates. Likewise, the presence of some of the other cha-
racteristics of thrombus found in our study, such as the presence of extruded cho-
lesterol crystal clefts and cellular infiltration within a formed thrombus, may 
interfere with the action of thrombolytic agents:12 
It has been emphasized that in the acute coronary syndromes Ihrombosis is a 
dynamic proces~3.5>'13 with waxing and waning of the cause of coronary occlusion 
(either red or platelet-rich thrombus). The presence of protruding thrombus may 
also stimulate thrombus progression due to a combination of rheological factors 
and the high thrombogenic activity of the actual surface of the thrombus itself."" 
Likewise,the resulting increase in shear stress may lead to new episodes of throm-
bosis if intermittent fissuring or exposure of its core to the bloodstream occurs 
later during thrombus organisation, where thrombin remains protected from cir-
culating antithrombin.3-1 
It is important to keep in mind that the information provided by angioscopy is 
limited to the luminal aspect of the vessel, and that therefore changes in plaque 
geometry as a consequence of the development of intrainrimal hemorrhage or hae-
matoma formation can be missed, or underscored by visualization of a mural 
thrombus at the site of a fissure in the fibrous cap (a "tip of the iceberg" phenome-
non) (Fig. 1 A and B). It would be expected that the presence of hemorrhage or 
haematoma within the intima would constitute a major barrier to the action of 
thrombolytic agents."l'?: Alternatively, and since resolution and organisation of a 
thrombotic episode seems to be associated with enhanced smooth muscle cell pro-
liferation'i5 and development of neointimal hyperplasia;lcHs changes in plaque geo-
metry may also result from accelerated formation of fibrous tissue which had been 
initially triggered from a clinically silent episode of thrombosis. 
The results of this study reinforce the concept that coronary angioscopy constitute 
an useful research tool in the study of different coronary syndromes, and that such 
application is enhanced through concomitant use of directional atherecromy. The 
technique of angioscopy may additionally allow a more selective application of 
thrombolytic treatment in those patients with occluding thrombus. Likewise, it 
may playa important role in the context of clinical trials aimed at reducing coro-
nary thrombosis, such as in the control of restenosis POSt intervention, or in tes-
ting new pharmacological or mechanical thrombolytic approaches. 
Our experience shows that the performance of angioscopy in unstable patients can 
cause abrupt occlusion, which is probably due to the manipulation of the guide-
wire and a intracoronary device in an already disrupted vascular segment. In this 
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respect, it must be noted that, in contrast with previous studies, we attempted a 
complete angioscopic examination of the proximal and distal aspects of the steno-
sis. Despite the occasional local complications, our study shows that angioscopy 
with the system described remains a safe technique in unstable patients during 
percutaneous intervention. 
Limitations 
Although the capability of angioscopy for providing chromatic information on the 
vascular lumen constitutes one of its main advantages in the study of acute coro-
nary syndromes, this aspect remains also its main limitation. No studies on the 
intraobserver and interobserver variability of colorimetric observations are availa-
ble. However, in a normal population the ability to distinguish between colors 
varies significantly from one individual to another. We attempted to reduce such 
variability by panel review of the images, a method which has previously been 
validated in coronary angiography." Our population was biased by the fact that 
the patients studied were suitable for percutaneous recanalisation. Thus, informa-
tion of patients presenting triple vessel disease may have been lost. 
Our patients were somewhat selected, since they were refractory to medical the-
rapy and the findings may nOt be representative of the luminal environment early 
after the onset of the syndrome. In addition all our patients were suitable for per-
cutaneous recanalisation and dearly had already survived the early acure phase of 
the syndrome and thus may not be representative of patients who suffer a precipi-
tous clinical deterioration resulting in death. Nevertheless, we believe the combi-
nation of angioscopic, quantitative angiographic and histological findings in this 
study at least demonstrates the exciting possibility that comprehensive study of 
the elusive cause of unstable angina is dearly feasible. Thus, it is dear that we can 
anticipate further and rapid progress in this resistant and difficult area. 
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Abstract 
Background 
The paradigm of acute coronary syndromes is sudden disruption of the fibrous cap, overlying a soft, 
lipid-laden plaque followed by thrombus formation. Current percutaneous catheter-based imaging 
technology enables charaaerization of the coronary plaque and thus may confirm the paradigm in 
patients with unstable angina or postinforction angina. 
Aim of the study 
To determine in patients with umtable angina using angioscopy the frequency of thrombus, and whet-
her the lesion is complex or xanthomatous and to assess using ultrasound the composition of the ische-
mia-related lesion. 
Methods 
In 31 patients, 24 males, 7 females, mean age 60±10 years either presenting with unstable angina 
(19) or postinfarction angina (12), intracoronary angioscopy and ultrasound imaging of the ische-mia-
rehted lesion was peifonned before coronary intervention. Angioscopic derived images of the lesions 
were classified as either stable, (smooth surface, no thrombus) or complex (ulcerated surface with or 
without thrombus). The presence of thrombus (red intraluminal mass) and xanthomatous plaque 
(yellow colour) was recorded The ultrasound-derived images of the lesion were classified as predomi-
nantly calcified (highly echo-reflective with shadewing representing calcium), hard (highly echo-reflec-
tive representing dense fibrous tissue), soft (poorly echo-reflective representing loose fibrous tissue or 
lipid) or mixed 
Results 
Angioscopy: the lesion was stable in 26%, complex 74%, and yellow in 36%. A thrombus was present 
in 68% of the lesions. 
Ultrasound imaging: the composition of the ischemia-related plaque was predominantly soft in 41 %, 
hard in 6%, and none was extremely calcified The remaining 52% were mixed lesions: all of them 
were composed a/soft tissue in combination with hard or calcified tissue. 
Conclusious 
Combined imaging with angioscopy and ultrasound demonstrated a preponderance of complex ische-
mia-related lesions, frequently with associated thrombosis. Intravascular ultrasound revealed characte-
ristics of soft atheromatous plaques, and one-third of the lesions were yellow during angioscopy, sugges-
ting the presence of subintimal lipid deposits. Finally, 25% of all lesions did not presented associated 
thrombus or plaque disruption. In these patients other mechanisms to those proposed by the current 
paradigm of the syndrome may play an etiological role, and other treatment strategies may be required. 
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Introduction 
The cause of unstable anginal syndromes is considered ro be sudden disruption of 
the atheromatous plaque, setting into action several pathogenic mechanisms such 
as platelet activation, adhesion and aggregation. increased vasoconstriction and 
thrombus formation. 1 This may result in an abrupt transient reduction in coro-
nary flow. The presence of local and systemic Ihrombogenic risk factors at the 
time of plaque disruption may modifY the extent and dutation of thrombus for-
mation and account for the wa.xing and waning of pathologic and ensuing clinical 
manifestations. 1 Current available diagnostic tools do not provide direct informa-
tion about the underlying processes and it remains conjectural which major pat-
hogenic mechanism is operative or prevails in an individual patient at a certain 
time. This precludes tailored treatment and may pardy explain why patients beco-
me refractory to established treatment or progress to myocardial infarction or 
death which OCCurS respectively in 3.5% to 14% and 0.5% to 6% within 1-3 
months ofhospitalization.2-7 Clearly, additional information is required that provi-
des better insights into the underlying disease mechanism(s) to improve patient 
management and prognosis. 
Two recently developed diagnostic tools which have the potential to yield insights 
into the pathogenesis of unstable angina are currently available for clinical use. 
Intracoronary ultrasound imaging provides information about size and composi-
tion of the plaqueS-!.) and intracoronary angioscopy can accurately detect presence 
of intracoronary thrombus and complex plaque.'·'·" The purpose of this study was 
to determine the composition of the ischemia-related lesion and to assess the fre-
quency of complex lesions, yellow lesions and thrombi with the sequential use of 
intracoronary angioscopy and ultrasound imaging in patients with primary unsta-
ble and early postinfarction angina before undergoing percutaneous intervention. 
Patients and methods 
Between September 1992 and March 1993 thirty-five patients with unstable angi-
na were studied who were classified as having primary angina at rest class IIB and 
IIIB or postinfarction unstable angina class IIIC according to the recent 
Braunwald classification19 and who were scheduled for coronary intervention. 
In one patient the procedure was aborted because of development of severe ische-
mic chest pain after introduction of the angioscope in the ischemia related coro-
nary artety. Immediately performed PTCA was successful without adverse seque-
lae. In 3 patients the angioscope was introduced but the obtained images were of 
insufficient quality. These 4 patients were excluded from further analysis. Thus, 
the study population comprised 19 patients with unstable angina and 12 patients 
with postinfarction angina. The clinical and angiographic data of these patients 
are presented in Table 1. The investigations were approved by the Institutional 
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Table 1. Baseline patient and angiographic characteristics 
Total number patients 
Male/female (N) 
Age, mean±SD (years) 
Multivessel disease (N) 
Premedication: 
-Heparin/Aspirin (N) 
-Thrombolysis (N) 
-Nitroglycerin i.v. (N) 
-Ca2+ channel antagonists (N) 
-Beta-blockers (N) 
Days from onset instability 
Ischemia-related lesion: 
-LAD 
-RCA 
-CX 
Minimum luminal diameter (mm)* 
Reference diameter (mm)* 
Complex angiographic morphology (N) 
31 
24/7 
60 ± 10 
9 
31/25 
6 (all post MI) 
27 
23 
27 
14 ± 14 
13 
13 
5 
1.05 ± 0.50 
3.11 ±0./2 
16 
'" mean ± 1 SD, determined with quantitative coronary angiography. 
MI : myocardial infarction, i.v. : intravenous, LAD : left anterior 
descending artery, RCA: right coronary artery, ex : circumflex artery. 
Review Board of the Cardiology Department of the Dijkzigt Ziekenhuis and the 
patients were studied after giving informed consent. 
Procedures 
Selective coronary angiography in multiple projections was performed before and after 
angioplasry. All patients received aspirin (250 mg) and intracoronary nitroglycerin before 
the procedure. They were all on full anticoagulation with heparin, such that activated clot-
ting time was over 300$. During the procedure patients received a combination of diaze-
pam and thalarnonal intravenously to relieve an:dety and to promote comfort. 
After passage of a 0.014 in. guide wire across the lesion intracoronary imaging was perfor-
med before dilation. Angioscopy was always performed first, and there after intracoronary 
ultrasound imaging was carried out. The coronary segment proximal to the ischemia-rela-
ted lesion was imaged with the ultrasound catheter: In all cases an artempt was made to 
cross the lesion with both devices to obtain information about the entire lesion. Coronary 
angioplasty or orner interventional techniques were used according to standard practise. 
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Sekction of ischemic-related ksion 
The selection of the ischemic-related lesion for analysis with angioscopy and ultra-
sound imaging was determined as follows. In cases with single vessel disease the 
most severe lesion within that vessel was selected. In cases with multivessel disease 
the selection was determined by the combination of the electrocardiographic area 
indicated by transient ST-T segment changes occurring during ischemia at rest 
and the closely corresponding coronary vessel containing the most severe lesion. 
Angiography 
A modified classification of angiographic motphology proposed by Ambtose et 
al.20 was used to categorize each target lesion as non compie,'( (concentric or eccen-
tric with smooth borders) and complex (eccenrrir with irregular borders or over-
hanging edges; multiple irregularities or intraluminal filling defects). Segments 
proximal to the ischemia-related lesion were classified as having an angiographi-
cally smooth normal lumen, or minimally to moderately severe lumen irregulari-
ties. 
Quantitative coronary angiography was performed with the CAAS-2 system (PIE 
Data, Maastricht, The Netherlands) using the non contrast-filled catheter as cali-
bration.,"1 
Angioscopic device 
The percutaneous coronary angioscopic device is a monorail type polyethylene 
catheter device, which has a size of 4.5 F and which is accommodated by a 8 F 
guiding catheter (Baxter-Edwards; Irvine California). The catheter featutes a com-
pliant occlusive cuff, a flush port, guidewire compatibility and a movable optical 
bundle. The depth of field is > 1 mm and the minimum resolution 3.5 lp/ mm. 
During angioscopic imaging the distal coronary artery was flushed with saline 
injected with a flow of 30 to 40 cc per minute. 
To facilitate the review process a real-time fluoroscopy or cineangiography is com-
bined with real-time angioscopy and ultrasound imaging by using split screen 
videotaping. This provides a better orientation of where the angioscopic and ultra-
sound images were derived from within the coronary tree. 
Ultrasound imaging device 
This study was performed witb a commercially available inrracoronary ultrasound 
device (Cardiovascular Imaging Systems Inc., Sunnyvale, Calif). Images were 
obtained with a 4.3 F, 30 MHz ultrasound catheter. Tbe device produces real-
time images of vessel cross sections via the rotation of a metallic mirror at 30 revo-
lutions/s with an axial resolution of75 ~ and lateral tesolution of approximately 
150 }.lm.15 After optimization of the time-gain compensation, reject and compres-
sion settings images, were tecorded on high-quality videotape ($ VHS) fot off-line 
review and quantification. 
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Figure .1 
Angioscopic images of occlusive (A.) and non-occlusive (mural) red thrombus. 
Angioscopic images 
Thrombi were defined as a red, intraluminal masses adherent to the intima (Fig. 1). 
Thrombi were categorised as non-mobile-mural (closely adherent to the vessel 
wall) or mobile-protruding into t..'>e lumen or totally occlusive. Also noted was the 
colour of the lesion: grey/white and yellow suggesting underlying lipid pool. 
Wall surface was classified as ulcerated when major disruption with lack of conti-
nuity was found. \X7hen ulceration was absent but wall irregularities were noted, 
the surface was classified as irregular. Finally, when none of these alterations was 
present and the wall presented the characteristic pattern noted in normal non-ste-
notic segmentS the surface was classified as smooth. 
Angioscopic images of lesions were classified into a complex lesion if they had a 
irregular, ulcerated raised surface with or without presence of thrombus or into a 
stable lesion if the raised surface was regular and smooth, without thrombus.~6 
Reddish streaks were defined as non-raised reddish-pink areas within the coronary 
artery walL White masses were defined as white mobile protruding masses atta-
ched to the wall or in close association with a red thrombus. 
Vlrrasound images 
Qualitative analysis was performed by consensus of three observers. The composi-
<ion of the ischemia-related lesion was classified as calcified, hard, or soft (Fig. 2), 
concentric or eccentric and as homogeneous or mixed (Fig. 2). 
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Figure 2 
Types of ultrasound-derived lesions. A : soft plaque: poorly echoreflective tissue predominantly between 4 
and 5) 0 'clock. B: hard plaque: highly echoref/ective tissue with eccentric localization between 1 and 4 
o clock. C: calcific plaque: highly echortflective tissue with shadowing: almost entirely calcified lesion. 
D: mixed plaque: composed of soft plaque at 9-20 clock, hard plaque at 5-80 'clock and calcific plaque 
with shadowing at 2-30 "clock 
The following definitions were used, which were a reflection of previous studies:~2.25 
Calcific plaque: highly echo-reflective intimal thickening with acoustic shadowing 
representing the presence of calcium. 
Hard plaque: highly echo-reflective intimal thickening witham shadowing repre-
senring dense fibrous tissue. 
Soft plaque: poorly echo-reflective intimal thickening representing soft structures 
such as loose fibrous tissue, lipid, thrombus. 
Quantitative measurements included measurement of plaque area. Total vessel 
area was defined as the area central to the ultrasound-defined medial-adventitial 
boundary. Lumen area was defined as the area central to lumen-intimal boundary. 
Plaque area was calculated as the difference between total vessel area and lumen 
area. 
--170--
According to the distribution of atheroma, lesions were categorized as; 
Concentric lesions: atheroma distributed along the entire circumference of the ves-
sel wall in a cross-section, or as 
Eccentric lesions: atheroma involving part of the circumference of the vessel wall in 
a cross-section leaving a disease-free or minimal diseased part of the vessel walL 
The eccentricity of the plaque was determined using the ratio between thickest 
and thinnest pan of the intimal thickening. Eccentricity was defined by a tatio of 
more than 1.5. A soft or hard lesion was consideted homogeneous if the plaque 
consisted of> 75% of one type of lesion determined from an integrated pull-back 
image of the entire lesion. A calcified lesion was considered homogeneous if the 
intimal thickening occupied> 180 degrees of the vessel circumference. A mLxed 
soft/hard lesion was defined if the lesion contained both types of tissue. A mixed 
calcific lesion was defined as calcified intimal thickening more than 90 degrees of 
the vessel circumference in combination with a son or hard lesion. 
Statistical analysis 
All measured values are represented as mean ± standard deviation. Analysis of 
variance was performed by using the chi-square test with Yates correction applied 
when required. A p value < 0.05 was considered statistically significant. 
Results 
The introduction of the imaging catheters at the ischemia-related lesion was inva-
riably blood flow obstructive and in the majority ofrhe cases (25/31) associated 
with cheSt pain and electrocardiographic ST-T segment changes. These changes 
wete quickly reversible after withdrawal of the catheter. although in two patients 
abrupt occlusion occurred at the site of the ischemia related lesion. This was effec-
tively treated with balloon angioplasty, without adverse sequelae. The angioscope 
caused a small non-occlusive dissection in one patient. Subsequent balloon angio-
plasty resulted in an occlusive dissection which was effectively managed by stent 
implantation. In another patient the atherectomy guiding catheter caused an 
occlusive ostial dissection afi:er a technically successful procedure of a lesion in the 
RCA. A non-q-wave infarction developed (max. CK GOO UIl); the recovery was 
uneventful. 
In 4 cases the culprit lesion was not crossed with the angioscope, and the observa-
tions were restricted to the proximal aspect of the stenosis. In the 2 cases where 
the lesion could not be crossed with the ultrasound probe, the plaque composition 
and size were taken from POSt angioplasty examination. 
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Combined im4ging of ischemia-related lesion and coronary segment proximal 
to the lesion 
The data obtained with intracoronary angioscopy and ultrasound are shown in 
Table 2 and 3. The prevalence of red thrombus was not different in patients with 
unstable angina (12/19;63%) or early postinfuction angina (9/12;75%). White 
masses were found in 10 (32%) and reddish streaks in 6 (19%) of the patients. 
fable 2. Ang;oscopic characteristics 
of ischaemia related lesions 
(1\1=31) 
Thrombus 
-Occlusive 
-Mural 
-Protruding 
Surface lesion 
-Ulcerated 
-Irregular 
-Smooth 
Yellow plaque 
Stable plaque 
Complex plaque 
N(%) 
21 (68) 
5 (24) 
14 (67) 
2 (10) 
19 (62) 
6 (19) 
6 (19) 
11 (36) 
8 (26) 
23 (74) 
Twenty-nine of the ischemia-
related lesions were either predo-
minantly soft (13) or did have 
significant soft areas (16); only 2 
patients had a predominantly 
fibrous plaque without soft 
areas. The segments proximal of 
the ischemia-related lesion were 
diseased in all patients, although 
these segments were angiograp-
hically normal in 50% of the 
cases. The characteristics of these 
plaques are tabulated in Table 3. 
The relationship between the 
angioscopic-derived presence of 
a thrombus, the angioscopic-
derived surface characteristics of 
the lesion and the ultrasound-
derived composition of the pla-
ques is shown in figure 3. An ulcerated surface was associated with the presence of 
thrombus, whereas a smooth surface was noted more frequent in lesions without 
thrombus. 
Relation between coronary angiography and intracoronary angioscopy 
In figure 4 is shown that an angiographically-determined complex lesion is either 
almost always associated with an angioscopic determined ulcerated or irregular 
surface or is often associated with the presence of a angioscopic determined 
thrombus. A non-complex lesion is neither predictive of a smooth surface nor of 
absence of thrombus. 
Discussion 
Morphology of ischemia-related lesion 
Angiographic, morphologic and angioscopic studies have described the degrees of 
luminal narrowing, the angiographic characteristics of the lesions, and the presen-
ce of thrombus in patients with acute ischemic syndromes.l"'l1l.~O.~7-}~ Limited morp-
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Table 3. Intracoronary .. Itraso .. nd deriveli composition ischemia· 
related lesions and segments proximal to the lesion 
Stenoses Proximal 
N(%) Segments N(%) 
Total number 31 31 
Composition plaque 
-Soft 13 (87) 18 (95) 
-Hard 2 (13) 1 ( 5) 
-Calcific o ( 0) o (0) 
-Mixed 16 (52) 12 (39) 
-Soft/hard 5 (31) 1 (8) 
-Softlcalcific 1 ( 6) 3 (25) 
-Hard/calcific 0(0) 5 (42) 
-Soft/hard/calcific 10 (63) 3 (25) 
Eccentric 27 (87) 19 (61) 
Extent plaque (mm') 14.48 ±4.20 9.64 ±3.09 
hologic information is available on the composition of the individual coronary 
anerial atherosclerotic plaque in patients with unstable angina3U': and until now 
very limited information is available on the ultrasound derived composition of the 
plaque in living humans with unstable angina. 13 Recently, Kragel et al.-B have des-
cribed the composition of all atherosclerotic plaques in patients with unstable 
angina, shortly before death. They found that the major component of the pla-
ques consisted of a combination of dense acellular and cellular fibrous tissue (82% 
to 86%) whereas much smaller portions of the plaques were composed of pultace-
ous debris, calcium, foam cells and inflammatory infiltrates. No anempt was 
made to identifY the "culprit" lesion and whether the composition of this indivi-
dual lesion was different from the "stable" lesions. This may explain their findings 
that the volume of lipid deposition apparently did not playa significant role in 
unstable patients, which is contrary to the opinion that unstable plaques are pla-
ques which often contain an extensive volume of extracellular lipid.3L34 
Hodgson et al. U performed a morphologic analysis of the ultrasound images obtai-
ned from ischemia-related lesions in patients with unstable angina. They found 
that in these patients soft lesions were present in 74%, and calcified or fibrocalci-
fic lesions in 25%. There were only few intralesional calcium deposits (16%). 
In our study we confirmed that the majority of the ischemia related lesions were 
either predominantly soft lesions or contained areas with soft material, as defined 
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Relationship between angioscopic-derived presence of thrombus, the angioscopic-derived surface 
characteristics of the lesion and ultrasound-derived composition of the plaque. 
above. However, these findings should be interpreted with caution because, alt-
hough soft lesions are thought to represent lipid-containing lesions, ultrasound 
images cannot distinguish between loose fibrous tissue, lipid-rich lesions and 
thrombus. 
We confirm previous angioscopic studies'+l:> which also demonstrated that ulcera-
ted plaques with some degree of associated thrombus were present in the majority 
of the cases, and that components of the lesion were yellow coloured in one-third 
to about half of the cases. 16 However, in 23% of the patients the ischemia-related 
lesion was smooth, and not associated with thrombus suggesting that possibly 
other mechanisms than plaque disruption and thrombus formation may playa 
role. In our study we found that approximately one-third of the lesions was 
yellow. This rather low frequency may be related to the insensitivity of angioscopy 
to discern yellow components of the plaque~ and to the criteria used in our study, 
where, in order to be avoid pitfalls such as colour distortion, an adjacent area of 
normal (white) arterial wall was requiered to qualify as xanthomatous plaque. 
Another possibility is that the yellow components of the plaque are covered by the 
overlying red thrombus and thus escape detection or the fibrous cap is too thick 
rendering the lipid-pool invisible. Angioscopy also revealed the presence of white 
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characteristics a/the lesion and angioscopic-derived presence of red thrombus. 
masses at the site of the ischemia-related lesion. These white masses possibly may 
represent early platelet rhrombi, organized thrombi or intimal flaps covered with a 
thick layer of fibrin. Since we were not certain of their nature, we decided to clas-
suy them objectively as white masses. In 6 patients we found reddish streaks in the 
wall of the coronary arrery. These streaks may represem areas of bleeding within 
the wall. 
The data provide furrher evidence for the theory that plaque disrup<ion of a 
fibrous cap overlying a lipid-rich lesion which is followed by non-occlusive throm-
bus formation occurs frequent in patients with unstable angina pectoris or early 
postinfarction angina. 
Possible consequence for the management unstable angina 
The major recognised physiopathologic mechanisms underlying unstable angina 
include a) plaque fissuring. which sets into action a complex imerplay of b) plate-
let activation, adhesion and aggregation c) activation of coagulation system with 
formation of a transient, labile intraluminal thrombus and d) increased vasocons-
triction by the platelet release of vasoactive products, serotonin and thromboxane 
and producrion of thrombin in combination with abnormal endothelial derived 
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relaxing factor modulated vasomotor response caused by endothelial dysfunction. 
All these eventS culminate into transient vessel occlusion and myocardial 
ischemia. 1 In the clinical setting of unstable angina it is largely speculative which 
of these mechanisms is dominant ar a certain period. This precludes the employ-
ment of a more specific causal-related treatment. In an individual patient one 
assumes that all these mechanisms are operative at the same time and pragmati-
cally treatment: is directed to counteract all these mechanisms. Thus treatment 
includes antiplatelet aggregation, anticoagulation, and vasodilation in combina-
tion with treatment directed towards reduction in myocardial ox-ygen demand 
such as bedrest, reduction in both heart rate (~-blockers), and preload or afterload 
(systemic and arterial vasodilators). In addition thrombolytic treatment has also 
been used, but a large body of evidence is available indicating that thrombolytic 
treatment is, surprisingly, not efficacious in the setting of unstable angina.35.r This 
is the more surprising because of the expected high frequency of thrombi in these 
patients. It could be argued that these thrombi are resistent to thrombolytic treat-
ment because they represent older organized thrombi. 
The majority of the patients with unstable angina can be stabilized, and the pre-
sence and extent of remaining ischemia dictate further management. However, 
despite our increased knowledge, the mortality and infarction incidence in these 
patients remains high. Knowledge of the composition of the plaque and vessel 
wail, in combination with information about the presence of thrombus or com-
plex plaque as can be offered by intracoronaty angioscopy and ultrasound may 
increase our understanding and may allow better individualisation of patient 
management. 
A severe, concentric lesion, composed of "hard" tissue (fibrocalcific or predomi-
nantly calcific) may be indicative of low likelihood of a beneficial response to 
pharmacological therapy and may require early revascularisation. A vety soft lesion 
may be more amenable to remodelling and initial pharmacologic treatment, inclu-
ding cholesterol lowering drugs, may stabilize or reduce this lesion. An eccentric 
lesion with a opposite normal disease free vessel wall capable of dilatation may 
suggest that vasomotion does playa significant role and may require intensive use 
of vasodilator treatment.5S The presence of an angioscopically determined smooth 
stable lesion may be a significant clue to suspect vasomotion as a major pathoge-
nic mechanism. An occlusive red thrombus or the presence of abundant non-
occlusive thrombus, easily detected by the angioscope, may suggest that adjunctive 
thrombolytic treatment is useful, whereas mural, non-occlusive thrombus, often 
seen in these patients may nOt require adjunctive thrombolytic therapy. 
Information about the location of the thrombus in the lesion may enhance treat-
ment. At the apex of the lesion a high-shear rate induced white platelet thrombus 
is formed" which is resistent to aspirin and probably requires therapy directed 
against von Willebrand FactOr specific domain on CPIIb-IIIa and CPIb.""··" 
Proximal and distal of the lesion a low shear rate red coagulation thrombus is for-
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med; the latter is often angiographically visible as a free floating tail. Aspirin, 
heparin or thrombolytics may be required in these situations. 1.:'.9 
Knowledge of the composition of the plaque may optimize the selection of an 
appropriate intervention technique. Calcific lesions may be more amenable to 
rorablation techniques or non-calcified eccentric lesions may be better suitable to 
directional atherectOffiY. Calcified target lesions have a higher likelihood of dissec-
tion after balloon angioplasry. 
Limit:ations of this study 
This study was performed in unstable patients having angina at rest class nIB or 
early postinfarction angina class HIC according to the Braunwald classification 
and selected for balloon angioplasry. They represent only a sample from the broad 
spectrum of patientS with unstable angina and thus precludes generalisation of the 
findings. 
Unstable angina pectoris is a dynamic process with different pathophysiologic 
mechanisms which waxe and wane over time. In this study the images were obtai-
ned only once, and the presence of certain processes may have been missed. Only 
longer-term monitoring would resolve this problem. 
The current available imaging devices are yet still bulk)' and stiff. Somerimes the 
ischemia-related lesions could not be crossed, so that entire interrogation of the 
lesion was not always possible. Even, after crossing the lesion, certain aspects may 
escape detection because the current angioscopic design does not include a flexi-
ble, steerable feature so that the entire surface area cannot always be inspected. 
Also, stmcmres lying behind calcific lesions cannot be detected with ultrasound 
because the plaque prevents penetration of the ultrasonic beam. 
Cerrain features may have been missed because the device may have detached 
thrombi or other structures or during angioscopy loosely attached thrombi may 
have been flushed away. 
Currently, assessment of angioscopy and ultrasound images, is qualitative, and 
thus subject to differences in interpretation. In the near future 3-dimensional 
reconstructed longitudinal display of ultrasound images of lesions may provide a 
more accurate delineation of e..xtent and composition of the plaque and may allow 
quantification of the lesions:l~ 
Final remarks 
Sequential imaging of the ischemia-related lesion with intracoronary angioscopy 
and ultrasound is feasible, and currently only safe in the setring of patients who 
are scheduled for coronary intervention. Inadvertent damage to the lesion can be 
reversed by immediate angioplasry. The obtained information is complementary 
and adjunctive to coronary angiography. Angiography defines the contour of the 
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lumen of the vessel, provides information about extent and severity of coronary 
atherosclerosis along the entire coronary tree and provides rather crude qualitative 
information abour antegrade blood flow (TIM! 0 to 3) or presence of collateral 
flow. In addition it serves as the necessary road map for angioscopic and ultra-
sound catheters. Angioscopy provides direct information about the endovascular 
surface that is relatively easily interpretable. Ultrasound imaging provides infor-
mation about the wall thickness and composition of the lesion. 
The integrated information substantiates some of the suggested mechanisms in 
the pathogenesis of unstable angina. Soft, lipid-rich plaques are prone to rupture 
and subsequent thrombus formation. However, in some patients the dominant 
paradigm of the syndrome could nOt be confirmed. It remains speculative to pro-
pose that this happened because the fissuring or thrombus formation were roo 
transient and too subtle to be detected, or because other pathogenetic mechanisms 
may have played a role in these patients. Further miniaturization of these devices 
will allow investigation of the lesions without the necessity for subsequent coro-
nary intervention and is expected to provide useful additional information to 
improve patient management and prognosis. 
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Abstract 
Background 
Automated stenosis analysis is a common feature of commercially available quantitative angiography 
systems (QC4), allowing automatic detection of the proximal and distal boundaries of the stenosis, 
interpolation of the expected dimensions of the coronary vessel at the point of obstruction, and angio-
graphically-derived estimation of atheromatous plaque size. However, the ultimate meaning of this 
type of analysis as to the degree of underlying atherosclerotic disease lAD) remains unclear. 
Aim of the study 
We investigated the relationship between stenosis analysis performed with the G4AS system and the 
underlying degree of atherosclerotic disease as judged from intracoronary ultrasound (I CUS) imaging. 
Methods 
In 40 coronary stenoses QC4 was used for automated identification of the sites of maximal luminal 
obstruction and start of the stenosis using curvature analysis of the diameter function. Plaque size was 
mel1SUred using [CUS at both locations, with an additioruzl [CUS measurement immediately proxi-
mal to the start of the stenosis. Crescent-like distribution of plaque, indicating an ADfee arc of the 
arterial wall, was recorded. 
Results 
At the site of the obstruction total vessel area mel1Sured with [CUS was 16.65±4.04 mm', while an 
equivalent measurement obtained from interpolated reference dimensions was 7.48±3.30 mm:', 
(p=0.0001). Plaque area derived from angiographic data was significantly lower than that calculated 
from intravascular ultrasound data, (6.32±3.21 and 13.29±4.22 mm', respectively, mean difference 
6.92±4.43 mm', p=O.OOOl). At the site identified as the start of the stenosis by automated analysis, 
[CUS luminal cross-sectional area was 9.38±3.17 mm', and total vessel area was 18.77±5.19 mm', 
(50±11 % total vessel area stenosis). The arterial wall presented a d.iseasefee segment in 28 (70%) of 
proximal locations, but only in 5 (12%) sites corresponding to the start of the stenosis and no at the 
obstruction (p=0.0001). At the site of obstruction all vessels showed a complete absence of a disease 
free segment, and the atheroma presented a cufflike or all-around distribution with a variable degree 
of eccentricity. 
Conclusions 
1/ AD was consistently present at the start of the stenosis used as a reference site by automated stenosis 
analysis. 21 The mean degree of AD involvement at the start of the stenosis was 50% total area steno-
sis. 31 A significant change from crescent to all-around distribution of AD was found at the start of 
the stenosis. These findings suggest that the start of the stenosis identified by automated stenosis analy-
sis represents the point where compensatory vessel enlargement fails to preserve luminal dimensions, 
and provide insights on the mechanisms involved in this phenomenon. 
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Introiluction 
During its relatively shorr history. the role of coronary angiography as a standard 
in the assessment of coronary artery disease has been challenged by two rypes of 
limitations. First, visual assessment of stenosis severity from the cineangiogram is 
associated with a high intra- and interobserver variability.1 .. ' Second, major discre-
pancies between the appearance of the opacified vascular lumen and the actual 
degree of underlying atherosclerosis have been reported. 5•9 These can be due to the 
presence of extensive diffuse disease which affects the whole length of the opaci-
fied coronary tree, without a remnant "healthy" reference segment. More impor-
tantly, underestimation of the extent of atherosclerotic disease may occur due to 
the fact that during the development of both diffuse and focal atherosclerotic 
lesions coronary arteries undergo compensatory enlargement.10,11 
The advent of quantitative angiography has reduced significantly the first limita-
tion. Several quantitative angiography systems~ including the Cardiovascular 
Angiography Analysis System (CAAS) which was developed at our Institution, are 
capable of performing automated stenosis detection in a given coronary seg-
ment. 11.U Using information obtained from computerised analysis of the entire 
segment, automated analysis detects nOt only the proximal and distal boundaries 
of the stenosis, but also an interpolation of the expected dimensions of the coro-
nary vessel at the point of obstruction (a so-called interpolated reference). The 
angiographic estimation of the amount of atheromatous plaque derived from this 
data is also a common feature of commercially available quantitative angiography 
packages, which are likely to become more widely used since they are now built-in 
features of many modern digital angiographic systems. In spite of this~ it remains 
unknown whether the data calculated from automated stenosis analysis can provi-
de reliable information on the degree or presence of underlying atherosclerotic 
disease. The use of automatic stenosis detection techniques may reduce the varia-
bility associated with the arbitrary selection of a reference segment, being useful in 
longitudinal angiographic studies. However~ its basic premise, that is, that compu-
terised analysis of a large coronary segment encompassing the stenosis can identify 
the actual boundaries of the stenosis, has never been tested. 
Intracoronary ultrasound can provide information on the characteristics of the 
arterial waIL1',.15 This characteristic justifies its growing application in the study of 
atherosclerotic coronary artery disease~ 15-22 and its proposal as an alternative gold 
standard to coronary angiography. 1·, However, comparisons between intracoronary 
ultrasound and quantitative angiography have been confined only to its ability to 
measure luminal dimensions, and never used to investigate the significance of 
other findings obtained during automated stenosis analysis.1" 
The objective of this study was twofold. First, we wanted to investigate with intra-
coronary ultrasound the characteristics of the arterial wall at the site identified by 
automated stenosis analysis as the proximal boundary of the stenosis, since pre-
--J86--
vious studies with quantitative angiography have assumed the absence of atheros-
clerotic disease at this location for the calculation of interpolated refernce dimen-
sions.23 Secondly, we were interested in assessing whether, at the site of maximal 
luminal obstruction, the amount of atheroma derived from automated stenosis 
analysis reflects the degree of atherosclerotic involvement as judged by intracoro-
nary ultrasound. 
Methods 
Patient population 
The study population consisted of forry patients (31 male and 9 female) with de 
novo coronary stenosis undergoing cardiac catheterisation immediately prior co 
percutaneous revascularisation. Mean age was 61±10 years. All investigations were 
approved by the Institutional Review Board of the Thoraxcenter, and patients 
were studied after giving informed consent. 
Quantitative angiography 
In this study both on line and off-line quantitative coronary angiography was per-
formed. On line measurements were performed immediately prior to intravascular 
ultrasound examination using a Philips DCI angiography system in conjunction 
with a commercially available quantitative angiography package (ACA, Philips, 
Eindhoven, The Netherlands). The results of the analysis, including the location 
of the beginning and end of the stenosis, as well as the point of maximal luminal 
obstruction identified by the computerized analysis, were permanently displayed 
in a video monitor, serving as a guide for the operator during the ultrasound 
study. Coronary cineangiograms were also obtained and later analysed off-line in a 
3rd generation edge detection quantitative angiography system (CAAS 2, Pie 
Data, Maastricht, the Netherlands),'""" which uses a similar algorithm as the ACA 
for the purpose of stenosis identification and reference diameter interpolation. 26 A 
description of the consecutive steps followed during the analysis of the cineangio-
gram is given below: 
11 Image acquisition: End-diastolic angiographic frames showing the stenosed ves-
sel were selected. Using a CCD camera, a region of interest of 512x512 pixels 
encompassing a wide vascular segment proximal to the stenosis was selected in the 
cineframe and digitized for subsequent analysis (Fig. lA). 
21 Identification o/luminal edges: Following the identification of rhe vessel centerli-
ne by the computer algorithm~ a number of scanlines perpendicular to it were 
obtained. Luminal edges were detected on the basis of a weighted sum of the first 
and second derivative function of the brightness profile of each of these scanlines 
(Fig. IB). 
3/ Diameter fUnction: Vessel diameters were determined by computing the shortest 
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Figure :I. 
Quantitative angiographic analysis as performed in the present study. After a region of interest 
in the coronary angiogram showing a wide vascular segment encompassing the stenosis was 
digitised (Aj, luminal edges were identified using a contour detection algorithm (Bj. After 
calibration using the coronary actehter as a scaling device was performed plotting, the 
consecutive vessel diameters were plotted to create a so-coted vessel diameter fonction (C). 
Application o/specific algorithms to this function made possible the identification a/the poitn 
with minimal luminal diameter (solid bar) as well as the proximal and distal boundaries of 
the stenosis (dotted bars). Based in the diameter junction, the expected dimensions a/the vessel 
at the site olthe obstrnction (interpolated reference diameter) were calculated. (See text for 
detaiL) 
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distance benveen the left and right edge positions. These measurements were con-
vened to absolute values using the coronary guiding catheter as a scaling device. 
By plotting all consecutive diameter values obtained at approximately 0.2 mm 
intervals over the analysed vessellengrh, a so-called diameter function was created 
(Fig. I C). 
41 Identification of the start of the stenosis. Application of specific algorithms to the 
diameter function made possible the identification of vessel location where critical 
change in the diameter values occurred. In any coronary segment subject of analy-
sis it is possible to observe dips in the diameter function resulting from changes in 
luminal diameter or image noise. To discriminate between these artifactual chan-
ges and the actual change in luminal diameter associated with the start of a steno-
sis, the diameter function is analysed in the CAAS II system using a curvature 
detection algorithm which identifies maxima in curvature using variable degrees 
of smoothing. The algorithm is nearly identical to that described by Rosenfeld 
and Johnston." The proximal and distal boundaries of the obstruction are defined 
by the positions featuring the first local maximum in curvature in proximal and 
distal directions respectively with respect to the minimal diameter position. The 
extent of the stenosis is indicated in the diameter function by twO dotted lines as 
is represented as a shaded area superimposed on the artery (Fig. I C) 
51 Identification of the site of obstruction. From the diameter function, the site of 
obstruction is identiEed as that corresponding to the lowest diameter value in the 
segment encompassed berv:.reen the start and end of the stenosis. 
61 Interpolated reference diameter. The third parameter derived from the analysis of 
the diameter curve is the interpolated reference diameter. After the creation of a 
first degree polynomial computed through the diameter values of the proximal 
and distal portions of the anerial segment, a translation to the 80th percentile 
level was performed. Combining this information with the location of the obs-
truction, the expected diameter of the vessel at the site of minimal luminal diame-
ter was calculated. In this way, a correction for the expected changes in vessel dia-
meter between the start and end of me stenosis, such as those resulting from the 
origin of side branches. is introduced. 
71 Angiographically-derived plaque area. Based in the above discussed premises, pla-
que area was defined as the difference between the interpolated and luminal 
dimensions at the obstruction site (Fig. 2A). This is a variation of the calculation 
of plaque area performed in the CAAS and other commercially available sys-
tems11.13 in the longitudinal axis (Fig. 1 B), and was chosen to facilitate itS compa-
rison with cross-sectional areas measured during intravascular ultrasound (Fig. 2B). 
Intravascular ultrasound 
Intravascular ultrasound was performed using a 30 MHz intravascular ultrasound 
system (Cardiovascular Imaging Systems, Inc., California). Collection of data was 
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Method used for the calculation of atherosclerotic plaque area using quantitative angiography and 
intravascular ultrasound. Assuming a circular cross section. plaque area WI1S calculated from quantitative 
angiography as the difference between the arctlS derived jT()m the interpolated reference (lnt.Re/D) and 
minima/luminal (MID) diameters. Plaque area was defined with intravtlScular ultrasound imaging as 
the difference between the areas comprised within the media! and luminal boundaries, obtained directly 
from planimetric measurements. 
restricted to the pre angioplasty stage. The observer was free to adjust gain, mag-
nification and other settings of the ultrasound system to obtain optimal visualiza-
tion of the plaque and luminal borders. Particular attention was paid to ensure 
that the collection of echocardiographic data matched the sites identified by QCA 
as the beginning of the lesion and the obstruction site. In order to do this, on-line 
quantitative analysis was performed and displayed in one of the monitors to be 
used as a reference during the procedure. Once the stenosis was crossed with the 
guidewire, the operator was free to perform any Contrast injection, maneuver with 
the guiding catheter that were required in order to advance safely the ultrasound 
catheter until a location distal to or wedged in the stenosis. This location was 
documented by COntrast injection. A slow pull back of the ultrasound catherer was 
then performed, documenting its location with new contrast injections at the 
points identified by quantitative angiography as the obstruction site, beginning of 
the lesion and its adjacent proximal site. During the whole procedure, simultane-
ous recording of fluroscopy and echocardiographic images was performed using a 
digital videomixer. This facilitated later the correlation becween ultrasound images 
and the location of the echo probe in the opacified vessel. Furthermore, the loca-
tion of the echo probe was documented in pre-designed printed forms during the 
procedure, using the time counter of the echo machine (which was recorded along 
the images) as a temporal landmark. After the procedure, off-line area measure-
ments in the locations of interest were performed using digital planimetry which 
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Figure 3 
Intravascular ultrasound findings at the site proxima! to the stenosis (AJ, at the start a/the stenosi~' as 
defined by automated stenosis analysis (B) and at the site of maximoJ lumina! obstruction (C), defined 
also by automated ,I'teno,,·js analysis. Note the marked change in distribudon of atheroma around the 
lumen (centre of the cross-hair) at the three U'Ve/s. 
is a build-in feature of the described ulrrasound system. Total vessel area was defi-
ned as that comprised within the echolucent medial layer, while luminal area as 
that comprised within the luminal edges. Plaque area was defines as the difference 
between total vessel and luminal areas. All measurements were performed inde-
pendently in twO separate sessions by cwo observers with expertise in intravascular 
ultrasound. 
Exclusion criteria 
Vessels with anatomical features that interfere with computerized stenosis analysis, 
including ostial lesions where a proximal segment of the vessel was not present, 
and total or functional occlusions with incomplete opacification of the coronary 
segment distal to the stenosis,were excluded from the study. 
Statistical analysis 
Mean ± standard deviation were calculated for all continuous variables. Least 
squares linear regression 3.i.,alysis was performed and correlation coefficients calcu-
lated. Continuous variables were compared using ClNo-tailed paired and unpaired 
Student's t test as required. Bonferroni correction was applied when comparison 
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between more than 2 groups were done. A p value less than 0.05 was considered 
statistically significant. 
Results 
Findings at the site of obst:ruction. 
In the 40 patients studied, quantitative angiography revealed a minimal luminal 
cross-sectional area of 1.24±L 12 mm::. At the site of obstruction, intravascular 
ultrasound yielded a luminal area of2.80±J .64 mm'. Wedging of the catheter was 
observed in 24 cases (60%). In the J6 cases where the ultrasound catheter was not 
wedged a good correlation between angiographic and intravascular ultrasound 
luminal measurements was observed (r=0.78, p=0.0002). 
At the site of the obstruction intravascular ultrasound revealed a tOtal vessel area 
of 16.65±4.04 mm' (83±1 0% total vessel area stenosis). This was significanrly lar-
ger than that calculated from the interpolated reference dimensions obtained with 
quantitative angiography (7.48±3.30 mm', p=O.OOOJ). Thus, quantitative angio-
graphy underestimated the dimensions of the original vessel as assessed with intra-
vascular ultrasound. As a result of this differences, plaque area derived from angio-
graphic data was significantly lower than that calculated from intravascular ultra-
sound data, (6.32±3.21 and J3.29±4.22 mm'respectively, mean difference 
6.92±4.43 mm', p=O.OOOJ). Regression analysis yielded a correlation coefficient 
between both estimates of plaque size of 0.23 (R-squared =0.05, p=NS). 
Findings at the start of the stenosis and in the proximal vessel 
At the site identified as the starr of the stenosis by automated analysis, intravascu-
lar ultrasound cross-sectional area was 9.38±3.17 mm', and total vessel area was 
18.77±5.19 mm' (50±11 % total vessel area stenosis). Significant differences were 
found in the distriburion of the atheromatous plaque around the lumen in the 
proximal vessel, start of the stenosis and site of the obstruction. Thus, the arterial 
wall presented a disease-free segment in 28 (70%) of proximallocarions, but only 
in 5 (12%) sites corresponding to rhe starr of the stenosis and no at the obstruc-
tion (p=O.OOOl)(Fig. 2). At the site of obstruction all vessels showed a complete 
absence of a disease free segment, and the atheroma presented a cuff-like or all-
around distribution with a variable degree of eccentricity 
Discussion 
From a historical point of view, the reason for the development of computerized 
analysis of the stenosis was to reduce the variability associated with arbitrary selec-
tion for the user of a reference segment, since atherosclerotic involvement could 
be demonstrated at that location.18.19 Coronary angiography represents a "lumino-
gram" or "shadowgram" of the vessel, and its visual interpretation conveys little or 
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Scht??Zatic represenuztion a/the findings in the present study. Proxima! to the stenosis rAj, as defined by 
automated stenosis analysis (solid arrows in the diameter junction), atheroma caused a mean vessel stenosis 
0[40%. At the site idm.tified as the proximal boundary o/the stenosis mean vessel (B) stenosis was 50%, 
progressing to 83% at the site of maxima! obstntction (C). The discrepancy with plaque size calculated 
from the interpolated reference diameter (dotted line) may be related either to the incorrect assumption 
that at the start of the stenosis no disease was present, or to outward expansion of the plaque due to 
compensatory enlargement. 
no information as to the extent of atherosclerotic disease in the arterial wall. 
Studies comparing angiographic and pathological data have demonstrated that 
visual interpretation of the angiogram underscores the degree of underlying disea-
se both at the site of the obstruction and in segments which are apparendy free of 
disease. 5-9 Thus, although the advent of early quantitative angiographic systems 
had facilitated a more accurate assessment of luminal obstruction, choosing a refe-
rence coronary segment for clinical purposes such as the calculation of relative 
measurements of stenotic severity remained associated with high variability and 
Inaccuracy. 
In an attempt to find a solution to these problems, several automated methods of 
analysis of the luminal dimensions have ,Deen developed",13 with the aims of provi-
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figure 5 
Change in the distribution pattern of atheroma in the analysed vesseL Proxima! to the start of the stenosis 
(as defined by automated analysis) most vessels presented it characteristic crescent-like distribution of 
atheroma, with an apparently disease-free arc of the vessel waIL A significance change }Tom this pattern to 
a cuff-like or afl-around distribution of atheroma at the sites defined as the start of the stenosis and 
maxima! obstruction was noted The dissapearence of the disease-free arc in the vascular wall may 
constitute the landmark for the foilure of compensatory mechanisms of ve.'sci enlargement that preserve tha 
vascular lumen during the early stages of atherosclerosis progression. 
ding objective identification of the boundaries and length of the stenosis and 
identifying a segment apparendy free of atherosclerotic disease to be used as a refe-
rence during me calculation of relative measurements, and for the application of 
interpolated reference techniques. As we have described above, rhe approach follo-
wed by rhe CAAS sysrem consisrs in applying specific algorithms to a so-called 
diameter function, obtained by plotting all consecutive luminal diameters in the 
vascular segment encompassing the stenosis. However, the relationship between 
computerized analysis of the luminal dimensions in a segment that encompasses a 
stenosis and me underlying degree of atherosclerosis has not been previously stu-
died. 
The possibility of inferring information on the degree of underlying atherosclero-
tic disease from such computerized analysis of luminal dimensions would be sup-
ported by rhe concepr thar arherosclerosis is a focal" and not diffUse''-'' process. In 
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this regard, Baroldi et al." found in a pathological study of 565 athe-
rosclerotic coronary vessels that the length of coronary lesions was less 
than 5 mm in 13%, between 5 and 20 mm in 38%, and mote than 
20 mm in 490/0 of cases. Thus, a substantial number of coronarY 
lesions have a length covered by conventional computerized angio'-
graphic analysis of a vascular segment. 
Our observations with intravascular ultrasound indicate that atheros-
clerotic involvement at the site identified by QCA as the start of the 
lesion is common. Therefore, the site identified by the curvature 
detection algorithm in the diameter function does not correspond, as 
first thought, to a coronary location free of atherosclerotic disease. 
Interestingly, we found that at this level total vessel area stenosis is 
quite similar to that found by Glagov et al. W to be related with the 
failure of compensatory mechanisms of vessel enlargement, which is 
observed during the early phases of atherosclerosis progression. lo The 
observations reported by other authors in coronary segments with 
minimal or no luminal narrowing as assessed by angiography suppOrt 
our findings. In such segments tOtal vessel area was occupied by athe-
roma in 35±23% and 45±15% in the work of Tobis" and Hodgson" 
respectively. Although these observations were performed with a diffe-
rent aim, and therefore the collection of data was not matched with 
computer analysis of the stenosis, it is fair to conclude that protrusion 
of atheroma into the lumen probably does not occur below a atheros-
clerotic involvement causing 500/0 reduction in total vessel area, 
which is located at the stan of the angiographic stenosis. Based on 
these observations, we can formulate the first conclusion of our study 
by saying that the proximal boundary of the stenosis identified during 
automated stenosis analysis with the CAAS system does not corres-
pond to a location free of atherosclerotic disease but, presumably, 
where the compensatory mechanisms of vessel enlargement fail in 
preserving luminal dimensions. 
Some qualitative observations with intracoronary ultrasound in per-
formed in the present study may provide new insights on the mecha-
nisms underlying compensatory vessel enlargement. We found that at 
the level of the proximal boundary of the stenosis there was a signifi-
cant change in the distribution of the atheroma around the coronary 
lumen when compared with more proximal locations. This consisted 
of a change from a crescent-like panern of atheroma, which was the 
dominant pattern in a proximal location , to a cuff-like pattern at the 
start of the stenosis. At the point of maximal luminal obstruction, 
only this latter pattern of atheroma distribution was observed, an 
observation that fits with the findings of Hanganner et al.3'1 in a pat-
hological study. The loss of an arc of disease-free wall, characteristic of 
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the crescent-like distribution of atheroma, may, as first proposed by Glagov,'" be crirical 
in the loss of compensatory vessel enlargement, a phenomenon that, as the present 
study suggests, can be observed at the Start of the stenosis as defined from computerized 
analysis of the angiogram. Previous work has demonstrated that in the presence of a 
nonna! arterial wall, vessel enlargement occurs in circumstances of increased shear ratc, 
a phenomenon that appears to be endothelium-mediared.·" During the progression of 
coronary artery disease, reactive expansion to the increased shear stress may constitute 
the basis of compensatOry vessel enlargement, but it would be e.~pecred that would 
disappear when a complete loss of normal reactive wall occurs." The abolishment of 
such compensatOry response might be due to complete encroachment of the lumen by 
atheroma, leading to a rapid decrease in luminal dimensions caused by inward growth 
of the atheromatous plaque. Tills phenomenon might explain the disproportionately 
larger degree of progression in the reference diameter found in a major srudy on ame-
rosclerosis regression,37 since a relatively small progression in the disease process propitia-
ted by disturbances in flow caused by the neighbor narrowing'" may have led to the cri-
tical loss of a remnant arc of reactive vessel wall. These findings complement previous 
intravascular ultrasound" and pathological observations-" on the presence of multiple 
crescents of atheroma in "angiographically normal" coronary segments, representing 
foci of atheroma progression that have not caused luminal obliteration due to ongoing 
compensatory enlargement. 
Finally, we also observed that interpolated techniques are of no use in obtaining a relia-
ble estimare of the Wlderlying plaque area. The basic premise of tills principle could be 
stated by saying that at the point of minimal luminal narrowing the interpolated refe-
rence area should be representative of that comprised within the internal elastic lamina. 
However, we fOWld that the interpolated refetence area calculated by quantirative 
angiography was significantly smaller than total vessel area observed with intravascular 
uluasoWld. This may be pardy due to the initial flllure of the curvature detection algo-
rithm to identifY a segment where no disease was present on which the interpolation 
could be based. A second source of error could be due to compensatOry vessel e.nlarge-
ment may have occurred. 
We believe that the observations performed during this srudy introduce a change in the 
concepts mat are routinely used in quantitative coronary angiography with regard to 
automated stenosis analysis. 
study limi=Wns 
Since wed"oing of the uluasoWld catheter was required in a numbet of cases in order to 
visualize vessel wall at the site of maximal obstrUction. distortion of the vessel at that site 
may have occurred. However, since atheroma is not compressible, we believe that this 
would not influence substantially the measurement of plaque size nor the distribution of 
atheroma (which, as stated above. was distributed circumferentially aroWld the lumen at 
that level). Tracing of luminal and medial boWldaries was performed manually, and there-
fore subjectively. The calculation of plaque area from angiographic dimensions was perfor-
med assmning circular morphology for both the lumen and the internal elastic lamina. 
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Conclusion 
In this thesis three novel intracoronary tools available to the interventional cardio-
logist were used to investigate the characteristics of coronary atheroma in different 
coronary syndromes. The working hypothesis was that in-vivo imaging and sam-
pling of the atheromatous plaque might constitute complementary approaches in 
studying the pathobiological substrate of coronary atheroma, shedding further 
insights to the information which has been provided by post-morrem studies, 
which have been the main source of knowledge in this area. The basis for this 
hypotesis was that atherectomy specimens and intracoronary images provide 
information on an ongoing coronary syndrome, whereas the study of necropsy 
material is biased by restriction to the extreme of the clinical - and presumably 
pathological - spectrum of me syndrome. 
\X7hen atherectomy specimens are used as a form of biopsy of the target coronary 
stenosis, the researcher can make use of cell culture and molecular biology techni-
ques, in addition to conventional histopathological techniques, to infer informa-
tion as to the ongoing biological processes in the plaque, therefore the term "patho-
biology" used in me heading. On rhe other hand. atherectomy specimens do not 
provide information on the overall structure and spatial distribution of atheroma 
in the arterial wall, posing problems similar to those of the anthropologist using a 
single bony fragment retrieved in an archaeological dwelling to infer information 
on me skull from which it was originally derived. 
Patilobiological observations in coronary atheroma from patients 
with unstable ang"'in"'a"--__________________ _ 
With these principles in mind, a srudy of the pathological substrate of unstable 
angina was undertaken as one of the main subjects of this thesis to determine 
whether the information collected in-vivo with intracoronary techniques confirm, 
complement or challenge the current paradigm of the pathogenesis of primary 
unstable angina as a predominantly thrombotic syndrome secondary to plaque fis-
suring or disruption, which is largely based on post-mortem studies. 
Histological and angioscopic findings 
The information obtained substantiated aspects of previous autopsy studies, such 
as a higher prevalence of thrombotic material in unstable than in stable patients, 
or the presence of lipid-rich plaques in patients with post-infarction angina. More 
importantly, new insights on the substrate of unstable patients refractOry to medi-
cal treatment were obtained. Four major dues as to the thrombotic characteristics 
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in the population were provided. First. the overall prevalence of histological 
thrombus in unstable patients was lower than previously reported in necropsy 
studies, an observation complemented in further studies with intracoronary 
imaging which demonstrated that intraluminal thrombus causes significant 
obliteration of the coronary lumen in a relatively low percentage of unstable 
patients. Second, thrombus organisation was more common than expected 
from post-mortem studies, probably reflecting plaque evolution not interrup-
ted by fatal outcome. Third, the degree of organisation bore a poor relations-
hip with the time elapsed from the first episode of angina at rest, suggesting 
that the original thrombotic episode was frequently subclinical. Finally, 
thrombotic organisation was associated with a significant development of 
neointimal hyperplasia. 
Cell culture findings 
The smooth muscle cell has been relatively ignored in the pathogenesis of 
unstable angina, with more attention paid towards the mechanical and other 
cellular factors (eg distribution of tensile stress, infiltration by macrophages) 
which may contribute to destabilization and subsequent fissuring and throm-
bosis of the atheromatous plaque. A miniturised cell culture model was set up 
to study the functional characteristics of smooth muscle cells present in at:he-
rectomy specimens. Thrombus organisation was associated with an enhanced 
ability of these cells to colonise the surrounding culture environment, sugges-
ting a relationship between smooth muscle cell activation and plaque throm-
bosis which was probably causative in the disclosed development of neointi-
mal hyperplasia. 
From all the above, it is possible to speculate that some of the pitfalls in the 
pharmacological treatment of unstable angina are due to incomplete unders-
tanding of this evolving pathological substrate. The disappointing results of 
thrombolytic treatment in unstable patients, which might appear paradoxical 
under rhe current paradigm of unstable angina, are partially explained by the 
findings in this thesis from the comparatively low frequency of a lysable subs-
trate causing luminal occlusion. By promoting smooth muscle cell prolifera-
tion, thrombus organisation may cause plaque remodeling which results in 
accelerated luminal obstruction and clinical unstability. Furthermore, the use 
of angiography to assess thrombolytic therapy in unstable patients may have 
contributed to such confounding results, as some of the observations repor-
ted in this thesis, from eit:her histological analysis of retrieved atherectomy 
specimens or intracoronary angioscopy, cast doubts as to the actual relations-
hip between complex angiographic morphology and the presence of underl-
ying thrombus. Like in Plato; s myth of the cavern, angiography provides a 
mere shadow of the actual changes occurring in the vascular wall and lumen, 
which according to the belief in the current paradigm of the syndrome, is fre-
quently taken for real. 
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Pathobiology of accelerated atherosclerosis syndromes 
A second angle of research was to apply the techniques described above to compa-
re the pathobiology of de novo and restenOTIC atheromatous plaques. In agreement 
with other investigators, neointimal hyperplasia was frequently found in the latter 
group. Smooth muscle cell culture revealed significant differences in the growing 
characteristics of the cells, suggesting an enhanced potential in mose present in 
restenOTIC plaques. Furthermore, a significant gradient was observed in the reacti-
vity tOward extracellular matrix produced by smooth muscle cells from normal 
coronary media, primary atheromatous and restenotic plaque, the latter being the 
most reactive and promoting extensive platelet adhesion and spreading. Contrary 
to pathological studies, which cannot be sequential, patients in whom amerec-
wmy samples have been obtained may have a clinical, angiographic and, occasio-
nally, pathological follow-up - eg, either through subsequent directional atherec-
tomy or direct pathological srudy of the heart obtained at necropsy or after trans-
plantation. Taking advantage of this possibility, two studies were undertaken. 
First, the development of tviTO concomitant syndromes of accelerated atherosclero-
sis (restenosis and transplant allograph vasculopathy) was assessed in the long term 
in three cardiac transplant patients treated with directional atherectomy. Second, 
in a large population treated with directional atherectomy the results of smooth 
muscle cell culrure from the retrieved specimens were correlated with the develop-
ment of angiographic restenosis in the long term. A significant relationship was 
disclosed but, to our surprise, in an inverse fashion: smooth muscle cell outgrowth 
was associated with less restenosis at follow-up. This observation may have clinical 
relevance with regard to the use of atherectomy in selected patients. More impor-
tantly, when atherectomy is used to assess the baseline characteristics of the athe-
romatous plaque in longitudinal srudies, the researcher should be aware that the 
extraction of atheromatous tissue imposes a significant modification of plaque 
evolution, similarly as proposed by Heisenberg in the course of his work in experi-
mental physics in his famous uncertainty principle, stating that the actual practice 
of observation itself introduces modifications that invariably affect the interpreta-
tion of that observarion. 
Observations on a higher prevalence of neointimal hyperplasia in atherectomy 
specimens from primary lesions of younger patients reported in this thesis and 
which have received support from independent researchers, and serves as an exam-
ple of a clinical entity where potentially the pathophysiological mechanisms differ 
from the classic form of atherosclerosis. 
Comparison and validation of coronary imaging techniques 
Examination of tissue samples obtained during concomitant atherectomy appears 
as a valuable tool in providing an in-vivo validation of angioscopic observations, 
which may contribute to standarisation of the terminology used in coronary 
--203--
angioscopy. By the same token, intracoronary imaging can be used to validate 
other imaging techniques. The relationship bet\Veen angioscopy and intravascular 
ultrasound was explored. Furthermore, valuable insights on the significance of 
computerised analysis of the angiogram, now widely applied widespread due to its 
inclusion as a built-in feature of many digital angiography systems, were perfor-
med by using intravascular ultrasound. Changes in the distribution of coronary 
atheroma in the vessel wall kept a significant relationship with features identified 
by quantitative angiographic analysis, suggesting that protrusion of atheroma in 
the arreriallumen happens when encroachment of the lumen by atheroma occurs. 
This latter phenomenon is presumably due to the loss of compensatory enlarge-
ment provided by an arc of disease-free arterial wall, and has implications for our 
understanding of the progression of coronary atherosclerosis. 
final remarks 
It is foreseeable that generalisation in the use of intracoronary techniques for the 
in-vivo investigation of coronary atheroma will bring a diversification of atheros-
clerotic syndromes beyond the categories used currendy, in accordance with diffe-
rent etiological and physiopathological mechanisms. Some of the limitations of 
techniques which have been fundamental instruments in clinical and research 
fields, such as coronary angiography, emerges from the use of the results of this 
thesis. Revision of the results obtained previously, like the use of thrombolytic 
agents in unstable angina, by application of intracoronary imaging techniques 
may be anticipated in the near future. Likewise, a close, interdisciplinary work 
bet\Veen cardiologists, pathologists and basic scientists appears as a requierement 
to obtain full benefit from the new access to the coronary arteries of the living 
man facilitated by interventional cardiology techniques. 
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